<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge" /><script type="text/javascript">window.NREUM||(NREUM={});NREUM.info = {"beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"598a124f17","applicationID":"3007887","transactionName":"MQcDMkECCkNSW0YMWghNLDBwTCVCR1FRCVAlDQ8SQQwIXFZKHSNACg41A0sXJkl3d3s=","queueTime":0,"applicationTime":336,"agent":"","atts":""}</script><script type="text/javascript">(window.NREUM||(NREUM={})).loader_config={xpid:"VgUHUl5WGwAAVFZaDwY="};window.NREUM||(NREUM={}),__nr_require=function(t,n,e){function r(e){if(!n[e]){var o=n[e]={exports:{}};t[e][0].call(o.exports,function(n){var o=t[e][1][n];return r(o||n)},o,o.exports)}return n[e].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<e.length;o++)r(e[o]);return r}({1:[function(t,n,e){function r(t){try{s.console&&console.log(t)}catch(n){}}var o,i=t("ee"),a=t(15),s={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(s.console=!0,o.indexOf("dev")!==-1&&(s.dev=!0),o.indexOf("nr_dev")!==-1&&(s.nrDev=!0))}catch(c){}s.nrDev&&i.on("internal-error",function(t){r(t.stack)}),s.dev&&i.on("fn-err",function(t,n,e){r(e.stack)}),s.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(s,function(t,n){return t}).join(", ")))},{}],2:[function(t,n,e){function r(t,n,e,r,o){try{d?d-=1:i("err",[o||new UncaughtException(t,n,e)])}catch(s){try{i("ierr",[s,c.now(),!0])}catch(u){}}return"function"==typeof f&&f.apply(this,a(arguments))}function UncaughtException(t,n,e){this.message=t||"Uncaught error with no additional information",this.sourceURL=n,this.line=e}function o(t){i("err",[t,c.now()])}var i=t("handle"),a=t(16),s=t("ee"),c=t("loader"),f=window.onerror,u=!1,d=0;c.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(l){"stack"in l&&(t(8),t(7),"addEventListener"in window&&t(5),c.xhrWrappable&&t(9),u=!0)}s.on("fn-start",function(t,n,e){u&&(d+=1)}),s.on("fn-err",function(t,n,e){u&&(this.thrown=!0,o(e))}),s.on("fn-end",function(){u&&!this.thrown&&d>0&&(d-=1)}),s.on("internal-error",function(t){i("ierr",[t,c.now(),!0])})},{}],3:[function(t,n,e){t("loader").features.ins=!0},{}],4:[function(t,n,e){function r(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var o=t("ee"),i=t("handle"),a=t(8),s=t(7),c="learResourceTimings",f="addEventListener",u="resourcetimingbufferfull",d="bstResource",l="resource",p="-start",h="-end",m="fn"+p,w="fn"+h,v="bstTimer",y="pushState",g=t("loader");g.features.stn=!0,t(6);var b=NREUM.o.EV;o.on(m,function(t,n){var e=t[0];e instanceof b&&(this.bstStart=g.now())}),o.on(w,function(t,n){var e=t[0];e instanceof b&&i("bst",[e,n,this.bstStart,g.now()])}),a.on(m,function(t,n,e){this.bstStart=g.now(),this.bstType=e}),a.on(w,function(t,n){i(v,[n,this.bstStart,g.now(),this.bstType])}),s.on(m,function(){this.bstStart=g.now()}),s.on(w,function(t,n){i(v,[n,this.bstStart,g.now(),"requestAnimationFrame"])}),o.on(y+p,function(t){this.time=g.now(),this.startPath=location.pathname+location.hash}),o.on(y+h,function(t){i("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),f in window.performance&&(window.performance["c"+c]?window.performance[f](u,function(t){i(d,[window.performance.getEntriesByType(l)]),window.performance["c"+c]()},!1):window.performance[f]("webkit"+u,function(t){i(d,[window.performance.getEntriesByType(l)]),window.performance["webkitC"+c]()},!1)),document[f]("scroll",r,{passive:!0}),document[f]("keypress",r,!1),document[f]("click",r,!1)}},{}],5:[function(t,n,e){function r(t){for(var n=t;n&&!n.hasOwnProperty(u);)n=Object.getPrototypeOf(n);n&&o(n)}function o(t){s.inPlace(t,[u,d],"-",i)}function i(t,n){return t[1]}var a=t("ee").get("events"),s=t(18)(a,!0),c=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";n.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,n){var e=t[1],r=c(e,"nr@wrapped",function(){function t(){if("function"==typeof e.handleEvent)return e.handleEvent.apply(e,arguments)}var n={object:t,"function":e}[typeof e];return n?s(n,"fn-",null,n.name||"anonymous"):e});this.wrapped=t[1]=r}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],6:[function(t,n,e){var r=t("ee").get("history"),o=t(18)(r);n.exports=r,o.inPlace(window.history,["pushState","replaceState"],"-")},{}],7:[function(t,n,e){var r=t("ee").get("raf"),o=t(18)(r),i="equestAnimationFrame";n.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],8:[function(t,n,e){function r(t,n,e){t[0]=a(t[0],"fn-",null,e)}function o(t,n,e){this.method=e,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,e)}var i=t("ee").get("timer"),a=t(18)(i),s="setTimeout",c="setInterval",f="clearTimeout",u="-start",d="-";n.exports=i,a.inPlace(window,[s,"setImmediate"],s+d),a.inPlace(window,[c],c+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(c+u,r),i.on(s+u,o)},{}],9:[function(t,n,e){function r(t,n){d.inPlace(n,["onreadystatechange"],"fn-",s)}function o(){var t=this,n=u.context(t);t.readyState>3&&!n.resolved&&(n.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,y,"fn-",s)}function i(t){g.push(t),h&&(x?x.then(a):w?w(a):(E=-E,O.data=E))}function a(){for(var t=0;t<g.length;t++)r([],g[t]);g.length&&(g=[])}function s(t,n){return n}function c(t,n){for(var e in t)n[e]=t[e];return n}t(5);var f=t("ee"),u=f.get("xhr"),d=t(18)(u),l=NREUM.o,p=l.XHR,h=l.MO,m=l.PR,w=l.SI,v="readystatechange",y=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],g=[];n.exports=u;var b=window.XMLHttpRequest=function(t){var n=new p(t);try{u.emit("new-xhr",[n],n),n.addEventListener(v,o,!1)}catch(e){try{u.emit("internal-error",[e])}catch(r){}}return n};if(c(p,b),b.prototype=p.prototype,d.inPlace(b.prototype,["open","send"],"-xhr-",s),u.on("send-xhr-start",function(t,n){r(t,n),i(n)}),u.on("open-xhr-start",r),h){var x=m&&m.resolve();if(!w&&!m){var E=1,O=document.createTextNode(E);new h(a).observe(O,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===v||a()})},{}],10:[function(t,n,e){function r(t){var n=this.params,e=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<d;r++)t.removeEventListener(u[r],this.listener,!1);if(!n.aborted){if(e.duration=a.now()-this.startTime,4===t.readyState){n.status=t.status;var i=o(t,this.lastSize);if(i&&(e.rxSize=i),this.sameOrigin){var c=t.getResponseHeader("X-NewRelic-App-Data");c&&(n.cat=c.split(", ").pop())}}else n.status=0;e.cbTime=this.cbTime,f.emit("xhr-done",[t],t),s("xhr",[n,e,this.startTime])}}}function o(t,n){var e=t.responseType;if("json"===e&&null!==n)return n;var r="arraybuffer"===e||"blob"===e||"json"===e?t.response:t.responseText;return h(r)}function i(t,n){var e=c(n),r=t.params;r.host=e.hostname+":"+e.port,r.pathname=e.pathname,t.sameOrigin=e.sameOrigin}var a=t("loader");if(a.xhrWrappable){var s=t("handle"),c=t(11),f=t("ee"),u=["load","error","abort","timeout"],d=u.length,l=t("id"),p=t(14),h=t(13),m=window.XMLHttpRequest;a.features.xhr=!0,t(9),f.on("new-xhr",function(t){var n=this;n.totalCbs=0,n.called=0,n.cbTime=0,n.end=r,n.ended=!1,n.xhrGuids={},n.lastSize=null,p&&(p>34||p<10)||window.opera||t.addEventListener("progress",function(t){n.lastSize=t.loaded},!1)}),f.on("open-xhr-start",function(t){this.params={method:t[0]},i(this,t[1]),this.metrics={}}),f.on("open-xhr-end",function(t,n){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&n.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid)}),f.on("send-xhr-start",function(t,n){var e=this.metrics,r=t[0],o=this;if(e&&r){var i=h(r);i&&(e.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"===t.type&&(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof n.onload))&&o.end(n)}catch(e){try{f.emit("internal-error",[e])}catch(r){}}};for(var s=0;s<d;s++)n.addEventListener(u[s],this.listener,!1)}),f.on("xhr-cb-time",function(t,n,e){this.cbTime+=t,n?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof e.onload||this.end(e)}),f.on("xhr-load-added",function(t,n){var e=""+l(t)+!!n;this.xhrGuids&&!this.xhrGuids[e]&&(this.xhrGuids[e]=!0,this.totalCbs+=1)}),f.on("xhr-load-removed",function(t,n){var e=""+l(t)+!!n;this.xhrGuids&&this.xhrGuids[e]&&(delete this.xhrGuids[e],this.totalCbs-=1)}),f.on("addEventListener-end",function(t,n){n instanceof m&&"load"===t[0]&&f.emit("xhr-load-added",[t[1],t[2]],n)}),f.on("removeEventListener-end",function(t,n){n instanceof m&&"load"===t[0]&&f.emit("xhr-load-removed",[t[1],t[2]],n)}),f.on("fn-start",function(t,n,e){n instanceof m&&("onload"===e&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),f.on("fn-end",function(t,n){this.xhrCbStart&&f.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,n],n)})}},{}],11:[function(t,n,e){n.exports=function(t){var n=document.createElement("a"),e=window.location,r={};n.href=t,r.port=n.port;var o=n.href.split("://");!r.port&&o[1]&&(r.port=o[1].split("/")[0].split("@").pop().split(":")[1]),r.port&&"0"!==r.port||(r.port="https"===o[0]?"443":"80"),r.hostname=n.hostname||e.hostname,r.pathname=n.pathname,r.protocol=o[0],"/"!==r.pathname.charAt(0)&&(r.pathname="/"+r.pathname);var i=!n.protocol||":"===n.protocol||n.protocol===e.protocol,a=n.hostname===document.domain&&n.port===e.port;return r.sameOrigin=i&&(!n.hostname||a),r}},{}],12:[function(t,n,e){function r(){}function o(t,n,e){return function(){return i(t,[f.now()].concat(s(arguments)),n?null:this,e),n?void 0:this}}var i=t("handle"),a=t(15),s=t(16),c=t("ee").get("tracer"),f=t("loader"),u=NREUM;"undefined"==typeof window.newrelic&&(newrelic=u);var d=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",p=l+"ixn-";a(d,function(t,n){u[n]=o(l+n,!0,"api")}),u.addPageAction=o(l+"addPageAction",!0),u.setCurrentRouteName=o(l+"routeName",!0),n.exports=newrelic,u.interaction=function(){return(new r).get()};var h=r.prototype={createTracer:function(t,n){var e={},r=this,o="function"==typeof n;return i(p+"tracer",[f.now(),t,e],r),function(){if(c.emit((o?"":"no-")+"fn-start",[f.now(),r,o],e),o)try{return n.apply(this,arguments)}finally{c.emit("fn-end",[f.now()],e)}}}};a("setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,n){h[n]=o(p+n)}),newrelic.noticeError=function(t){"string"==typeof t&&(t=new Error(t)),i("err",[t,f.now()])}},{}],13:[function(t,n,e){n.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(n){return}}}},{}],14:[function(t,n,e){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),n.exports=r},{}],15:[function(t,n,e){function r(t,n){var e=[],r="",i=0;for(r in t)o.call(t,r)&&(e[i]=n(r,t[r]),i+=1);return e}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],16:[function(t,n,e){function r(t,n,e){n||(n=0),"undefined"==typeof e&&(e=t?t.length:0);for(var r=-1,o=e-n||0,i=Array(o<0?0:o);++r<o;)i[r]=t[n+r];return i}n.exports=r},{}],17:[function(t,n,e){n.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],18:[function(t,n,e){function r(t){return!(t&&t instanceof Function&&t.apply&&!t[a])}var o=t("ee"),i=t(16),a="nr@original",s=Object.prototype.hasOwnProperty,c=!1;n.exports=function(t,n){function e(t,n,e,o){function nrWrapper(){var r,a,s,c;try{a=this,r=i(arguments),s="function"==typeof e?e(r,a):e||{}}catch(f){l([f,"",[r,a,o],s])}u(n+"start",[r,a,o],s);try{return c=t.apply(a,r)}catch(d){throw u(n+"err",[r,a,d],s),d}finally{u(n+"end",[r,a,c],s)}}return r(t)?t:(n||(n=""),nrWrapper[a]=t,d(t,nrWrapper),nrWrapper)}function f(t,n,o,i){o||(o="");var a,s,c,f="-"===o.charAt(0);for(c=0;c<n.length;c++)s=n[c],a=t[s],r(a)||(t[s]=e(a,f?s+o:o,i,s))}function u(e,r,o){if(!c||n){var i=c;c=!0;try{t.emit(e,r,o,n)}catch(a){l([a,e,r,o])}c=i}}function d(t,n){if(Object.defineProperty&&Object.keys)try{var e=Object.keys(t);return e.forEach(function(e){Object.defineProperty(n,e,{get:function(){return t[e]},set:function(n){return t[e]=n,n}})}),n}catch(r){l([r])}for(var o in t)s.call(t,o)&&(n[o]=t[o]);return n}function l(n){try{t.emit("internal-error",n)}catch(e){}}return t||(t=o),e.inPlace=f,e.flag=a,e}},{}],ee:[function(t,n,e){function r(){}function o(t){function n(t){return t&&t instanceof r?t:t?c(t,s,i):i()}function e(e,r,o,i){if(!l.aborted||i){t&&t(e,r,o);for(var a=n(o),s=h(e),c=s.length,f=0;f<c;f++)s[f].apply(a,r);var d=u[y[e]];return d&&d.push([g,e,r,a]),a}}function p(t,n){v[t]=h(t).concat(n)}function h(t){return v[t]||[]}function m(t){return d[t]=d[t]||o(e)}function w(t,n){f(t,function(t,e){n=n||"feature",y[e]=n,n in u||(u[n]=[])})}var v={},y={},g={on:p,emit:e,get:m,listeners:h,context:n,buffer:w,abort:a,aborted:!1};return g}function i(){return new r}function a(){(u.api||u.feature)&&(l.aborted=!0,u=l.backlog={})}var s="nr@context",c=t("gos"),f=t(15),u={},d={},l=n.exports=o();l.backlog=u},{}],gos:[function(t,n,e){function r(t,n,e){if(o.call(t,n))return t[n];var r=e();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,n,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[n]=r,r}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],handle:[function(t,n,e){function r(t,n,e,r){o.buffer([t],r),o.emit(t,n,e)}var o=t("ee").get("handle");n.exports=r,r.ee=o},{}],id:[function(t,n,e){function r(t){var n=typeof t;return!t||"object"!==n&&"function"!==n?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");n.exports=r},{}],loader:[function(t,n,e){function r(){if(!x++){var t=b.info=NREUM.info,n=l.getElementsByTagName("script")[0];if(setTimeout(u.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&n))return u.abort();f(y,function(n,e){t[n]||(t[n]=e)}),c("mark",["onload",a()+b.offset],null,"api");var e=l.createElement("script");e.src="https://"+t.agent,n.parentNode.insertBefore(e,n)}}function o(){"complete"===l.readyState&&i()}function i(){c("mark",["domContent",a()+b.offset],null,"api")}function a(){return E.exists&&performance.now?Math.round(performance.now()):(s=Math.max((new Date).getTime(),s))-b.offset}var s=(new Date).getTime(),c=t("handle"),f=t(15),u=t("ee"),d=window,l=d.document,p="addEventListener",h="attachEvent",m=d.XMLHttpRequest,w=m&&m.prototype;NREUM.o={ST:setTimeout,SI:d.setImmediate,CT:clearTimeout,XHR:m,REQ:d.Request,EV:d.Event,PR:d.Promise,MO:d.MutationObserver};var v=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-1044.min.js"},g=m&&w&&w[p]&&!/CriOS/.test(navigator.userAgent),b=n.exports={offset:s,now:a,origin:v,features:{},xhrWrappable:g};t(12),l[p]?(l[p]("DOMContentLoaded",i,!1),d[p]("load",r,!1)):(l[h]("onreadystatechange",o),d[h]("onload",r)),c("mark",["firstbyte",s],null,"api");var x=0,E=t(17)},{}]},{},["loader",2,10,4,3]);</script>
    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">

    <title>Frontiers | Altered Mitochondrial Signalling and Metabolism in Cancer | Oncology</title>

    <link rel="shortcut icon" href="https://3718aeafc638f96f5bd6-d4a9ca15fc46ba40e71f94dec0aad28c.ssl.cf1.rackcdn.com/favicon_16x16.ico" type="image/x-icon" />

    <meta property="og:type" content="article"/>
    <meta property="frontiers:type" content="Article" />
    <meta property="og:site_name" name="site_name" content="Frontiers" />
    <meta property="og:title" name="Title" content="Altered Mitochondrial Signalling and Metabolism in Cancer" />
    <meta property="og:description" name="Description" content="Mitochondria being the central organelle for metabolism and other cell signalling pathways have remained the topic of interest to tumour biologists. In spite of the wide acceptance of Warburg’s hypothesis, role of mitochondrial metabolism in cancer is still unclear. Uncontrolled growth and proliferation, hallmarks of tumour cells, are maintained when the cells adapt to metabolic reprogramming with the help of altered metabolism of mitochondria. This review has focused on different aspects of mitochondrial metabolism and inter-related signalling pathways which have been found to be modified in cancer." />
    <meta property="og:url" name="url" content="http://journal.frontiersin.org/article/10.3389/fonc.2017.00043/full" />
        <meta property="og:image" name="image_src" content="http://www.frontiersin.org/files/MyHome%20Article%20Library/254974/254974_Thumb_400.jpg" />
            <meta name="citation_volume" content="7" />
        <meta name="citation_journal_title" content="Frontiers in Oncology" />
        <meta name="citation_publisher" content="Frontiers" />
        <meta name="citation_journal_abbrev" content="Front. Oncol." />
        <meta name="citation_issn" content="2234-943X" />
        <meta name="citation_doi" content="10.3389/fonc.2017.00043" />
        <meta name="citation_pages" content="43" />
        <meta name="citation_language" content="English" />
        <meta name="citation_title" content="Altered Mitochondrial Signalling and Metabolism in Cancer" />
        <meta name="citation_keywords" content="mtiochondria; Cancer; Altered metabolism; signaling; Therapeutics" />
        <meta name="citation_abstract" content="Mitochondria being the central organelle for metabolism and other cell signalling pathways have remained the topic of interest to tumour biologists. In spite of the wide acceptance of Warburg’s hypothesis, role of mitochondrial metabolism in cancer is still unclear. Uncontrolled growth and proliferation, hallmarks of tumour cells, are maintained when the cells adapt to metabolic reprogramming with the help of altered metabolism of mitochondria. This review has focused on different aspects of mitochondrial metabolism and inter-related signalling pathways which have been found to be modified in cancer." />
        <meta name="description" content="Mitochondria being the central organelle for metabolism and other cell signalling pathways have remained the topic of interest to tumour biologists. In spite of the wide acceptance of Warburg’s hypothesis, role of mitochondrial metabolism in cancer is still unclear. Uncontrolled growth and proliferation, hallmarks of tumour cells, are maintained when the cells adapt to metabolic reprogramming with the help of altered metabolism of mitochondria. This review has focused on different aspects of mitochondrial metabolism and inter-related signalling pathways which have been found to be modified in cancer." />
        <meta name="citation_online_date" content="2017/03/03" />
        <meta name="citation_date" content="2017" />
        <meta name="citation_publication_date" content="2017/03/20" />
        <meta name="citation_author" content="Chattopadhyay, Esita" />
        <meta name="citation_author_institution" content="Human Genetics Unit, Indian Statistical Institute, India" />
        <meta name="citation_author_email" content="" />
        <meta name="citation_author" content="Roy, Bidyut" />
        <meta name="citation_author_institution" content="Human Genetics Unit, Indian Statistical Institute, India" />
        <meta name="citation_author_email" content="broy@isical.ac.in" />
    <meta name="Keywords" content="mtiochondria, Cancer, Altered metabolism, signaling, Therapeutics" />

        <meta name="dc.identifier" content="doi:10.3389/fonc.2017.00043"> <!--CrossMark widget-->
    
    <script type="text/javascript">

        var CurrentIBarMenu = 'bysubjects';
        var CurrentPageCode = 'ARTICLE_PAGE_NEW';

        var FRConfiguration = (function() {
            return {
                Environment: 'Live',
                SANVirtualPath: 'http://www.frontiersin.org/files/',
                SharepointWebsiteUrl: 'http://www.frontiersin.org',
                CommunityWebsiteUrl: 'http://community.frontiersin.org',
                FrontiersJournalUIUrl: 'http://journal.frontiersin.org',
                FrontiersJournalAPIUrl: 'https://api-journal.frontiersin.org',
                FrontiersReviewUIUrl: '',
                FrontiersReviewAPIUrl: '',
                FrontiersNetworkingAPIUrl: 'http://api-network.frontiersin.org',
                FrontiersCookie: 'frontiersN',
                FrontiersCookieRememberMe: 'frontiersNt',
                FrontiersLoginUrl: 'https://www.frontiersin.org/Login.aspx',
                FrontiersRegistrationUrl: 'http://www.frontiersin.org/Registration/Register.aspx'
            };
        })();

        var FRLanguage = (function() {
            var languageSet = {"ART_FRONTIERS":"Frontiers ","Article_AcceptedDate":"Accepted: ","Article_AnalyticsToolTip":"The total view count is updated once a day, so not to worry if you don\u0027t see immediate results.","Article_AnalyticsTotalViews":"total views","Article_AnalyticsViewImpact":"View Article Impact","Article_ArchiveLinkText":"Articles","Article_BibTex":"BibTex","Article_Citation":"Citation: ","Article_Commentary":"COMMENTARY","Article_Copyright":"Copyright: ","Article_CopyrightText":"This is an open-access article distributed under the terms of the \u003ca href=\"http://creativecommons.org/licenses/by/4.0/\"\u003eCreative Commons Attribution License (CC BY)\u003c/a\u003e. The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.","Article_Correspondence":"* Correspondence: ","Article_DownloadArticle":"Download Article","Article_DownloadPDF":"Download PDF","Article_DownloadProvisionalArticle":"Download Provisional Article","Article_DownloadProvisionalPDF":"Download Provisional PDF","Article_EditedBy":"Edited by: ","Article_EndNote":"EndNote","Article_EPUB":"EPUB","Article_ExportCitation":"Export Citation","Article_JATS":"JATS","Article_Keywords":"Keywords: ","Article_NLM":"XML (NLM)","Article_OriginalArticle":"ORIGINAL ARTICLE","Article_PaperPendingPublishedDate":"Paper pending published: ","Article_PDF":"PDF","Article_ProvisionalPDF":"Provisional PDF","Article_PublishedDate":"Published online: ","Article_ReadFullText":"Read Full Text","Article_ReceivedDate":"Received: ","Article_ReferenceManager":"Reference Manager","Article_ReviewedBy":"Reviewed by: ","Article_RTInfoText":"This article is part of the Research Topic","Article_ShareOn":"SHARE ON","Article_SimpleTEXTfile":"Simple TEXT file","Article_SupplementalData":"SUPPLEMENTAL DATA","Article_TableOfContent":"TABLE OF CONTENTS","Article_ViewEnhancedPDF":"ReadCube","Article_XML":"XML","BrowserWarningText":"\u003ch2\u003eWarning!\u003c/h2\u003e\u003cp\u003eYou are using an \u003cstrong\u003eoutdated\u003c/strong\u003e browser. This page doesn\u0027t support Internet Explorer 6, 7 and 8.\u003cbr /\u003ePlease \u003ca class=\"blue\" href=\"http://browsehappy.com/\"\u003eupgrade your browser\u003c/a\u003e or \u003ca class=\"blue\" href=\"http://www.google.com/chromeframe/?redirect=true\"\u003eactivate Google Chrome Frame\u003c/a\u003e to improve your experience.\u003c/p\u003e","COMMENT_HEADERTEXT":"Comment text too long","COMMENT_WARNINGTEXT":"Comments must be less than 4,000 characters. You have entered ","Impact_BackToArticle":"Back to article","People_Also_LookedAt":"People also looked at"};

            return {
                value: function(key) {
                    if (languageSet[key]) {
                        return languageSet[key];
                    } else {
                        throw new Error('Unable to get the value status from the language set'); // Use Error, not FRError
                    }
                }
            };

        })();

        var FRJournalDetails = (function() {
            return {
                JournalType: 'section',
                JournalId: '451',
                SectionId: '508'
            };
        })();
    </script>

    <script src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-535f7e222fc3ca72"></script>


    <script language="javascript">
        var addthis_config = addthis_config || {};
        addthis_config.data_track_addressbar = false;
        addthis_config.data_track_clickback = false;
    </script>

    
    
    <!--[if lt IE 9]>
      <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>

      <script src="https://oss.maxcdn.com/libs/respond.js/1.4.2/respond.min.js"></script>

    <![endif]-->

    <script src="https://maps.googleapis.com/maps/api/js?sensor=false"></script>

    <script src="/Areas/ResearchTopic/Scripts/frontiers/common/frontiers.markerclusterer.js"></script>

   
    
    <link href="http://b6adc309cb583410ebe3-877d2ecaf11b88d5e17327c758e17ef6.r98.cf2.rackcdn.com/font-awesome-4.3.0/css/font-awesome.css" rel="stylesheet"/>

    <link href="http://b6adc309cb583410ebe3-877d2ecaf11b88d5e17327c758e17ef6.r98.cf2.rackcdn.com/museo-sans-1.0.1/css/museo-sans.css" rel="stylesheet"/>

    <link href="http://b6adc309cb583410ebe3-877d2ecaf11b88d5e17327c758e17ef6.r98.cf2.rackcdn.com/museo-slab-1.0.1/css/museo-slab.css" rel="stylesheet"/>

    <link href="http://b6adc309cb583410ebe3-877d2ecaf11b88d5e17327c758e17ef6.r98.cf2.rackcdn.com/open-sans-1.0.0/css/open-sans.css" rel="stylesheet"/>

    <link href="/article/css/app?v=wXCFLc97Lvr_Qiw15BAPQ_CRkE9reS6segDHDi1DwHo1" rel="stylesheet"/>

    
    <style type="text/css"> .journal-oncology {
 background: #fff url('https://3718aeafc638f96f5bd6-d4a9ca15fc46ba40e71f94dec0aad28c.ssl.cf1.rackcdn.com/journal-oncology.png') no-repeat 100% -700px;
background-size: 31%;
}
/* Displays/Screens (e.g. 19" WS @ 1440x900) --------------- */ @media only screen and (max-width: 1649px) {
 .journal-oncology {
  background: #fff url('https://3718aeafc638f96f5bd6-d4a9ca15fc46ba40e71f94dec0aad28c.ssl.cf1.rackcdn.com/journal-oncology.png') no-repeat 165% 80px;
background-size: 61%;
 }}
/* Displays/Screens (e.g. MacBook @ 1280x800) -------------- */
@media only screen and (max-width: 1409px) {
 .journal-oncology {
  background: #fff url('https://3718aeafc638f96f5bd6-d4a9ca15fc46ba40e71f94dec0aad28c.ssl.cf1.rackcdn.com/journal-oncology.png') no-repeat 165% 90px;
background-size: 61%;
 }}
/* Large Devices, Wide Screens --------- */  @media only screen and (max-width : 1250px) {
 .journal-oncology {
  background: #fff url('https://3718aeafc638f96f5bd6-d4a9ca15fc46ba40e71f94dec0aad28c.ssl.cf1.rackcdn.com/journal-oncology.png') no-repeat 165% 90px;
background-size: 61%;
 }}
/* Medium Devices, Desktops ---------- */  @media only screen and (max-width : 992px) { 
 .journal-oncology {
  background: #fff url('https://3718aeafc638f96f5bd6-d4a9ca15fc46ba40e71f94dec0aad28c.ssl.cf1.rackcdn.com/journal-oncology.png') no-repeat 185% 110px;
background-size: 66%;
 }}
/* Small Devices, Tablets ------------ */  @media only screen and (max-width : 768px) {
 .journal-oncology {
  background: #fff url('https://3718aeafc638f96f5bd6-d4a9ca15fc46ba40e71f94dec0aad28c.ssl.cf1.rackcdn.com/journal-oncology.png') no-repeat 300px 100px;
background-size: 98%;
 }}
/* Small Devices, Tablets  --------- */ @media only screen and (max-width : 640px) {
 .journal-oncology {
  background: #fff url('https://3718aeafc638f96f5bd6-d4a9ca15fc46ba40e71f94dec0aad28c.ssl.cf1.rackcdn.com/journal-oncology.png') no-repeat 270px 110px;
background-size: 98%;
 }}
/* Extra Small Devices, Phones-----------  */  @media only screen and (max-width : 480px) {
 .journal-oncology {
  background: #fff url('https://3718aeafc638f96f5bd6-d4a9ca15fc46ba40e71f94dec0aad28c.ssl.cf1.rackcdn.com/journal-oncology.png') no-repeat 190px 120px;
background-size: 98%;
 }
} </style>
    
</head>
    <body class="journal-oncology section-molecular-and-cellular-oncology">

        <link href="https://api-journal.frontiersin.org/areas/header/content/styles/frontiers.header.v3.css" rel="stylesheet"></link><div class="header-compact">
    <div class="navbar navbar-fixed-top">
        <div class="row container">
            <div class="navbar-header">
                <div class="col-xs-6 header-left-container">
                    <ul class="navbar-toggle inline-list navbar-mobile" data-toggle="collapse" data-target="#">
    <li class="no-left-margin">
        <a class="brand home" href="http://www.frontiersin.org">
            <img class="header-logo">
        </a>
    </li>
    <li class="clickable no-left-margin">
        <div class="journal-dropdown-responsive">
            <span class="sr-only">Toggle navigation</span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
        </div>
    </li>
</ul>

<ul class="inline-list navbar-collapse collapse navbar-desktop">
    <li class="header-inline-element no-left-margin">
        <a class="brand home" href="http://www.frontiersin.org" onclick="FRHeader.trackOutboundLink('Header_Action', 'link', 'click_header_home', 'http://www.frontiersin.org');return false;">
            <img class="header-logo">
        </a>
    </li>
    <li class="no-left-margin">
        <a class="home" href="http://www.frontiersin.org" onclick="FRHeader.trackOutboundLink('Header_Action', 'link', 'click_header_home', 'http://www.frontiersin.org');return false;">
            Home
        </a>
    </li>
    <li class="no-left-margin">
        <a class="about" href="http://www.frontiersin.org/AboutFrontiers.aspx" onclick="FRHeader.trackOutboundLink('Header_Action', 'link', 'click_header_about', 'http://www.frontiersin.org/AboutFrontiers.aspx');return false;">
            About
        </a>
    </li>
    <li class="submit-container">
        <a class="submit" href="http://www.frontiersin.org/Submission/SubmissionInfo.aspx" onclick="FRHeader.trackOutboundLink('Header_Action', 'link', 'click_header_submit', 'http://www.frontiersin.org/Submission/SubmissionInfo.aspx');return false;">
            Submit
        </a>
    </li>
    <li class="no-padding-right journal-drop hidden">
        <a class="byjournal bysubjects" data-test-id="journal-bydropdown">
            <span>Journals</span><img class="drop-down-arrow" src="https://api-journal.frontiersin.org/Areas/Header/Content/Images/header-arrow-down.png" alt="" />
        </a>
    </li>
    <li class="journalAZ hidden">
        <a class="bysubjects" href="http://www.frontiersin.org/AboutFrontiers.aspx?stage=journalseries" data-test-id="journal-atoz">
            Journals A-Z
        </a>
    </li>
    
    <li class="research-topic-container">
        <a class="research-topic" href="http://journal.frontiersin.org/researchtopic" onclick="FRHeader.trackOutboundLink('Header_Action', 'link', 'click_header_rt', 'http://journal.frontiersin.org/researchtopic');return false;">
            Research Topics
        </a>
    </li>
    
</ul>

                </div>
                <div class="header-search">
                    <div class="search-swappable hidden-xs">
    <a class="search-icon-container hidden" data-test-id="search-icon">
        <img class="search-icon" src="https://api-journal.frontiersin.org/Areas/Header/Content/Images/header-search.png" />
    </a>
    <form class="search-bar-container hide">
        <input data-test-id="search-field" placeholder="Search for articles, people, events and more." class="header-search-field">
        <input data-test-id="search-btn" type="button" class="header-search-btn" value="">
    </form>
</div>

                </div>
                <div class="col-xs-6 pull-right unlogged-user hidden">
                    <ul class="inline-list pull-right">
    <li>
        <a class="login-container popover-login-trigger" data-test-id="login-link" data-header-tracking='{ "category": "Header_Action", "action": "link", "label": "click_header_login" }'>
            <span>Login</span>
        </a>
    </li>
    <li>
        <a class="register-container" data-test-id="register-link" href="http://www.frontiersin.org/Registration/Register.aspx" onclick="FRHeader.trackOutboundLink('Header_Action', 'link', 'click_header-register', 'http://www.frontiersin.org/Registration/Register.aspx');return false;">
            <span>Register</span>
        </a>
    </li>
</ul>

<div class="popover-wrapper popover-login" style="display: none">
    <div class="popover-menu login-popover">
        <form action="https://www.frontiersin.org/Login.aspx" name="login-form" method="POST" class="login-form">
            <div class="third-party-signin-row row-inside-column">
                <h1>Login using</h1>
                <div class="third-party-buttons">
                    <div class="third-party-button-wrapper" id="third-party-btn-for-linkedin">
                        <a data-type="3">
                            <div class="radius">
                                <div class="third-party-icon linkedin-icon-wrapper">
                                    <div class="linkedin-icon"></div>
                                </div>
                            </div>
                            <div class="third-party-name">LinkedIn</div>
                        </a>
                    </div><div class="third-party-button-wrapper" id="third-party-btn-for-twitter">
                        <a data-type="2">
                            <div class="radius">
                                <div class="third-party-icon twitter-icon-wrapper">
                                    <div class="twitter-icon"></div>
                                </div>
                            </div>
                            <div class="third-party-name">Twitter</div>
                        </a>
                    </div>
                    <div class="third-party-button-wrapper" id="third-party-btn-for-facebook">
                        <a data-type="1">
                            <div class="radius">
                                <div class="third-party-icon facebook-icon-wrapper">
                                    <div class="facebook-icon"></div>
                                </div>
                            </div>
                            <div class="third-party-name">Facebook</div>
                        </a>
                    </div>
                    <div class="info-button-wrapper" id="third-party-information-button">
                        <a class="popover-login-info-trigger">
                            <div class="info-button">i</div>
                        </a>
                        <div class="popover-wrapper popover-login-info" style="display: none">
                            <div class="popover-menu">
                                <h1 class="popover-title">You can login by using one of your existing accounts.</h1>
                                <span style="float: none; display: inline">
                                    We will be provided with an authorization token (please note: passwords are not shared with us) and will sync your accounts for you. This means that you will not need to remember your user name and password in the future and you will be able to login with the account you choose to sync, with the click of a button.
                                </span>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="clear"></div>
            <div class="or-row" id="or-circle-divider">
                <div class="or-divider or-divider-inside-column">
                    <div class="or-circle">OR</div>
                </div>
            </div>
            <div class="loginForm">
                <div class="form-field-label">Email *</div>
                <div class="form-field">
                    <input runat="server" tabindex="5" name="txtLoginEmail" type="text">
                    <div class="form-field-error-msg">
                        <div class="error-icon-small"></div>
                        Please fill in this field
                        <div class="clear"></div>
                    </div>
                </div>
                <div class="form-field-label">Password *</div>
                <div class="form-field">
                    <input runat="server" tabindex="6" name="txtLoginPassword" type="password">
                    <div class="form-field-error-msg">
                        <div class="error-icon-small"></div>
                        Please fill in this field
                        <div class="clear"></div>
                    </div>
                </div>
                <div id="rememberMeWrapper">
                    <div class="checkbox-remember-container">
                        <input runat="server" tabindex="7" name="chkLoginRememberMe" type="checkbox">
                    </div>
                    <div class="checkbox-remember-label">Remember me</div>
                    <div class="forgot-password">
                        <a href="https://registration.frontiersin.org/people/forgot-password">Forgot Password?</a>
                    </div>
                </div>
                <div class="login-page-submit" id="formSubmitWrapper">
                    <div>
                        <input name="hdnIsPopupLogin" runat="server" value="1" type="hidden">
                        <button type="submit" tabindex="8" class="btn btn-loginlogout-blue btn-flat input-block-level">Login</button>
                    </div>
                </div>
            </div>
        </form>
    </div>
</div>

                </div>
                <div class="col-xs-6 pull-right logged-user hidden">
                    <ul class="logged navbar-toggle inline-list pull-right navbar-mobile" data-toggle="collapse" data-target="#LefttHeader">
    <li>
        <div class="clickable profile-dropdown-responsive">
            <p class="frontiers-letter">
                Frontiers
            </p>
            <em class="down-arrow-rhs"></em>
        </div>
    </li>
    <li class="no-left-margin profile-container-responsive">
        <a href="javascript:void(0)">
            <img class="profile-pic responsive">
        </a>
    </li>
</ul>

<ul class="logged inline-list pull-right navbar-collapse collapse navbar-desktop">
    <li class="myfrontiers-container">
        <a>
            <span>My frontiers</span>
            <em></em>
        </a>
    </li>
    <li class="myhome-container">
        <a class="myhome" title="My Home" data-placement="left" data-header-tracking='{ "category": "Header_Action", "action": "link", "label": "click_header_loop" }'>
            <i class="fromSprite loop-logo"></i>
        </a>
    </li>
    <li class="no-left-margin impact-container">
        <a class="popover-impact-disabled" title="My Impact" data-placement="left" data-header-tracking='{ "category": "Header_Action", "action": "link", "label": "click_header_impact" }'>
            <i class="fromSprite impactLogo"></i>
        </a>
    </li>
    <li class="no-left-margin notification-container">
        <a class="popover-notification-trigger" title="Notifications" data-placement="left" data-header-tracking='{ "category": "Header_Action", "action": "link", "label": "click_header_alerts" }'>
            <i class="fromSprite bellLogo"></i>
            <div class="notifications-count hidden">0</div>
        </a>
    </li>
    <li class="no-left-margin username-container">
        <a class="username" data-header-tracking='{ "category": "Header_Action", "action": "link", "label": "click_header_user" }'></a>
    </li>
    <li class="no-left-margin profile-container">
        <a class="popover-profile-trigger">
            <img class="profile-pic desktop">
        </a>
    </li>
</ul>

<div class="popover-wrapper popover-impact" style="display: none">
    <em></em>
    <div class="popover-menu impact-popover"></div>
</div>

<div class="popover-wrapper popover-notification" style="display: none">
    <em></em>
    <input id="hdnLastNotificationId" type="hidden" />
    <div class="popover-menu notifications-popover"></div>
</div>

                </div>
            </div>
        </div>
    </div>
</div>
    

        <!--[if lte IE 8]>
            <div class="row">
                <div class="col-md-16">
                    <div style="margin-bottom: 15px;"><h2>Warning!</h2><p>You are using an <strong>outdated</strong> browser. This page doesn't support Internet Explorer 6, 7 and 8.<br />Please <a class="blue" href="http://browsehappy.com/">upgrade your browser</a> or <a class="blue" href="http://www.google.com/chromeframe/?redirect=true">activate Google Chrome Frame</a> to improve your experience.</p></div>
                </div>
            </div>
        <![endif]-->

        <div class="page-container">
            


        <a href="https://blog.frontiersin.org/2017/06/28/frontiers-top-quality-journals-impact-factors-citations-analysis/?utm_source=F-EDP&amp;utm_medium=WBAN&amp;utm_campaign=CCO_CORPO_20170628_IM17-summary" target="_blank" data-tracking='{ "category": "AP_Action", "action": "link", "label": "goto-marketing-banner" }'>
            <div class="marketing no-impact">
                
                <span class="message">
                    <p>Frontiers reaches <strong>6.4 on Journal Impact Factors</strong></p>
                </span>

            </div>
        </a>
<div id="journal-header" class="journal-home" style="position: relative;">
    <div class="container-fluid main-container-xxl">
        <table id="logo-table" style="width:100%">
            <tr>
                    <td width="50%" valign="bottom" align="right" class="left-cell">
                        <h1>
                            <a href="http://journal.frontiersin.org/journal/451" data-test-id="journal-link" data-tracking='{ "category": "AP_Action", "action": "navigation", "label": "goto-journal-home" }'>
                                <span>Frontiers </span>in Oncology
                            </a>
                        </h1>
                    </td>
                        <td class="right-cell" width="50%" style="vertical-align: bottom">
                            <h2>
                                <a href="http://journal.frontiersin.org/journal/451/section/508" data-test-id="section-link"  class="btn btn-link" data-tracking='{ "category": "AP_Action", "action": "navigation", "label": "goto-journal-section" }'>
                                    Molecular and Cellular Oncology


                                </a>
                            </h2>
                        </td>
            </tr>
        </table>
    </div>
</div>


<div id="journal-nav">
    <div class="container-fluid main-container-xxl">
        <div class="row">
            <div class="col-md-12">
                <div class="nav-wrapper">
                    <nav class="navbar navbar-default">
                        <!-- Brand and toggle get grouped for better mobile display -->
                        <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#journal-navbar-collapse">
                            <span class="sr-only">Toggle navigation</span>
                            <span class="pull-left">
                                <span class="icon-bar"></span>
                                <span class="icon-bar"></span>
                                <span class="icon-bar"></span>
                            </span>
                            <span class="pull-right hidden-xs">Section</span>
                        </button>
                        <!-- Collect the nav links, forms, and other content for toggling -->
                        <div class="collapse navbar-collapse no-transition journal-nav-bar" id="journal-navbar-collapse">
                            <ul class="nav navbar-nav">
                                <li class="tab-overview icon icon-left">
                                    <a href="http://journal.frontiersin.org/journal/oncology/section/molecular-and-cellular-oncology#" data-tracking='{ "category": "JP_Action", "action": "navigation", "label": "nav_home" }'><span class="sr-only">(current)</span><i class="fa fa-home"></i>Section</a>
                                </li>
                                <li class="tab-about">
                                    <a href="http://journal.frontiersin.org/journal/oncology/section/molecular-and-cellular-oncology#about" data-tracking='{ "category": "JP_Action", "action": "navigation", "label": "nav_about" }'>About</a>
                                </li>
                                <li class="tab-archive active">
                                    <a href="http://journal.frontiersin.org/journal/oncology/section/molecular-and-cellular-oncology#articles" data-tracking='{ "category": "JP_Action", "action": "navigation", "label": "nav_articles" }'>Articles</a>
                                </li>
                                <li class="tab-research-topics">
                                    <a href="http://journal.frontiersin.org/journal/oncology/section/molecular-and-cellular-oncology#research-topics" data-tracking='{ "category": "JP_Action", "action": "navigation", "label": "nav_rt" }'>Research topics</a>
                                </li>
                                <li class="dropdown">
                                    <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false" data-tracking='{ "category": "JP_Action", "action": "navigation", "label": "nav_authinfo" }'>For authors <span class="caret"></span></a>
                                    <ul class="dropdown-menu" role="menu">
                                        <li><a href="http://journal.frontiersin.org/journal/oncology/section/molecular-and-cellular-oncology#why-submit" data-tracking='{ "category": "JP_Action", "action": "navigation", "label": "nav_authinfo_why_submit" }'>Why submit?</a></li>
                                        <li><a href="https://www.frontiersin.org/about/publishing-fees" target="_blank" data-tracking='{ "category": "JP_Action", "action": "navigation", "label": "nav_authinfo_fees" }'>Fees</a></li>
                                        <li><a href="http://journal.frontiersin.org/journal/oncology/section/molecular-and-cellular-oncology#article-types">Article types</a></li>
                                        <li><a href="http://journal.frontiersin.org/journal/oncology/section/molecular-and-cellular-oncology#author-guidelines">Author guidelines</a></li>
                                        <li><a href="http://journal.frontiersin.org/journal/oncology/section/molecular-and-cellular-oncology#review-guidelines" data-tracking='{ "category": "JP_Action", "action": "navigation", "label": "nav_authinfo_rev_guidelines" }'>Review guidelines</a></li>
                                        <li><a href="http://journal.frontiersin.org/journal/oncology/section/molecular-and-cellular-oncology#submission-checklist" data-tracking='{ "category": "JP_Action", "action": "navigation", "label": "nav_authinfo_sub_check" }'>Submission checklist</a></li>
                                        <li><a href="http://journal.frontiersin.org/journal/oncology/section/molecular-and-cellular-oncology#contact-editorial-office" data-tracking='{ "category": "JP_Action", "action": "navigation", "label": "nav_authinfo_contact" }'>Contact editorial office</a></li>
                                            <li><a href="http://www.frontiersin.org/submission/submissioninfo.aspx" onclick="FRTracking.trackOutboundLink('JP_Action', 'navigation', 'submit_paper', 'http://www.frontiersin.org/submission/submissioninfo.aspx');return false;" class="action-link">Submit your manuscript</a></li>
                                    </ul>
                                </li>
                                <li class="tab-editorial-board">
                                    <a href="http://journal.frontiersin.org/journal/oncology/section/molecular-and-cellular-oncology#editorial-board" data-tracking='{ "category": "JP_Action", "action": "navigation", "label": "nav_eb" }'>Editorial board</a>
                                </li>
                            </ul>
                        </div><!-- /.navbar-collapse -->
                        <ul class="list-inline follow-us nav navbar-nav">
                            <li class="twitter icon button">
                                <a data-test-id="twitter-link" href="https://twitter.com/@FrontOncology" onclick="FRTracking.trackOutboundLink('JP_Action', 'button', 'follow_twitter', 'https://twitter.com/@FrontOncology');return false;">
                                    <i class="fa fa-twitter"></i>
                                </a>
                            </li>
                            <li class="rss icon button">
                                <a data-test-id="rss-link" href="http://journal.frontiersin.org/journal/oncology/section/molecular-and-cellular-oncology/rss" onclick="FRTracking.trackOutboundLink('JP_Action', 'button', 'follow_rss', 'http://journal.frontiersin.org/journal/oncology/section/molecular-and-cellular-oncology/rss');return false;">
                                    <i class="fa fa-rss"></i>
                                </a>
                            </li>
                            <li class="alerts icon button">
                                <a data-test-id="alert-link" href="http://connect.frontiersin.org/subscriptions/subscribe?item=1&amp;field=57" onclick="FRTracking.trackOutboundLink('JP_Action', 'button', 'follow_alerts', 'http://connect.frontiersin.org/subscriptions/subscribe?item=1&amp;field=57');return false;">
                                    <i class="fa fa-bell" style="width: auto; padding-right: 7px; padding-left: 7px;"><span class="article-alert-text" style="font-family: MuseoSans, 'Helvetica Neue', Helvetica, Arial, sans-serif; margin-left: 6px; font-weight: 700; letter-spacing: 0px; font-size: 13px;">Article alerts</span></i>
                                </a>
                            </li>
                                    
                            
                        </ul>

                    </nav>
                </div><!-- / .nav-wrapper -->
            </div>
        </div>
    </div>
</div>


<div class="journal-actions article-actions">
    <div class="container-fluid main-container-xxl">
        <div class="row">
            <div class="col-lg-6 col-md-6 col-lg-push-6 col-md-push-6 col-research-topic">
                    <div class="research-topic-container">
                        <div class="research-topic-data">
                            <span class="topic-title"><span>This article is part of</span> the Research Topic</span>
                            <a href="http://journal.frontiersin.org/researchtopic/5067" data-test-id="relatedRT-link" class="topic-link-trim" data-tracking='{ "category": "AP_Action", "action": "button", "label": "goto-rt" }'>
                                Reprogramming of Mitochondrial Signalling and Metabolism in Cancer
                            </a>
                        </div>
                    </div>
            </div>
            <div class="col-lg-4 col-lg-offset-2 col-md-6 col-md-offset-0 col-lg-pull-6 col-md-pull-6">
                <a href="http://journal.frontiersin.org/journal/451/section/508#articles" class="archive-link hidden-sm hidden-xs" data-test-id="archive-link" data-tracking='{ "category": "AP_Action", "action": "navigation", "label": "goto-articles" }'>
                    <i class="fa fa-angle-left"></i> Articles
                </a>
            </div>
        </div>
    </div>
</div>


<div id="anchors" class="pull-left table-of-contents side-article">
    <div class="side-people hidden-sm hidden-xs">
                <div class="side-article-editors">
                    <h4>Edited by</h4>                    
                    <p><a class="authors" href="http://loop.frontiersin.org/people/172855/overview"><img class="pr5" src="http://loop.frontiersin.org/images/profile/172855/24"></img>Nad&#232;ge Bellance</a></p>
                    <span class="notes">Universit&#233; de Bordeaux, France</span>
                </div>
                <div class="side-article-editors">
                    <h4>Reviewed by</h4>
                        <p><a class="authors" href="http://loop.frontiersin.org/people/246282/overview"><img class="pr5" src="http://loop.frontiersin.org/images/profile/246282/24"></img>JUAN A. ROSADO DIONISIO</a></p>
                        <span class="notes">University of Extremadura, Spain</span>
                        <p><a class="authors" href="http://loop.frontiersin.org/people/298374/overview"><img class="pr5" src="http://loop.frontiersin.org/images/profile/298374/24"></img>Giovanni Sorrentino</a></p>
                        <span class="notes">&#201;cole Polytechnique F&#233;d&#233;rale de Lausanne, Switzerland</span>
                    <p class="disclaimer">The editor and reviewers' affiliations are the latest provided on their Loop research profiles and may not reflect their situation at the time of review.</p>
                </div>
    </div>
        <ul class="nav nav-list list-unstyled contents">
            <li>
                <h4>TABLE OF CONTENTS</h4>
            </li>
<ul class="flyoutJournal">
<li><a href="#h1">Abstract</a></li>
<li><a href="#h2">Introduction</a></li>
<li><a href="#h3">Hypoxia and Mitochondria</a></li>
<li><a href="#h4">Mitochondrial Metabolism and Tumour Growth</a></li>
<li><a href="#h5">Mitophagy</a></li>
<li><a href="#h6">Redox Signalling</a></li>
<li><a href="#h7">Mitochondria Biogenesis</a></li>
<li><a href="#h8">Mitochondrial Fission and Fusion</a></li>
<li><a href="#h9">Calcium Homoeostasis</a></li>
<li><a href="#h10">Cell Death</a></li>
<li><a href="#h11">Mutations in Mitochondrial Genome</a></li>
<li><a href="#h12">Conclusion</a></li>
<li><a href="#h13">Author Contributions</a></li>
<li><a href="#h14">Conflict of Interest Statement</a></li>
<li><a href="#h15">Acknowledgments</a></li>
<li><a href="#h16">Funding</a></li>
<li><a href="#h17">Abbreviations</a></li>
<li><a href="#h18">References</a></li>
</ul>        </ul>
</div>


<div id="article" class="boxed white no-padding">
    <div class="container-fluid main-container-xxl">
            <div class="side-article-mrk hidden-md hidden-lg top clearfix">
                <style type="text/css"><!--
.spotlight-title:hover,
.spotlight-title:focus {
 color: #555 !important; 
}
.spotlight-link {
 color: #f2b12f !important;
}
.spotlight-link:hover,
.spotlight-link:focus {
 color: #e5a812 !important;
}
--></style>
<div class="spotlight"><a href="https://blog.frontiersin.org/2016/11/25/second-annual-frontiers-spotlight-award-announced-for-2018/" target="_blank"><img src="http://e01f3a53c0bf5cbade8a-d4a9ca15fc46ba40e71f94dec0aad28c.r40.cf1.rackcdn.com/article-marketing-message-cbd91558-e517-4b02-9a0c-98fd19c36511.jpeg" alt="" /></a>
<h3 style="font-weight: 500;"><a class="spotlight-title" tabindex="0" href="https://blog.frontiersin.org/2016/11/25/second-annual-frontiers-spotlight-award-announced-for-2018/" target="_blank">Win $100,000 to host your own conference.</a></h3>
<a class="spotlight-link" href="https://blog.frontiersin.org/2016/11/25/second-annual-frontiers-spotlight-award-announced-for-2018/" target="_blank">Submit your Research Topic</a></div>
            </div>
        <div class="row">

            
<div class="a col-xs-12 col-sm-12 col-lg-2 col-md-3 pull-right side-article right-container">
        <button type="button" class="navbar-toggle navbar-download collapsed" data-toggle="collapse" data-target=".show" aria-expanded="false">
            <span class="icon"><i class="fa fa-download"></i></span>
        </button>
    <button type="button" class="navbar-toggle navbar-share collapsed" data-toggle="collapse" data-target=".show" aria-expanded="false">
        <span class="icon"><i class="fa fa-share-alt"></i></span>
    </button>
        <div class="side-article-download show collapse clearfix">
            <ul class="list-unstyled list-inline clearfix">
                    <li class="dropdown text-center paper">
                        <a data-target="#" class="dropdown-toggle" data-test-id="download-button" data-tracking='{ "category": "AP_Action", "action": "button", "label": "open-downloads" }' data-toggle="dropdown" role="button" aria-expanded="false">
                            <span class="icon icon-article"><i class="fa fa-file-pdf-o"></i></span>
                            <span class="icon-label">Download Article</span>
                        </a>
                        <ul class="dropdown-menu" role="menu">
                                <li>
                                    <a class="download-files-pdf action-link" href="/article/10.3389/fonc.2017.00043/pdf" data-test-id="article-downloadpdf" data-tracking='{ "category": "AP_Action", "action": "button", "label": "download-pdf" }'>
                                        Download PDF
                                    </a>
                                </li>
                                <li>
                                    <a class="download-files-readcube" href="http://www.readcube.com/articles/10.3389/fonc.2017.00043" data-test-id="article-viewenhancedpdf" data-tracking='{ "category": "AP_Action", "action": "button", "label": "download-readcube" }'>
                                        ReadCube
                                    </a>
                                </li>
                                <li>
                                    <a class="download-files-epub" href="/article/10.3389/fonc.2017.00043/epub" data-test-id="article-epub" data-tracking='{ "category": "AP_Action", "action": "button", "label": "download-epub" }'>
                                        EPUB
                                    </a>
                                </li>
                                <li>
                                    <a class="download-files-nlm" href="/article/10.3389/fonc.2017.00043/xml/nlm" data-test-id="article-nlm" data-tracking='{ "category": "AP_Action", "action": "button", "label": "download-xml" }'>
                                        XML (NLM)
                                    </a>
                                </li>
                                                            <li>
                                    <a data-test-id="supplementary-button" id="supplementary_view" data-tracking='{ "category": "AP_Action", "action": "button", "label": "view-supplementary-impact" }'>
                                        Supplementary
                                        <br>
                                        Material
                                    </a>
                                </li>
                        </ul>
                    </li>
                <li class="dropdown text-center citation">
                    <a data-target="#" class="dropdown-toggle" data-test-id="citation-button" data-tracking='{ "category": "AP_Action", "action": "button", "label": "open-export-citation" }' data-toggle="dropdown" role="button" aria-expanded="false">
                        <span class="icon icon-citation"><i class="fa fa-quote-left"></i></span>
                        <span class="icon-label">Export citation</span>
                    </a>
                    <ul class="dropdown-menu" role="menu">
                            <li>
                                <a data-test-id="article-endnote" href="http://journal.frontiersin.org/article/10.3389/fonc.2017.00043/endNote" data-tracking='{ "category": "AP_Action", "action": "button", "label": "export-citation-endnote" }'>
                                    EndNote
                                </a>
                            </li>
                            <li>
                                <a data-test-id="article-referencemanager" href="http://journal.frontiersin.org/article/10.3389/fonc.2017.00043/reference" data-tracking='{ "category": "AP_Action", "action": "button", "label": "export-reference-manager" }'>
                                    Reference Manager
                                </a>
                            </li>
                            <li>
                                <a data-test-id="article-simpletextfile" href="http://journal.frontiersin.org/article/10.3389/fonc.2017.00043/text" data-tracking='{ "category": "AP_Action", "action": "button", "label": "export-citation-text" }'>
                                    Simple TEXT file
                                </a>
                            </li>
                            <li>
                                <a data-test-id="article-bibtex" href="http://journal.frontiersin.org/article/10.3389/fonc.2017.00043/bibTex" data-tracking='{ "category": "AP_Action", "action": "button", "label": "export-citation-bibtext" }'>
                                    BibTex
                                </a>
                            </li>
                    </ul>
                </li>
            </ul>
        </div>
    <div class="side-article-impact">
        <ul class="nav">
            <li class="impact-data" title="The total view count is updated once a day, so not to worry if you don&#39;t see immediate results.">
                <span class="title-number"></span>
                <span class="title-text">total views</span>
            </li>
            <li class="hidden-sm hidden-xs">
                <div class="altmetric-icon">
                    <div class='altmetric-embed' data-badge-type='1' data-doi='10.3389/fonc.2017.00043' data-link-target="new"></div>
                </div>
            </li>
        </ul>
                <a type="button" class="btn btn-default hidden-sm hidden-xs btn-impact " data-tracking='{ "category": "AP_Action", "action": "button", "label": "view-impact" }' data-test-id="view-article-impact" href="http://loop-impact.frontiersin.org/impact/article/254974#views" target="_blank">
                    <span class="icon-impact"><i class="fa fa-line-chart"></i></span> View Article Impact
                </a>
    </div>
        <div class="side-article-mrk hidden-sm hidden-xs clearfix">
            <style type="text/css"><!--
.spotlight-title:hover,
.spotlight-title:focus {
 color: #555 !important; 
}
.spotlight-link {
 color: #f2b12f !important;
}
.spotlight-link:hover,
.spotlight-link:focus {
 color: #e5a812 !important;
}
--></style>
<div class="spotlight"><a href="https://blog.frontiersin.org/2016/11/25/second-annual-frontiers-spotlight-award-announced-for-2018/" target="_blank"><img src="http://e01f3a53c0bf5cbade8a-d4a9ca15fc46ba40e71f94dec0aad28c.r40.cf1.rackcdn.com/article-marketing-message-cbd91558-e517-4b02-9a0c-98fd19c36511.jpeg" alt="" /></a>
<h3 style="font-weight: 500;"><a class="spotlight-title" tabindex="0" href="https://blog.frontiersin.org/2016/11/25/second-annual-frontiers-spotlight-award-announced-for-2018/" target="_blank">Win $100,000 to host your own conference.</a></h3>
<a class="spotlight-link" href="https://blog.frontiersin.org/2016/11/25/second-annual-frontiers-spotlight-award-announced-for-2018/" target="_blank">Submit your Research Topic</a></div>
        </div>
    <div class="side-article-share show collapse">
    
  <div class="share-media clearfix">
            <h4>SHARE ON</h4>
            <div class="social_block">
                <div class="atButton">
                    <a class="addthis_button_facebook" addthis:title="Altered Mitochondrial Signalling and Metabolism in Cancer" addthis:description="Mitochondria being the central organelle for metabolism and other cell signalling pathways have remained the topic of interest to tumour biologists. In spite of the wide acceptance of Warburg’s hypothesis, role of mitochondrial metabolism in cancer is still unclear. Uncontrolled growth and proliferation, hallmarks of tumour cells, are maintained when the cells adapt to metabolic reprogramming with the help of altered metabolism of mitochondria. This review has focused on different aspects of mitochondrial metabolism and inter-related signalling pathways which have been found to be modified in cancer." addthis:url="http://journal.frontiersin.org/article/10.3389/fonc.2017.00043" title="Facebook" data-tracking='{ "category": "AP_Action", "action": "button", "label": "addthis-click" }'></a>
                </div>
                <a><span class="facebook_count"></span></a>
            </div>
            <div class="social_block">
                <div class="atButton">
                    <a class="addthis_button_twitter" addthis:title="Altered Mitochondrial Signalling and Metabolism in Cancer" addthis:description="Mitochondria being the central organelle for metabolism and other cell signalling pathways have remained the topic of interest to tumour biologists. In spite of the wide acceptance of Warburg’s hypothesis, role of mitochondrial metabolism in cancer is still unclear. Uncontrolled growth and proliferation, hallmarks of tumour cells, are maintained when the cells adapt to metabolic reprogramming with the help of altered metabolism of mitochondria. This review has focused on different aspects of mitochondrial metabolism and inter-related signalling pathways which have been found to be modified in cancer." addthis:url="http://journal.frontiersin.org/article/10.3389/fonc.2017.00043" title="Tweet" data-tracking='{ "category": "AP_Action", "action": "button", "label": "addthis-click" }'></a>
                </div>
                <a><span class="twitter_count"></span></a>
            </div>
            <div class="social_block">
                <div class="atButton">
                    <a class="addthis_button_google" addthis:title="Altered Mitochondrial Signalling and Metabolism in Cancer" addthis:description="Mitochondria being the central organelle for metabolism and other cell signalling pathways have remained the topic of interest to tumour biologists. In spite of the wide acceptance of Warburg’s hypothesis, role of mitochondrial metabolism in cancer is still unclear. Uncontrolled growth and proliferation, hallmarks of tumour cells, are maintained when the cells adapt to metabolic reprogramming with the help of altered metabolism of mitochondria. This review has focused on different aspects of mitochondrial metabolism and inter-related signalling pathways which have been found to be modified in cancer." addthis:url="http://journal.frontiersin.org/article/10.3389/fonc.2017.00043" title="Google" data-tracking='{ "category": "AP_Action", "action": "button", "label": "addthis-click" }'></a>
                </div>
                <a><span class="googleplus_count"></span></a>
            </div>
            <div class="social_block">
                <div class="atButton">
                    <a class="addthis_button_linkedin" addthis:title="Altered Mitochondrial Signalling and Metabolism in Cancer" addthis:description="Mitochondria being the central organelle for metabolism and other cell signalling pathways have remained the topic of interest to tumour biologists. In spite of the wide acceptance of Warburg’s hypothesis, role of mitochondrial metabolism in cancer is still unclear. Uncontrolled growth and proliferation, hallmarks of tumour cells, are maintained when the cells adapt to metabolic reprogramming with the help of altered metabolism of mitochondria. This review has focused on different aspects of mitochondrial metabolism and inter-related signalling pathways which have been found to be modified in cancer." addthis:url="http://journal.frontiersin.org/article/10.3389/fonc.2017.00043" title="LinkedIn" data-tracking='{ "category": "AP_Action", "action": "button", "label": "addthis-click" }'></a>
                </div>
                <a><span class="linkedin_count"></span></a>
            </div>
            <div class="social_block">
                <div class="atButton">
                    <a class="addthis_button_more" addthis:title="Altered Mitochondrial Signalling and Metabolism in Cancer" addthis:description="Mitochondria being the central organelle for metabolism and other cell signalling pathways have remained the topic of interest to tumour biologists. In spite of the wide acceptance of Warburg’s hypothesis, role of mitochondrial metabolism in cancer is still unclear. Uncontrolled growth and proliferation, hallmarks of tumour cells, are maintained when the cells adapt to metabolic reprogramming with the help of altered metabolism of mitochondria. This review has focused on different aspects of mitochondrial metabolism and inter-related signalling pathways which have been found to be modified in cancer." addthis:url="http://journal.frontiersin.org/article/10.3389/fonc.2017.00043" title="View more services" data-tracking='{ "category": "AP_Action", "action": "button", "label": "addthis-click" }'></a>
                </div>
                <a><span class="total_count"></span></a>
            </div>
        </div>
    </div>
</div>


            
<div class="b col-xs-12 col-sm-12 col-lg-8 col-lg-push-2 col-md-7 col-md-push-2 pull-left">
    <div class="article-section">
        <div class="article-container" data-html="True">
            <div class="abstract-container">
                
                <div class="article-header-container">
                    <!-- Start CrossMark Snippet v2.0 -->
                         <!-- the external CrossMark script to load the crossmark logo responsive  JPB-5562 -->
                        <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script>
                        <a data-target="crossmark" class="crossmark pull-right" style="padding: 3px 0 13px 0;"><img id="crossmark-icon" style="border: 0; width:64px; height:64px;" src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_square.svg"  /></a>
                        <div id="crossmark-dialog" style="display: none;" title="">
                            <!-- the external CrossMark data is loaded inside this iframe -->
                            <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
                        </div>
                    <!-- End CrossMark Snippet -->
                    <div class="header-bar-one">
                      <h2>Review ARTICLE

                        </h2>
                    </div>
                    <div class="header-bar-three">
                        Front. Oncol., 20 March 2017
                                 | <a href="https://doi.org/10.3389/fonc.2017.00043">https://doi.org/10.3389/fonc.2017.00043</a>
                    </div>
                </div>
                
<div class="JournalAbstract">
<a id="h1"></a><h1>Altered Mitochondrial Signalling and Metabolism in Cancer</h1>
<div class="authors">
<a style="text-decoration:none;line-height:1.3em;" href="http://www.frontiersin.org/people/u/422259" class="user-id-422259"><img class="pr5" src="http://journal.frontiersin.org/image/user/422259/24" onerror="this.src='http://3b76aaf63d1816bb57bf-a34624e694c43cdf8b40aa048a644ca4.r96.cf2.rackcdn.com/Design/Images/newprofile_default_profileimage_new.jpg'" alt="image"/>Esita Chattopadhyay</a> and <a style="text-decoration:none;line-height:1.3em;" href="http://www.frontiersin.org/people/u/400260" class="user-id-400260"><img class="pr5" src="http://journal.frontiersin.org/image/user/400260/24" onerror="this.src='http://3b76aaf63d1816bb57bf-a34624e694c43cdf8b40aa048a644ca4.r96.cf2.rackcdn.com/Design/Images/newprofile_default_profileimage_new.jpg'" alt="image"/>Bidyut Roy</a>*
</div>
<ul class="notes">
<li class="pl0">Human Genetics Unit, Indian Statistical Institute, Kolkata, India</li>
</ul>
<p>Mitochondria being the central organelle for metabolism and other cell signalling pathways have remained the topic of interest to tumour biologists. In spite of the wide acceptance of Warburg&#x02019;s hypothesis, role of mitochondrial metabolism in cancer is still unclear. Uncontrolled growth and proliferation, hallmarks of tumour cells, are maintained when the cells adapt to metabolic reprogramming with the help of altered metabolism of mitochondria. This review has focussed on different aspects of mitochondrial metabolism and inter-related signalling pathways which have been found to be modified in cancer.</p>
<div class="clear"></div>
</div>
<div class="JournalFullText">
<a id="h2"></a><h2>Introduction</h2>
<p class="mb0">Production of major amount of energy for the cell by oxidative phosphorylation is the most essential function of mitochondria. Other mitochondrial functions include apoptosis or programmed cell death, Ca<sup>2&#43;</sup> homoeostasis, etc. It has its own circular genome [mitochondrial DNA (mtDNA)], which codes for protein subunits for oxidative phosphorylation, tRNAs, and rRNAs. Some of the proteins involved in mitochondrial structure and functions are encoded by nuclear genome. Mutations in mtDNA are being studied and found to be causal for different mitochondrial diseases including cancer (<a href="#B1">1</a>, <a href="#B2">2</a>). Implications of mitochondrial function in cancer seem to be well-debated question. Manifestation of cancer includes uncontrollable cell proliferation, inhibited cell death, angiogenesis, invasion into other tissues, etc. Proper functioning of mitochondria is required to maintain rapid growth and proliferation of cancer cells since tumour cell devoid of mitochondria grows very slowly (<a href="#B3">3</a>&#x02013;<a href="#B5">5</a>). On the other hand, functional impairment of mitochondria is a common phenomenon in cancer cells since they undergo certain changes in metabolic pathways for their survival and maintenance (Figure <a href="#F1">1</a>). This review highlights metabolic reprogramming in cancer cell due to altered mitochondrial signalling.</p>
<div class="DottedLine"></div>
<div class="Imageheaders">FIGURE 1</div>
<div class="FigureDesc">
<a href="http://www.frontiersin.org/files/Articles/254974/fonc-07-00043-HTML/image_m/fonc-07-00043-g001.jpg" target="_blank">
<img src="http://www.frontiersin.org/files/Articles/254974/fonc-07-00043-HTML/image_t/fonc-07-00043-g001.gif" id="F1" alt="www.frontiersin.org" /></a>
<p><strong>Figure 1. Genes responsible for functional alterations in metabolic and signalling pathways of mitochondria in cancer cells</strong>.</p>
</div>
<div class="clear"></div>
<div class="DottedLine"></div>
<a id="h3"></a><h2>Hypoxia and Mitochondria</h2>
<p class="mb15">Hypoxia or oxygen deprivation is one of the key features of solid tumours and plays a significant role in different cellular functions including cell proliferation, survival, angiogenesis, metabolism, tumour evasion, and metastasis (<a href="#B6">6</a>). It also regulates tumour cells to have reduced response to radiotherapy, resistance to chemotherapy and lower pH than normal cells (<a href="#B7">7</a>&#x02013;<a href="#B9">9</a>). Proliferation rate of tumour cells is higher than the growth rate of new blood vessel formation, so newly generated cells are supplied with lower amount of oxygen. Depending on the aggressiveness of hypoxia, tumour cells either undergo apoptosis or adapt to the low oxygen environment and survive (<a href="#B10">10</a>). The key coordinator of cellular mechanisms to adapt and survive in hypoxic condition is hypoxia-inducible factor 1 (<i>HIF-1</i>). It is a transcription factor which consists of two subunits: <i>HIF-1&#x003B1;</i> whose expression is regulated by abundance of oxygen and <i>HIF-1&#x003B2;</i> which is constitutively expressed. Limited oxygen availability induces expression of <i>HIF-1</i> which regulates expression of several other genes (<a href="#B11">11</a>) functionally involved in the pathways of angiogenesis, cell death/survival, metabolism, pH regulation, cell adhesion, extracellular matrix remodelling, cell migration, and metastasis (<a href="#B9">9</a>).</p>
<p class="mb0">In presence of low oxygen in cell, pyruvate is mostly converted to lactate instead of acetyl CoA (Figure <a href="#F2">2</a>) and <i>HIF-1</i> induces expression of genes involved in the glycolytic pathway (such as glucose transporter, glycolytic enzymes, etc). <i>HIF-1</i> increases expression of pyruvate dehydrogenase kinase 1, a subunit of <i>PDK</i>, which blocks function of pyruvate dehydrogenase (<i>PDH</i>) enzyme leading to increase production of lactate (<a href="#B12">12</a>). Increased amount of lactate also induces <i>HIF-1</i>, which not only blocks acetyl-CoA metabolism in mitochondria, but also reduces mitochondrial biogenesis as well as oxygen consumption (<a href="#B13">13</a>, <a href="#B14">14</a>).</p>
<div class="DottedLine"></div>
<div class="Imageheaders">FIGURE 2</div>
<div class="FigureDesc">
<a href="http://www.frontiersin.org/files/Articles/254974/fonc-07-00043-HTML/image_m/fonc-07-00043-g002.jpg" target="_blank">
<img src="http://www.frontiersin.org/files/Articles/254974/fonc-07-00043-HTML/image_t/fonc-07-00043-g002.gif" id="F2" alt="www.frontiersin.org" /></a>
<p><strong>Figure 2. Schematic representation of metabolic pathways involving mitochondrial metabolites</strong>. Pathways or use of metabolites mentioned in red font are favoured in cancer cells for altered metabolism.</p>
</div>
<div class="clear"></div>
<div class="DottedLine"></div>
<p class="mb0 w100pc float_left mt15">Although mitochondrial energy production is a more efficient method than that of glycolytic pathway, tumour cells perform glycolytic and other/altered metabolic pathways to generate energy. Mitochondrial electron transport chain (<i>ETC</i>) is involved in oxygen sensing since <i>ETC</i> consume most of the cellular oxygen. Certain inhibitors of <i>ETC</i> can block stabilisation of <i>HIF-1&#x003B1;</i> in hypoxic conditions, which signifies that functioning of <i>ETC</i> is required for hypoxia-mediated activities of <i>HIF-1</i>. During hypoxia, <i>ETC</i> complex III can release reactive oxygen species (<i>ROS</i>) into mitochondrial inter-membrane space and subsequently into the cytosol. Thus, mitochondrial <i>ROS</i> generation contributes to <i>HIF-1</i>&#x003B1; stabilisation under hypoxic condition of the cell (<a href="#B15">15</a>).</p>
<a id="h4"></a><h2>Mitochondrial Metabolism and Tumour Growth</h2>
<p class="mb15">Mitochondria coordinate anabolic as well as catabolic reactions combined with energy production to achieve the needs of cellular bioenergetics and biosynthesis. Acetyl CoA, the key ingredient of mitochondrial metabolism and energy production is generated from breakdown of glucose, amino acids, and fatty acids. Necessity of mitochondrial metabolism for tumour growth is a well-discussed but yet it is an inconclusive area of research. According to one hypothesis, rapid proliferation and growth of tumour cells require functional mitochondria as it is the major source of energy as well as supplier of metabolic building blocks for tumour cells. Anaplerotic pathways which maintain pools of metabolic intermediates for repeated usage of rapid growth and proliferation are well-adapted in cancer cells. TCA cycle intermediates are also utilised as carbon sources, such as production of &#x003B1;-ketoglutarate (&#x003B1;-KG) from glutamine by glutaminolysis, oxaloacetate production from pyruvate by pyruvate carboxylation, oxidation of branched chain amino acids, etc., to the anaplerotic activity of cancer cells (<a href="#B16">16</a>&#x02013;<a href="#B18">18</a>).</p>
<p class="mb15">Perturbation of cell signalling pathways, such as <i>K-Ras, PI3K&#x02013;Akt&#x02013;mTROC1, Myc</i> signalling, play significant roles in mitochondrial metabolism of cancer cells. <i>K-Ras</i> oncogene decouples glucose and glutamine metabolism. It exhibits enhanced glycolytic activity as well as increased usage of glutamine as a carbon source of TCA cycle (<a href="#B19">19</a>). <i>PI3K&#x02013;Akt</i> signalling pathway is found to be altered very frequently in different cancers. <i>mTORC1</i>, being one of the major targets of activated <i>Akt</i>, regulates growth factor signalling, energy state, and nutrient and oxygen availability in cancer cells (<a href="#B20">20</a>&#x02013;<a href="#B23">23</a>). Oncogenic activation of <i>Myc</i> leads to activation of genes involved in glycolysis, glutamine metabolism, and mitochondrial biogenesis (<a href="#B24">24</a>&#x02013;<a href="#B27">27</a>).</p>
<p class="mb0">Mitochondrial TCA cycle enzymes, such as succinate dehydrogenase (SDH) and fumarate hydratase (FH), could function as mitochondrial tumour suppressors (<a href="#B28">28</a>). Individuals with germline loss-of-function mutations in <i>FH</i> gene are predisposed to hereditary paraganglioma, pheochromocytoma, leiomyomatosis, and renal carcinoma (<a href="#B29">29</a>, <a href="#B30">30</a>). Mutation-induced inactivation of SDH and FH results in accumulation of succinate and fumarate, respectively. These two metabolites leak out to cytosol to inhibit prolyl hydroxylase enzymes, which can promote cellular resistance to apoptotic signals or can activate pseudohypoxic response for triggering <i>HIF-1</i>-mediated glycolysis in cancer (<a href="#B31">31</a>, <a href="#B32">32</a>). Elevated succinate and fumarate can also lead to consequent alteration of genome-wide histone and DNA methylation by inhibiting &#x003B1;-KG dependent dioxygenase (such as histone demethylases and TET family of 5-methylcytosine hydroxylases) activity (<a href="#B30">30</a>, <a href="#B33">33</a>).</p>
<h3>Bioenergetics and Altered Metabolism</h3>
<p class="mb0">Warburg&#x02019;s hypothesis (1956) suggested cancer cells exhibit increased glycolysis and lactate production irrespective of the presence of oxygen (<a href="#B34">34</a>). Loss of tumour suppressors, activation of oncogenes, upregulation of <i>PI3K</i> pathway, and altered expression of mitochondrial metabolic enzymes may also result in increased glycolysis (<a href="#B35">35</a>, <a href="#B36">36</a>). Rate of glycolysis is increased in cancer cells but glycolytic products may enter mitochondria at different points of TCA cycle for energy production and growth, migration and metastasis of cancer cells (<a href="#B37">37</a>). On the other hand, cancer cells with mitochondrial respiration defects rely on energy generated by glycolysis. Inhibiting glycolysis in these cancers results in depletion in ATP production and finally leads to apoptosis of the cells (<a href="#B35">35</a>, <a href="#B38">38</a>). But in general, mitochondrial metabolism is necessary for cancer cell survival, proliferation, and growth. So, cancer cells adopt multiple mechanisms to maintain proper functioning of mitochondria. Moreover, in hypoxia and nutrient deficient conditions, mitochondria can modify its energy production as well as utilisation to adapt to the tumour microenvironment since mitochondrial ETC can produce ATP even at very low oxygen level (<a href="#B39">39</a>, <a href="#B40">40</a>). In these conditions, cancer cells can adapt different mechanisms to maintain their ATP/ADP ratio and decrease their demand for ATP as well as cellular functions which are ATP-dependent. In lower energy state (higher ADP/ATP or AMP/ATP ratio), activation of AMP kinase (<i>AMPK</i>) is triggered by mitochondrial adenylate kinase (<i>AK4</i>) and activates catabolic pathways (such as fatty acid oxidation) to stimulate ATP production (<a href="#B41">41</a>, <a href="#B42">42</a>).</p>
<h3>Biosynthesis of Metabolites</h3>
<p class="mb15">Rapid cell division and growth of cancer cells require good supply of macromolecules. Various anabolic pathways utilise simpler and smaller nutrient molecules such as glucose, fatty acids, and amino acids to produce larger molecules or building blocks for the cells. Mitochondria which work as a central organelle of cellular metabolic pathways perform different anabolic reactions to generate intermediate products for macromolecules.</p>
<p class="mb0">Biosynthetic pathways of fatty acids and amino acids were found to be upregulated in cancer cells indicating their importance as metabolites (<a href="#B43">43</a>, <a href="#B44">44</a>). Except pyruvate from glycolysis, other metabolic substrates from amino acid and fatty acid metabolism are also transported to mitochondria for further metabolic activities. When pyruvate is mostly being used for lactate production, the metabolites from fatty acid and amino acid metabolism pathways play central role for providing metabolic substrates to mitochondria. In hypoxic condition, when acetyl CoA production from pyruvate is impaired, glutamine acts as a biosynthetic precursor of acetyl CoA for sustainability of the tumour (<a href="#B40">40</a>).</p>
<h4>Glucose</h4>
<p class="mb15">Glucose is the most widely used nutrient in the body. Uptake of fluorodeoxyglucose (Fl-18), a glucose analogue, measured by positron emission tomography in cancer cells, was found to be increased as the cancer progresses (<a href="#B45">45</a>, <a href="#B46">46</a>). Recent evidences indicate, although lactate production is induced in cancer cells, glucose also produces pyruvate which enters into mitochondrial TCA cycle. Pyruvate is metabolized into <i>acetyl CoA</i> by mitochondrial <i>PDH</i> complex and it is then converted to citrate by citrate synthase. Citrate is either converted to isocitrate within TCA cycle or is transported to the cytosol to yield cytosolic <i>acetyl CoA</i> which is used as a substrate for lipogenesis and acetylation.</p>
<p class="mb0">The final and rate limiting factor of glycolytic pathway is the M2 isoform of pyruvate kinase (<i>PKM2</i>). <i>PKM2</i> dimer has low kinase activity and drives pyruvate to lactate formation, whereas <i>PKM2</i> tetramer which has higher kinase activity promotes the pyruvate to enter mitochondria for ATP production <i>via</i> oxidative phosphorylation pathway (<a href="#B47">47</a>). <i>PKM2</i> is commonly found to be highly expressed in cancers and induces rate of glycolysis, cell proliferation, migration, and invasion (<a href="#B48">48</a>&#x02013;<a href="#B50">50</a>). It functions as a coactivator of <i>HIF-1</i> by enhancing the Warburg effect in cancer. <i>PKM2</i> can also regulate cancer progression by activating mTOR or EGFR signalling pathway (<a href="#B47">47</a>, <a href="#B51">51</a>, <a href="#B52">52</a>).</p>
<h4>Amino Acids</h4>
<p class="mb15">Besides glucose, amino acids are also important substrates in mitochondrial biosynthesis of lipid and protein molecules. In absence of glucose, glutamine acts as major nutrient in cancer cells. Importance of glutamine in cellular metabolism is due to its ability to donate its carbon and nitrogen into different growth promoting pathways. Although, glutamine is a non-essential amino acid, during rapid growth and cell proliferation in tumour, it is required to be imported from outside source to meet the high demands of it. Glutamine catabolism occurs inside mitochondria by glutaminase to produce glutamate and ammonia. Glutamate functions as a precursor of cellular antioxidant glutathione and donates amino groups to synthesise non-essential amino acids like glycine, alanine, aspartate, and serine. Glutamate is also converted to &#x003B1;-KG, enters mitochondrial TCA cycle to provide carbon skeleton for macromolecules and contribute in ATP synthesis by oxidative phosphorylation (<a href="#B53">53</a>). Requirement of glutamine can be variable in different tumours. In some tumours, glutamine plays as an essential amino acid, whereas some tumours seem to be independent of glutamine and utilise glucose-derived pyruvate as major source of nutrient (<a href="#B54">54</a>).</p>
<p class="mb15">Glycine and serine are two other amino acids which have been identified to have significant importance in cancer metabolism. They are inter-convertible and biosynthesis of both the amino acids comprises cytosolic as well as mitochondrial enzymatic pathways. Hyper-activation of serine and glycine biosynthesis can accelerate tumourigenesis (<a href="#B55">55</a>). Activation of mitochondrial, but not cytosolic, enzymes for glycine biosynthesis, which is known to be significantly correlated with cancer cell proliferation, implicates importance of mitochondria in cell proliferation in cancer (<a href="#B56">56</a>). Moreover, glycine and succinyl CoA might condense to form 5-aminolevulinate which is key precursor for haem biosynthesis in mitochondria (<a href="#B57">57</a>). Iron modulates expression of four enzymes of TCA cycle, aconitase, citrate synthase, isocitrate dehydrogenase, and SDH. It also reduces glucose utilisation by increasing oxygen consumption and ATP synthesis in mitochondria. When iron is depleted, glycolysis and lactate formation are significantly increased to compensate for ATP production in mitochondria (<a href="#B58">58</a>). Increased supply and generation of <i>haem</i> induces oxygen consumption and energy production in mitochondria for progression of cancer cells, such as lung cancer (<a href="#B59">59</a>).</p>
<p class="mb0">Mutations in isocitrate dehydrogenase enzymes <i>IDH1</i> (cytosolic) and <i>IDH2</i> (mitochondrial) are highly frequent in glioma and AML, though rare in other cancers. Recurrent mutations in <i>Arg132</i> in <i>IDH1</i> and <i>Arg140</i> and <i>Arg172</i> in <i>IDH2</i> gene comprise 90% of the total mutations (<a href="#B60">60</a>&#x02013;<a href="#B63">63</a>). Mutant <i>IDH1 or IDH2</i> produces 2-hydroxyglutarate (2-HG), instead of &#x003B1;-KG (<a href="#B64">64</a>, <a href="#B65">65</a>), which functions as an oncometabolite. Accumulation of 2-HG in cells results in epigenetic dysregulation followed by aberrant gene expression (<a href="#B62">62</a>). <i>IDH1</i> and <i>IDH2</i> mutations are also responsible for hypermethylation, decreased differentiation, and increased stemness of cancer cells as well as <i>HIF-1</i>&#x003B1;-mediated angiogenesis and growth of tumour (<a href="#B66">66</a>&#x02013;<a href="#B68">68</a>).</p>
<h4>Fatty Acids</h4>
<p class="mb0">Lipogenesis is a common feature of different cancers. Although normal cells mostly depend on exogenous sources of lipid, cancer cells can execute <i>de novo</i> synthesis of fatty acids. It is one of the major components of cellular lipid which is needed for cell membrane synthesis, energy production, lipid modification of proteins, and signalling molecule production in highly proliferative cancer cells. In most of the cancers, cause of increased lipogenesis is due to overproduction of enzyme, fatty acid synthase (<i>FASN</i>). It performs the final catalytic step to convert acetyl CoA and malonyl CoA to fatty acids and functions as an oncogene by promoting cancer cell proliferation and growth. Suppression of <i>FASN</i> results in cell cycle arrest, reduction in cancer cell proliferation, and increase in apoptosis (<a href="#B69">69</a>&#x02013;<a href="#B74">74</a>). Another enzyme monoacylglycerol lipase that controls monoacylglycerol levels in normal cells is highly expressed in aggressive cancers and regulates a fatty acid network. This network has lipids with oncogenic potential and increases pathogenicity by promoting invasion, survival, and growth of the tumour (<a href="#B44">44</a>). Alternatively, low glucose content or food deprivation has been found to increase fatty acid oxidation in cancer (<a href="#B75">75</a>). Fatty acids are considered major source of energy in healthy cells as they can provide twice ATP than carbohydrates. Fatty acid oxidation (also known as &#x003B2;-oxidation) promotes cell proliferation and inhibits apoptosis in tumour cells (<a href="#B76">76</a>, <a href="#B77">77</a>). Other than ATP production, &#x003B2;-oxidation-derived NADPH is the key mediator of oxidative stress as well as the coenzyme for anabolic reactions (<a href="#B78">78</a>). <i>PPAR</i> genes play essential roles in &#x003B2;-oxidation by modulating enzymes involved in the pathway (<a href="#B79">79</a>). PPAR-gamma coactivator-1&#x003B1; (<i>PGC-1&#x003B1;</i>) is activated by low glucose content and activates <i>SIRT1</i>. Both <i>SIRT1</i> and <i>Sirtuin-3</i> (<i>SIRT3</i>) activate metabolic enzymes for &#x003B2;-oxidation of fatty acids into acetyl CoA (<a href="#B80">80</a>, <a href="#B81">81</a>) in mitochondria. Acetyl-CoA carboxylase (<i>ACC</i>) converts acetyl CoA to malonyl CoA in fatty acid synthetic pathway and is suppressed by <i>AMPK</i>. Hormones, such as leptin and adiponectin, activate <i>AMPK</i> and suppress <i>ACC</i> to inhibit fatty acid synthesis and increase fatty acid oxidation (<a href="#B82">82</a>, <a href="#B83">83</a>).</p>
<h4>Acetate</h4>
<p class="mb0">Recent studies on cancer metabolism have identified that certain tumours use exogenous acetate as an alternative source for producing acetyl CoA (<a href="#B84">84</a>&#x02013;<a href="#B86">86</a>). Even in a glucose abundant scenario, glucose and acetate are simultaneously used to produce TCA cycle intermediates. Tumours, especially those with hypoxic conditions can produce 50% of their acetyl CoA from acetate, while the remaining amount is produced by utilising glucose and glutamine as carbon sources (<a href="#B87">87</a>). Disease progression is correlated to the activity of the nucleo-cytosolic acetyl-CoA synthetase (<i>ACSS2</i>) (<a href="#B88">88</a>). <i>ACSS2</i> uses acetate as a carbon source to generate acetyl CoA. Tumours which utilise acetate as a carbon source also show elevated activity of <i>ACSS2</i>. Mutations causing <i>PTEN</i> and <i>BRAF</i> inactivation driving AKT and ERK pathways have been found to play role in increased expression of <i>ACSS2</i>. Tumours devoid of this enzyme consume less amount of acetate, undergo cell death, and subsequently reach to a reduced tumour size (<a href="#B86">86</a>).</p>
<h4>Mevalonate&#x02013;Isoprenoid Pathway</h4>
<p class="mb0">Mevalonate&#x02013;isoprenoid pathway is used for cellular cholesterol biosynthesis and protein prenylation and hyper-activated in many cancers. It activates proteins of RAS signalling pathway by prenylation leading to cell transformation and malignancy (<a href="#B89">89</a>, <a href="#B90">90</a>). Activation of this pathway shows chemoresistance in cancer cell line (<a href="#B91">91</a>) and also induces cancer metastasis by epithelial mesenchymal transition, remodelling of cytoskeleton, cell motility and cell polarity (non-canonical <i>Wnt</i>/planar pathway) (<a href="#B92">92</a>). Multiple factors can regulate mevalonate pathway. Mutant form of tumour suppressor protein <i>P53</i> induces protein prenylation of mevalonate pathway, thus maintaining malignancy, three-dimensional growth of tumour, and invasive growth (<a href="#B90">90</a>, <a href="#B93">93</a>, <a href="#B94">94</a>). Activation of <i>ARID1A</i> (a subunit of <i>SWI/SNF</i> chromatin remodelling complex) and <i>IGF-1R/AKT/mTOR</i> axis result in increased activity of mevalonate pathway in ovarian and colorectal cancer, respectively (<a href="#B95">95</a>, <a href="#B96">96</a>). <i>Kallikrein-related peptidase 5</i> (<i>KLK5</i>) protease can inhibit enzymes of mevalonate pathway in breast cancer (<a href="#B97">97</a>). Drugs like statin, quinazoline, and simvastatin show anticancer effects by inhibiting mevalonate pathway, which indicates possibility of building new therapeutic strategies targetting this pathway (<a href="#B92">92</a>, <a href="#B98">98</a>&#x02013;<a href="#B103">103</a>).</p>
<a id="h5"></a><h2>Mitophagy</h2>
<p class="mb0">Mitophagy or selective degradation of damaged mitochondria is a quality control mechanism for maintaining homoeostasis of functional mitochondria in cell (<a href="#B104">104</a>). Key regulation of mitophagy is executed through <i>PINK1&#x02013;Parkin</i> pathway. Under stress conditions like hypoxia and nutrient deficiency, <i>Parkin (E3 ubiquitin ligase</i>) is recruited by <i>PINK1</i> for proteasomal degradation of target proteins (VDAC1, mitofusin 1, mitofusin 2) at mitochondrial outer membrane (<a href="#B105">105</a>&#x02013;<a href="#B108">108</a>). Loss-of-function mutation, copy number variation, or deletion of <i>PARK2</i> (encoding Parkin protein) resulted in retaining damaged mitochondria in different cancers and, thus, indicates tumour suppressing role of mitophagy. In solid tumours, loss of Perkin induces aerobic glycolysis, thus supporting Warburg&#x02019;s hypothesis (<a href="#B109">109</a>).</p>
<a id="h6"></a><h2>Redox Signalling</h2>
<p class="mb0">Reactive oxygen species are, mostly, by-products of electron transporting systems in mitochondria. Although ROS have some important roles in transcriptional activation, cell proliferation, and other signalling pathways but excess amount of ROS is responsible for damaging cellular DNA, lipids, and proteins (<a href="#B110">110</a>). Antioxidant systems of the cell provide protection against excess amount of ROS. Excess redox signalling leads to carcinogenesis, tumour development and progression, cell migration, and angiogenesis. An increased quantity of ROS can activate hypoxia-mediated <i>HIF-1</i>&#x003B1; signalling pathway which might cause metabolic shift from oxidative phosphorylation to glycolysis by increasing expression of glycolytic enzymes. <i>HIF-1</i>&#x003B1; also reduces expression of tumour suppressor <i>SIRT3</i> which functions in activating antioxidants in mitochondria of healthy cell. Loss of <i>SIRT3</i> is reported in many cancers and it results in continuous steady state level of ROS and oxidative stress. Mitochondrial antioxidant systems which regulate ROS level are manganese superoxide dismutase (MnSOD or SOD2), mitochondrial glutaredoxin, glutathione peroxidise, and thioredoxin 2 (<a href="#B111">111</a>&#x02013;<a href="#B114">114</a>). Antioxidants have dual role in redox signalling pathway. In physiological ROS signalling, they function as tumour suppressor by inhibiting ROS-induced cell proliferation and survival needed for cancer progression. By contrast, excess ROS in tumour microenvironment promotes apoptotic signals and, then, antioxidants suppress those signals and act as tumour promoters. But, generally, these antioxidant systems protect cells against oxidative stress and ROS-induced cell death.</p>
<a id="h7"></a><h2>Mitochondria Biogenesis</h2>
<p class="mb0">Biogenesis of mitochondria is required in cells with high energy demands. DNA double strand breaks, induced by anticancer drugs, activate <i>ataxia telangiectasia mutated</i> to activate &#x003B1; subunit of <i>AMPK</i> to increase mitochondrial biogenesis (<a href="#B115">115</a>). Contradicting Warburg&#x02019;s hypothesis, recent studies have proposed a two-compartmental metabolic system in cancer (<a href="#B116">116</a>, <a href="#B117">117</a>). Cancer cell and surrounding stromal cells undergo metabolically symbiotic relationship, where the cancer cells have active mitochondria and increased mitochondrial biogenesis but the stromal cells contain dysfunctional mitochondria and take up glycolytic pathway (<a href="#B117">117</a>). Ketone bodies are also major energy sources for mitochondria and they are synthesized in tumour stroma with the help of enzymes, such as <i>HMGCS2, HMGCL, BDH1</i>, and re-utilised in tumour cells (<a href="#B116">116</a>). Severe oxidative stress leads to apoptotic cell death, whereas mild oxidative stress can increase mitochondrial biogenesis as well as mtDNA content in cancer cells. Key regulator of mitochondrial biogenesis is <i>PGC-1</i>&#x003B1;, which regulates expression of nuclear genes for respiratory chain function, transcription, and replication of mtDNA by activating transcription factors (<i>NRF-1</i> and <i>NRF-2</i>), tumour suppressor genes (<i>SIRT3</i>), nuclear coded mitochondrial enzymes (<i>POLRMT</i>), and transcription factor (mtTFA) (<a href="#B25">25</a>, <a href="#B118">118</a>&#x02013;<a href="#B121">121</a>). Activated <i>PGC-1</i>&#x003B1; in invasive cancer cells increases oxidative phosphorylation, oxygen consumption, and mitochondrial biogenesis and finally cell&#x02019;s potential for distant metastasis. Activation of <i>PGC-1</i>&#x003B1; for mitochondrial biogenesis can occur through different signalling pathways (such as <i>AMPK, NO&#x02013;cGMP, cAMP&#x02013;PKA&#x02013;CREB, p38</i>, and <i>ERR</i>&#x003B1; pathways) (<a href="#B122">122</a>&#x02013;<a href="#B124">124</a>). Alternatively, <i>HIF-1</i> negatively regulates mitochondrial biogenesis and oxygen consumption by inhibiting <i>C-MYC via MXI-1</i> dependent and <i>MXI-1</i> independent pathways in renal carcinoma (<a href="#B14">14</a>). Translation of nuclear-encoded mitochondrial function-related genes, protein folding, and entry in mitochondrial sub-compartments are regulated by <i>mTOR</i> which is often found to be hyper-activated in cancer (<a href="#B125">125</a>&#x02013;<a href="#B128">128</a>). Suppression of <i>mTOR</i> results in damage and loss of mitochondria in cancer (<a href="#B129">129</a>). <i>MYC</i>, which has known oncogenic effects in various cancers, induces nuclear-encoded mitochondrial gene expression and mitochondrial biogenesis in cancer (<a href="#B14">14</a>, <a href="#B25">25</a>, <a href="#B130">130</a>). Sustained expression of <i>MYC</i> can lead to increased production of <i>ROS</i> and subsequent genomic instability and mitochondrial dysfunction (<a href="#B131">131</a>, <a href="#B132">132</a>).</p>
<a id="h8"></a><h2>Mitochondrial Fission and Fusion</h2>
<p class="mb0">Fission and fusion, which are the key components in mitochondrial dynamics, modulate mitochondrial morphology and subsequently regulate essential cellular mechanisms such as cell growth, cell division, and distribution of mitochondria during differentiation (<a href="#B133">133</a>&#x02013;<a href="#B135">135</a>). Imbalance in expression of fission controlling protein dynamin-related protein 1 (<i>Drp1</i>) and fusion controlling protein <i>Mfn1</i> (mitofusin 1) is observed in different cancers. Increased fission or mitochondrial fragmentation due to high expression and activity of <i>Drp1</i> and decreased fusion due to loss of <i>Mfn1</i> activity are often linked to cancer cell migration, invasiveness, and metastasis (<a href="#B136">136</a>&#x02013;<a href="#B140">140</a>). Pathways mediated by <i>p53, PINK1</i>, and mitochondrial membrane proteins are also found to be involved in regulation of mitochondrial fission as well as chemosensitivity of cancer cells (<a href="#B141">141</a>&#x02013;<a href="#B144">144</a>). Other than proteins, mitochondrial lipids (cardiolipin, phosphatidylethanolamine, phosphatidic acid, diacylglycerol) also play important role in controlling mitochondrial dynamics (<a href="#B140">140</a>).</p>
<a id="h9"></a><h2>Calcium Homoeostasis</h2>
<p class="mb0">Calcium ion concentration is a key regulator of various signalling pathways of the cytosol and cellular organelles. Under physiological conditions, Ca<sup>2&#43;</sup> plays a beneficiary role by producing higher glycolytic and mitochondrial pathway enzymes (such as <i>PDH</i>, isocitrate dehydrogenase, &#x003B1;-KG dehydrogenase, ATP synthase, and &#x003B1;-glycerophosphate dehydrogenase), increasing oxidative phosphorylation activity and activating metabolite carriers (aspartate/glutamate carrier) of mitochondria. On the contrary, higher concentration of Ca<sup>2&#43;</sup> within mitochondria induces several negative effects on mitochondrial function which finally leads to apoptosis (<a href="#B145">145</a>, <a href="#B146">146</a>). Mitochondrial stress (such as mtDNA depletion) in cancer cells results in increased cytosolic Ca<sup>2&#43;</sup>, activation of calcium dependent <i>MAPK</i> (<i>ERK1</i> and <i>ERK2</i>) and calcineurin, increased anti-apoptotic proteins, and loss of pro-apoptotic proteins (<a href="#B147">147</a>). Mitochondria-associated membrane (MAM) structure which is the interacting interface between ER and mitochondrial outer membrane, functions as the gateway of Ca<sup>2&#43;</sup> release from ER to mitochondria. Oncoproteins and tumour suppressor proteins residing on MAM control apoptosis <i>via</i> Ca<sup>2&#43;</sup> homoeostasis. Ca<sup>2&#43;</sup> release from ER as well as uptake by mitochondria are inhibited by several oncogenes like <i>AKT, Bcl2</i>, and <i>K-Ras</i> to trigger anti-apoptotic signalling in cancer cells (<a href="#B148">148</a>&#x02013;<a href="#B150">150</a>). Functional loss of ER protein PERK and mitochondrial calcium channel (MCU) are also known to have anti-apoptotic effects in cancer (<a href="#B151">151</a>&#x02013;<a href="#B153">153</a>).</p>
<a id="h10"></a><h2>Cell Death</h2>
<p class="mb15">Cell death is a physiological regulator for development, tissue homoeostasis, stress, and also functions as tumour suppressor. Besides apoptosis, mitochondria are also found to be involved in other cell death mechanisms such as autophagy, necrosis, and necroptosis (programmed necrosis) (<a href="#B154">154</a>&#x02013;<a href="#B156">156</a>). Proteins known as inhibitors of apoptosis (<i>IAP</i>s) are overexpressed in cancer and inhibit caspases or procaspases (primarily caspase-3 and caspase-7) to suppress apoptosis. Cancer cells with activated IAPs become highly resistant to radiation or chemotherapy (<a href="#B157">157</a>). Anti-apoptotic proteins of <i>BCL2</i> family are overexpressed in cancer and inhibit the pro-apoptotic proteins to initiate the process of cell death. Thus, <i>BCL2</i> proteins are targetted by <i>BCL2</i>-inhibitors in cancer therapy to promote apoptosis (<a href="#B158">158</a>, <a href="#B159">159</a>). Tumour suppressor, <i>P53</i>, plays an important role in promoting cell death. It is activated in ROS-dependent pathway and inhibits oncogenes <i>via</i> JNK-mediated signalling pathway leading to apoptosis in cancer (<a href="#B160">160</a>, <a href="#B161">161</a>). Inhibited cell growth and increased apoptosis in cancer by P53 activation are also regulated by miRNA or SIRT2 dependent pathways (<a href="#B162">162</a>, <a href="#B163">163</a>).</p>
<p class="mb0">Mitochondrial fission- and fusion-related proteins, <i>Drp1</i> and mitofusin (<i>Mfn1</i> and <i>Mfn2</i>), are found to be involved in cell death (<a href="#B164">164</a>). <i>Drp1</i> induces mitochondrial fragmentation and apoptosis in a <i>BAX/BAK</i>-mediated pathway. Overexpression of <i>Drp1</i> increases <i>ROS</i> production, release of cytochrome <i>c</i>, and <i>PARP</i> cleavage (<a href="#B165">165</a>, <a href="#B166">166</a>). Being phosphorylated by <i>ERK, Mfn1</i> modulates apoptosis and fusion. Mutant <i>Mfn1</i> binds to <i>BAK</i> more strongly inducing <i>BAK</i> activation and cell death (<a href="#B167">167</a>). <i>Mfn2</i> promotes anti-proliferative and pro-apoptotic effects <i>via PI3K&#x02013;AKT</i> signalling pathway and lower expression of <i>Mfn2</i> is associated with poor survival in cancer (<a href="#B168">168</a>, <a href="#B169">169</a>).</p>
<a id="h11"></a><h2>Mutations in Mitochondrial Genome</h2>
<p class="mb0">Somatic mutations in mitochondrial genome (mtDNA) are common and frequently reported in different types of cancer (<a href="#B170">170</a>&#x02013;<a href="#B177">177</a>). Functional consequences of these mutations are not well understood. These mutations are mostly point mutations, small insertion&#x02013;deletions, or large scale deletions distributed in protein coding genes (<a href="#B177">177</a>, <a href="#B178">178</a>). These mutations are thought to arise due to poor DNA repair mechanism and direct exposure to ROS, although oxidative stress is not always considered as a major contributor to somatic mutations (<a href="#B179">179</a>). Mutations in coding genes might cause functional imbalance in respiratory chain. Mutant respiratory chain proteins promote elevation of ROS, tumour size, and glycolysis <i>via HIF-1</i>-mediated pathway in head and neck and prostate cancer (<a href="#B180">180</a>, <a href="#B181">181</a>).</p>
<a id="h12"></a><h2>Conclusion</h2>
<p class="mb0">Mitochondria are essential organelles for energy production but play important roles in carcinogenesis, cancer progression, and metastasis helping altered energy metabolism in cancer cells. Mitochondrial metabolism is also connected with other mitochondrial pathways such as redox signalling, Ca<sup>2&#43;</sup> signalling, mitophagy, and mitochondrial biogenesis. These pathways cross talk and seem to play important roles in cancer. Targeting mitochondrial pathways individually or in combination might be considered as future cancer therapy. Recently, cancer researchers are focussing on the metabolic reprogramming of cancer cells to use altered metabolites/oncometabolites for therapeutic approach.</p>
<a id="h13"></a><h2>Author Contributions</h2>
<p class="mb0">EC wrote the draft of the manuscript and BR revised and finished it.</p>
<a id="h14"></a><h2>Conflict of Interest Statement</h2>
<p class="mb0">Authors declare that the manuscript was written in absence of any commercial or financial relationships that could be constructed as a potential conflict of interest.</p>
<a id="h15"></a><h2>Acknowledgments</h2>
<p class="mb0">Indian Statistical Institute provided fellowship to EC.</p>
<a id="h16"></a><h2>Funding</h2>
<p class="mb0">No funding was needed for the manuscript.</p>
<a id="h17"></a><h2>Abbreviations</h2>
<p class="mb0">mtDNA, mitochondrial DNA; ETC, electron transport chain; ROS, reactive oxygen species.</p>
<a id="h18"></a><h2>References</h2>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.1em;" class="ReferencesCopy1"><a id="B1"></a>1. Taylor RW, Turnbull DM. Mitochondrial DNA mutations in human disease. <i>Nat Rev Genet</i> (2005) 6(5):389&#x02013;402. doi:10.1038/nrg1606</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1038/nrg1606" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Mitochondrial+DNA+mutations+in+human+disease&#x00026;author=R.+W.+Taylor&#x00026;author=D.+M.+Turnbull&#x00026;journal=Nat+Rev+Genet&#x00026;publication_year=2005&#x00026;volume=6&#x00026;pages=389&#x02013;402&#x00026;doi=10.1038/nrg1606" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.1em;" class="ReferencesCopy1"><a id="B2"></a>2. Falk MJ, Sondheimer N. Mitochondrial genetic diseases. <i>Curr Opin Pediatr</i> (2010) 22(6):711&#x02013;6. doi:10.1097/MOP.0b013e3283402e21</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=21045694" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1097/MOP.0b013e3283402e21" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Mitochondrial+genetic+diseases&#x00026;author=M.+J.+Falk&#x00026;author=N.+Sondheimer&#x00026;journal=Curr+Opin+Pediatr&#x00026;publication_year=2010&#x00026;volume=22&#x00026;pages=711&#x02013;6&#x00026;doi=10.1097/MOP.0b013e3283402e21&#x00026;pmid=21045694" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.1em;" class="ReferencesCopy1"><a id="B3"></a>3. Holmuhamedov E, Lewis L, Bienengraeber M, Holmuhamedova M, Jahangir A, Terzic A. Suppression of human tumor cell proliferation through mitochondrial targeting. <i>FASEB J</i> (2002) 16(9):1010&#x02013;6. doi:10.1096/fj.01-0996com</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=12087062" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1096/fj.01-0996com" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Suppression+of+human+tumor+cell+proliferation+through+mitochondrial+targeting&#x00026;author=E.+Holmuhamedov&#x00026;author=L.+Lewis&#x00026;author=M.+Bienengraeber&#x00026;author=M.+Holmuhamedova&#x00026;author=A.+Jahangir&#x00026;author=A.+Terzic&#x00026;journal=FASEB+J&#x00026;publication_year=2002&#x00026;volume=16&#x00026;pages=1010&#x02013;6&#x00026;doi=10.1096/fj.01-0996com&#x00026;pmid=12087062" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.1em;" class="ReferencesCopy1"><a id="B4"></a>4. Mullen AR, Wheaton WW, Jin ES, Chen PH, Sullivan LB, Cheng T, et al. Reductive carboxylation supports growth in tumour cells with defective mitochondria. <i>Nature</i> (2011) 481(7381):385&#x02013;8. doi:10.1038/nature10642</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=22101431" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nature10642" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Reductive+carboxylation+supports+growth+in+tumour+cells+with+defective+mitochondria&#x00026;author=A.+R.+Mullen&#x00026;author=W.+W.+Wheaton&#x00026;author=E.+S.+Jin&#x00026;author=P.+H.+Chen&#x00026;author=L.+B.+Sullivan&#x00026;author=T.+Cheng&#x00026;journal=Nature&#x00026;publication_year=2011&#x00026;volume=481&#x00026;pages=385&#x02013;8&#x00026;doi=10.1038/nature10642&#x00026;pmid=22101431" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.1em;" class="ReferencesCopy1"><a id="B5"></a>5. Tan AS, Baty JW, Dong LF, Bezawork-Geleta A, Endaya B, Goodwin J, et al. Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA. <i>Cell Metab</i> (2015) 21(1):81&#x02013;94. doi:10.1016/j.cmet.2014.12.003</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=25565207" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.cmet.2014.12.003" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Mitochondrial+genome+acquisition+restores+respiratory+function+and+tumorigenic+potential+of+cancer+cells+without+mitochondrial+DNA&#x00026;author=A.+S.+Tan&#x00026;author=J.+W.+Baty&#x00026;author=L.+F.+Dong&#x00026;author=A.+Bezawork-Geleta&#x00026;author=B.+Endaya&#x00026;author=J.+Goodwin&#x00026;journal=Cell+Metab&#x00026;publication_year=2015&#x00026;volume=21&#x00026;pages=81&#x02013;94&#x00026;doi=10.1016/j.cmet.2014.12.003&#x00026;pmid=25565207" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.1em;" class="ReferencesCopy1"><a id="B6"></a>6. Ruan K, Song G, Ouyang G. Role of hypoxia in the hallmarks of human cancer. <i>J Cell Biochem</i> (2009) 107(6):1053&#x02013;62. doi:10.1002/jcb.22214</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=19479945" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1002/jcb.22214" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Role+of+hypoxia+in+the+hallmarks+of+human+cancer&#x00026;author=K.+Ruan&#x00026;author=G.+Song&#x00026;author=G.+Ouyang&#x00026;journal=J+Cell+Biochem&#x00026;publication_year=2009&#x00026;volume=107&#x00026;pages=1053&#x02013;62&#x00026;doi=10.1002/jcb.22214&#x00026;pmid=19479945" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.1em;" class="ReferencesCopy1"><a id="B7"></a>7. Brahimi-Horn MC, Chiche J, Pouyssegur J. Hypoxia and cancer. <i>J Mol Med (Berl)</i> (2007) 85(12):1301&#x02013;7. doi:10.1007/s00109-007-0281-3</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1007/s00109-007-0281-3" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Hypoxia+and+cancer&#x00026;author=M.+C.+Brahimi-Horn&#x00026;author=J.+Chiche&#x00026;author=J.+Pouyssegur&#x00026;journal=J+Mol+Med+(Berl)&#x00026;publication_year=2007&#x00026;volume=85&#x00026;pages=1301&#x02013;7&#x00026;doi=10.1007/s00109-007-0281-3" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.1em;" class="ReferencesCopy1"><a id="B8"></a>8. Chiche J, Brahimi-Horn MC, Pouyssegur J. Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. <i>J Cell Mol Med</i> (2010) 14(4):771&#x02013;94. doi:10.1111/j.1582-4934.2009.00994.x</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1111/j.1582-4934.2009.00994.x" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Tumour+hypoxia+induces+a+metabolic+shift+causing+acidosis:+a+common+feature+in+cancer&#x00026;author=J.+Chiche&#x00026;author=M.+C.+Brahimi-Horn&#x00026;author=J.+Pouyssegur&#x00026;journal=J+Cell+Mol+Med&#x00026;publication_year=2010&#x00026;volume=14&#x00026;pages=771&#x02013;94&#x00026;doi=10.1111/j.1582-4934.2009.00994.x" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.1em;" class="ReferencesCopy1"><a id="B9"></a>9. Semenza GL. HIF-1: upstream and downstream of cancer metabolism. <i>Curr Opin Genet Dev</i> (2010) 20(1):51&#x02013;6. doi:10.1016/j.gde.2009.10.009</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=19942427" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.gde.2009.10.009" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=HIF-1:+upstream+and+downstream+of+cancer+metabolism&#x00026;author=G.+L.+Semenza&#x00026;journal=Curr+Opin+Genet+Dev&#x00026;publication_year=2010&#x00026;volume=20&#x00026;pages=51&#x02013;6&#x00026;doi=10.1016/j.gde.2009.10.009&#x00026;pmid=19942427" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B10"></a>10. Greijer AE, van der Wall E. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. <i>J Clin Pathol</i> (2004) 57(10):1009&#x02013;14. doi:10.1136/jcp.2003.015032</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1136/jcp.2003.015032" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=The+role+of+hypoxia+inducible+factor+1+(HIF-1)+in+hypoxia+induced+apoptosis&#x00026;author=A.+E.+Greijer&#x00026;author=E.+van+der+Wall&#x00026;journal=J+Clin+Pathol&#x00026;publication_year=2004&#x00026;volume=57&#x00026;pages=1009&#x02013;14&#x00026;doi=10.1136/jcp.2003.015032" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B11"></a>11. Mole DR, Blancher C, Copley RR, Pollard PJ, Gleadle JM, Ragoussis J, et al. Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts. <i>J Biol Chem</i> (2009) 284(25):16767&#x02013;75. doi:10.1074/jbc.M901790200</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=19386601" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1074/jbc.M901790200" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Genome-wide+association+of+hypoxia-inducible+factor+(HIF)-1alpha+and+HIF-2alpha+DNA+binding+with+expression+profiling+of+hypoxia-inducible+transcripts&#x00026;author=D.+R.+Mole&#x00026;author=C.+Blancher&#x00026;author=R.+R.+Copley&#x00026;author=P.+J.+Pollard&#x00026;author=J.+M.+Gleadle&#x00026;author=J.+Ragoussis&#x00026;journal=J+Biol+Chem&#x00026;publication_year=2009&#x00026;volume=284&#x00026;pages=16767&#x02013;75&#x00026;doi=10.1074/jbc.M901790200&#x00026;pmid=19386601" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B12"></a>12. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. <i>Cell Metab</i> (2006) 3(3):177&#x02013;85. doi:10.1016/j.cmet.2006.02.002</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16517405" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.cmet.2006.02.002" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=HIF-1-mediated+expression+of+pyruvate+dehydrogenase+kinase:+a+metabolic+switch+required+for+cellular+adaptation+to+hypoxia&#x00026;author=J.+W.+Kim&#x00026;author=I.+Tchernyshyov&#x00026;author=G.+L.+Semenza&#x00026;author=C.+V.+Dang&#x00026;journal=Cell+Metab&#x00026;publication_year=2006&#x00026;volume=3&#x00026;pages=177&#x02013;85&#x00026;doi=10.1016/j.cmet.2006.02.002&#x00026;pmid=16517405" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B13"></a>13. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. <i>Cell Metab</i> (2006) 3(3):187&#x02013;97. doi:10.1016/j.cmet.2006.01.012</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16517406" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.cmet.2006.01.012" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=HIF-1+mediates+adaptation+to+hypoxia+by+actively+downregulating+mitochondrial+oxygen+consumption&#x00026;author=I.+Papandreou&#x00026;author=R.+A.+Cairns&#x00026;author=L.+Fontana&#x00026;author=A.+L.+Lim&#x00026;author=N.+C.+Denko&#x00026;journal=Cell+Metab&#x00026;publication_year=2006&#x00026;volume=3&#x00026;pages=187&#x02013;97&#x00026;doi=10.1016/j.cmet.2006.01.012&#x00026;pmid=16517406" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B14"></a>14. Zhang H, Gao P, Fukuda R, Kumar G, Krishnamachary B, Zeller KI, et al. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. <i>Cancer Cell</i> (2007) 11(5):407&#x02013;20. doi:10.1016/j.ccr.2007.04.001</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.ccr.2007.04.001" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=HIF-1+inhibits+mitochondrial+biogenesis+and+cellular+respiration+in+VHL-deficient+renal+cell+carcinoma+by+repression+of+C-MYC+activity&#x00026;author=H.+Zhang&#x00026;author=P.+Gao&#x00026;author=R.+Fukuda&#x00026;author=G.+Kumar&#x00026;author=B.+Krishnamachary&#x00026;author=K.+I.+Zeller&#x00026;journal=Cancer+Cell&#x00026;publication_year=2007&#x00026;volume=11&#x00026;pages=407&#x02013;20&#x00026;doi=10.1016/j.ccr.2007.04.001" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B15"></a>15. Klimova T, Chandel NS. Mitochondrial complex III regulates hypoxic activation of HIF. <i>Cell Death Differ</i> (2008) 15(4):660&#x02013;6. doi:10.1038/sj.cdd.4402307</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1038/sj.cdd.4402307" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Mitochondrial+complex+III+regulates+hypoxic+activation+of+HIF&#x00026;author=T.+Klimova&#x00026;author=N.+S.+Chandel&#x00026;journal=Cell+Death+Differ&#x00026;publication_year=2008&#x00026;volume=15&#x00026;pages=660&#x02013;6&#x00026;doi=10.1038/sj.cdd.4402307" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B16"></a>16. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. <i>Cell Metab</i> (2008) 7(1):11&#x02013;20. doi:10.1016/j.cmet.2007.10.002</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.cmet.2007.10.002" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=The+biology+of+cancer:+metabolic+reprogramming+fuels+cell+growth+and+proliferation&#x00026;author=R.+J.+DeBerardinis&#x00026;author=J.+J.+Lum&#x00026;author=G.+Hatzivassiliou&#x00026;author=C.+B.+Thompson&#x00026;journal=Cell+Metab&#x00026;publication_year=2008&#x00026;volume=7&#x00026;pages=11&#x02013;20&#x00026;doi=10.1016/j.cmet.2007.10.002" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B17"></a>17. Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. <i>Nature</i> (2011) 476(7360):346&#x02013;50. doi:10.1038/nature10350</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1038/nature10350" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Functional+genomics+reveal+that+the+serine+synthesis+pathway+is+essential+in+breast+cancer&#x00026;author=R.+Possemato&#x00026;author=K.+M.+Marks&#x00026;author=Y.+D.+Shaul&#x00026;author=M.+E.+Pacold&#x00026;author=D.+Kim&#x00026;author=K.+Birsoy&#x00026;journal=Nature&#x00026;publication_year=2011&#x00026;volume=476&#x00026;pages=346&#x02013;50&#x00026;doi=10.1038/nature10350" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B18"></a>18. Sellers K, Fox MP, Bousamra M II, Slone SP, Higashi RM, Miller DM, et al. Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation. <i>J Clin Invest</i> (2015) 125(2):687&#x02013;98. doi:10.1172/JCI72873</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1172/JCI72873" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Pyruvate+carboxylase+is+critical+for+non-small-cell+lung+cancer+proliferation&#x00026;author=K.+Sellers&#x00026;author=M.+P.+Fox&#x00026;author=M.+Bousamra&#x00026;author=S.+P.+Slone&#x00026;author=R.+M.+Higashi&#x00026;author=D.+M.+Miller&#x00026;journal=J+Clin+Invest&#x00026;publication_year=2015&#x00026;volume=125&#x00026;pages=687&#x02013;98&#x00026;doi=10.1172/JCI72873" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B19"></a>19. Gaglio D, Metallo CM, Gameiro PA, Hiller K, Danna LS, Balestrieri C, et al. Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth. <i>Mol Syst Biol</i> (2011) 7:523. doi:10.1038/msb.2011.56</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1038/msb.2011.56" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Oncogenic+K-Ras+decouples+glucose+and+glutamine+metabolism+to+support+cancer+cell+growth&#x00026;author=D.+Gaglio&#x00026;author=C.+M.+Metallo&#x00026;author=P.+A.+Gameiro&#x00026;author=K.+Hiller&#x00026;author=L.+S.+Danna&#x00026;author=C.+Balestrieri&#x00026;journal=Mol+Syst+Biol&#x00026;publication_year=2011&#x00026;volume=7&#x00026;pages=523&#x00026;doi=10.1038/msb.2011.56" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B20"></a>20. Osaki M, Oshimura M, Ito H. PI3K-Akt pathway: its functions and alterations in human cancer. <i>Apoptosis</i> (2004) 9(6):667&#x02013;76. doi:10.1023/B:APPT.0000045801.15585.dd</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=15505410" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1023/B:APPT.0000045801.15585.dd" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=PI3K-Akt+pathway:+its+functions+and+alterations+in+human+cancer&#x00026;author=M.+Osaki&#x00026;author=M.+Oshimura&#x00026;author=H.+Ito&#x00026;journal=Apoptosis&#x00026;publication_year=2004&#x00026;volume=9&#x00026;pages=667&#x02013;76&#x00026;doi=10.1023/B:APPT.0000045801.15585.dd&#x00026;pmid=15505410" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B21"></a>21. Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Exploiting the PI3K/AKT pathway for cancer drug discovery. <i>Nat Rev Drug Discov</i> (2005) 4(12):988&#x02013;1004. doi:10.1038/nrd1902</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16341064" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nrd1902" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Exploiting+the+PI3K/AKT+pathway+for+cancer+drug+discovery&#x00026;author=B.+T.+Hennessy&#x00026;author=D.+L.+Smith&#x00026;author=P.+T.+Ram&#x00026;author=Y.+Lu&#x00026;author=G.+B.+Mills&#x00026;journal=Nat+Rev+Drug+Discov&#x00026;publication_year=2005&#x00026;volume=4&#x00026;pages=988&#x02013;1004&#x00026;doi=10.1038/nrd1902&#x00026;pmid=16341064" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B22"></a>22. Samuels Y, Ericson K. Oncogenic PI3K and its role in cancer. <i>Curr Opin Oncol</i> (2006) 18(1):77&#x02013;82. doi:10.1097/01.cco.0000198021.99347.b9</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1097/01.cco.0000198021.99347.b9" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Oncogenic+PI3K+and+its+role+in+cancer&#x00026;author=Y.+Samuels&#x00026;author=K.+Ericson&#x00026;journal=Curr+Opin+Oncol&#x00026;publication_year=2006&#x00026;volume=18&#x00026;pages=77&#x02013;82&#x00026;doi=10.1097/01.cco.0000198021.99347.b9" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B23"></a>23. Engelman JA. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. <i>Nat Rev Cancer</i> (2009) 9(8):550&#x02013;62. doi:10.1038/nrc2664</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=19629070" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nrc2664" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Targeting+PI3K+signalling+in+cancer:+opportunities,+challenges+and+limitations&#x00026;author=J.+A.+Engelman&#x00026;journal=Nat+Rev+Cancer&#x00026;publication_year=2009&#x00026;volume=9&#x00026;pages=550&#x02013;62&#x00026;doi=10.1038/nrc2664&#x00026;pmid=19629070" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B24"></a>24. Osthus RC, Shim H, Kim S, Li Q, Reddy R, Mukherjee M, et al. Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. <i>J Biol Chem</i> (2000) 275(29):21797&#x02013;800. doi:10.1074/jbc.C000023200</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1074/jbc.C000023200" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Deregulation+of+glucose+transporter+1+and+glycolytic+gene+expression+by+c-Myc&#x00026;author=R.+C.+Osthus&#x00026;author=H.+Shim&#x00026;author=S.+Kim&#x00026;author=Q.+Li&#x00026;author=R.+Reddy&#x00026;author=M.+Mukherjee&#x00026;journal=J+Biol+Chem&#x00026;publication_year=2000&#x00026;volume=275&#x00026;pages=21797&#x02013;800&#x00026;doi=10.1074/jbc.C000023200" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B25"></a>25. Li F, Wang Y, Zeller KI, Potter JJ, Wonsey DR, O&#x02019;Donnell KA, et al. Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. <i>Mol Cell Biol</i> (2005) 25(14):6225&#x02013;34. doi:10.1128/MCB.25.14.6225-6234.2005</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1128/MCB.25.14.6225-6234.2005" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Myc+stimulates+nuclearly+encoded+mitochondrial+genes+and+mitochondrial+biogenesis&#x00026;author=F.+Li&#x00026;author=Y.+Wang&#x00026;author=K.+I.+Zeller&#x00026;author=J.+J.+Potter&#x00026;author=D.+R.+Wonsey&#x00026;author=K.+A.+O&#x02019;Donnell&#x00026;journal=Mol+Cell+Biol&#x00026;publication_year=2005&#x00026;volume=25&#x00026;pages=6225&#x02013;34&#x00026;doi=10.1128/MCB.25.14.6225-6234.2005" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B26"></a>26. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. <i>Nature</i> (2009) 458(7239):762&#x02013;5. doi:10.1038/nature07823</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=19219026" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nature07823" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=c-Myc+suppression+of+miR-23a/b+enhances+mitochondrial+glutaminase+expression+and+glutamine+metabolism&#x00026;author=P.+Gao&#x00026;author=I.+Tchernyshyov&#x00026;author=T.+C.+Chang&#x00026;author=Y.+S.+Lee&#x00026;author=K.+Kita&#x00026;author=T.+Ochi&#x00026;journal=Nature&#x00026;publication_year=2009&#x00026;volume=458&#x00026;pages=762&#x02013;5&#x00026;doi=10.1038/nature07823&#x00026;pmid=19219026" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B27"></a>27. Dang CV. MYC on the path to cancer. <i>Cell</i> (2012) 149(1):22&#x02013;35. doi:10.1016/j.cell.2012.03.003</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.cell.2012.03.003" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=MYC+on+the+path+to+cancer&#x00026;author=C.+V.+Dang&#x00026;journal=Cell&#x00026;publication_year=2012&#x00026;volume=149&#x00026;pages=22&#x02013;35&#x00026;doi=10.1016/j.cell.2012.03.003" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B28"></a>28. Gottlieb E, Tomlinson IP. Mitochondrial tumour suppressors: a genetic and biochemical update. <i>Nat Rev Cancer</i> (2005) 5(11):857&#x02013;66. doi:10.1038/nrc1737</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16327764" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nrc1737" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Mitochondrial+tumour+suppressors:+a+genetic+and+biochemical+update&#x00026;author=E.+Gottlieb&#x00026;author=I.+P.+Tomlinson&#x00026;journal=Nat+Rev+Cancer&#x00026;publication_year=2005&#x00026;volume=5&#x00026;pages=857&#x02013;66&#x00026;doi=10.1038/nrc1737&#x00026;pmid=16327764" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B29"></a>29. Kuwada M, Chihara Y, Lou Y, Torimoto K, Kagebayashi Y, Tamura K, et al. Novel missense mutation in the FH gene in familial renal cell cancer patients lacking cutaneous leiomyomas. <i>BMC Res Notes</i> (2014) 7:203. doi:10.1186/1756-0500-7-203</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=24684806" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1186/1756-0500-7-203" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Novel+missense+mutation+in+the+FH+gene+in+familial+renal+cell+cancer+patients+lacking+cutaneous+leiomyomas&#x00026;author=M.+Kuwada&#x00026;author=Y.+Chihara&#x00026;author=Y.+Lou&#x00026;author=K.+Torimoto&#x00026;author=Y.+Kagebayashi&#x00026;author=K.+Tamura&#x00026;journal=BMC+Res+Notes&#x00026;publication_year=2014&#x00026;volume=7&#x00026;pages=203&#x00026;doi=10.1186/1756-0500-7-203&#x00026;pmid=24684806" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B30"></a>30. Hoekstra AS, de Graaff MA, Briaire-de Bruijn IH, Ras C, Seifar RM, van Minderhout I, et al. Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors. <i>Oncotarget</i> (2015) 6(36):38777&#x02013;88. doi:10.18632/oncotarget.6091</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=26472283" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.18632/oncotarget.6091" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Inactivation+of+SDH+and+FH+cause+loss+of+5hmC+and+increased+H3K9me3+in+paraganglioma/pheochromocytoma+and+smooth+muscle+tumors&#x00026;author=A.+S.+Hoekstra&#x00026;author=M.+A.+de+Graaff&#x00026;author=I.+H.+Briaire-de+Bruijn&#x00026;author=C.+Ras&#x00026;author=R.+M.+Seifar&#x00026;author=I.+van+Minderhout&#x00026;journal=Oncotarget&#x00026;publication_year=2015&#x00026;volume=6&#x00026;pages=38777&#x02013;88&#x00026;doi=10.18632/oncotarget.6091&#x00026;pmid=26472283" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B31"></a>31. Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, Chung YL, et al. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. <i>Cancer Cell</i> (2005) 8(2):143&#x02013;53. doi:10.1016/j.ccr.2005.06.017</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16098467" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.ccr.2005.06.017" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=HIF+overexpression+correlates+with+biallelic+loss+of+fumarate+hydratase+in+renal+cancer:+novel+role+of+fumarate+in+regulation+of+HIF+stability&#x00026;author=J.+S.+Isaacs&#x00026;author=Y.+J.+Jung&#x00026;author=D.+R.+Mole&#x00026;author=S.+Lee&#x00026;author=C.+Torres-Cabala&#x00026;author=Y.+L.+Chung&#x00026;journal=Cancer+Cell&#x00026;publication_year=2005&#x00026;volume=8&#x00026;pages=143&#x02013;53&#x00026;doi=10.1016/j.ccr.2005.06.017&#x00026;pmid=16098467" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B32"></a>32. King A, Selak MA, Gottlieb E. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. <i>Oncogene</i> (2006) 25(34):4675&#x02013;82. doi:10.1038/sj.onc.1209594</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1038/sj.onc.1209594" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Succinate+dehydrogenase+and+fumarate+hydratase:+linking+mitochondrial+dysfunction+and+cancer&#x00026;author=A.+King&#x00026;author=M.+A.+Selak&#x00026;author=E.+Gottlieb&#x00026;journal=Oncogene&#x00026;publication_year=2006&#x00026;volume=25&#x00026;pages=4675&#x02013;82&#x00026;doi=10.1038/sj.onc.1209594" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B33"></a>33. Xiao M, Yang H, Xu W, Ma S, Lin H, Zhu H, et al. Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. <i>Genes Dev</i> (2012) 26(12):1326&#x02013;38. doi:10.1101/gad.191056.112</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1101/gad.191056.112" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Inhibition+of+alpha-KG-dependent+histone+and+DNA+demethylases+by+fumarate+and+succinate+that+are+accumulated+in+mutations+of+FH+and+SDH+tumor+suppressors&#x00026;author=M.+Xiao&#x00026;author=H.+Yang&#x00026;author=W.+Xu&#x00026;author=S.+Ma&#x00026;author=H.+Lin&#x00026;author=H.+Zhu&#x00026;journal=Genes+Dev&#x00026;publication_year=2012&#x00026;volume=26&#x00026;pages=1326&#x02013;38&#x00026;doi=10.1101/gad.191056.112" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B34"></a>34. Warburg O. On the origin of cancer cells. <i>Science</i> (1956) 123(3191):309&#x02013;14. doi:10.1126/science.123.3191.309</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1126/science.123.3191.309" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=On+the+origin+of+cancer+cells&#x00026;author=O.+Warburg&#x00026;journal=Science&#x00026;publication_year=1956&#x00026;volume=123&#x00026;pages=309&#x02013;14&#x00026;doi=10.1126/science.123.3191.309" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B35"></a>35. Pelicano H, Martin DS, Xu RH, Huang P. Glycolysis inhibition for anticancer treatment. <i>Oncogene</i> (2006) 25(34):4633&#x02013;46. doi:10.1038/sj.onc.1209597</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16892078" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/sj.onc.1209597" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Glycolysis+inhibition+for+anticancer+treatment&#x00026;author=H.+Pelicano&#x00026;author=D.+S.+Martin&#x00026;author=R.+H.+Xu&#x00026;author=P.+Huang&#x00026;journal=Oncogene&#x00026;publication_year=2006&#x00026;volume=25&#x00026;pages=4633&#x02013;46&#x00026;doi=10.1038/sj.onc.1209597&#x00026;pmid=16892078" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B36"></a>36. Levine AJ, Puzio-Kuter AM. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. <i>Science</i> (2010) 330(6009):1340&#x02013;4. doi:10.1126/science.1193494</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1126/science.1193494" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=The+control+of+the+metabolic+switch+in+cancers+by+oncogenes+and+tumor+suppressor+genes&#x00026;author=A.+J.+Levine&#x00026;author=A.+M.+Puzio-Kuter&#x00026;journal=Science&#x00026;publication_year=2010&#x00026;volume=330&#x00026;pages=1340&#x02013;4&#x00026;doi=10.1126/science.1193494" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B37"></a>37. Bonuccelli G, Tsirigos A, Whitaker-Menezes D, Pavlides S, Pestell RG, Chiavarina B, et al. Ketones and lactate &#x0201C;fuel&#x0201D; tumor growth and metastasis: evidence that epithelial cancer cells use oxidative mitochondrial metabolism. <i>Cell Cycle</i> (2010) 9(17):3506&#x02013;14. doi:10.4161/cc.9.17.12731</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.4161/cc.9.17.12731" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Ketones+and+lactate+&#x0201C;fuel&#x0201D;+tumor+growth+and+metastasis:+evidence+that+epithelial+cancer+cells+use+oxidative+mitochondrial+metabolism&#x00026;author=G.+Bonuccelli&#x00026;author=A.+Tsirigos&#x00026;author=D.+Whitaker-Menezes&#x00026;author=S.+Pavlides&#x00026;author=R.+G.+Pestell&#x00026;author=B.+Chiavarina&#x00026;journal=Cell+Cycle&#x00026;publication_year=2010&#x00026;volume=9&#x00026;pages=3506&#x02013;14&#x00026;doi=10.4161/cc.9.17.12731" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B38"></a>38. Xu RH, Pelicano H, Zhou Y, Carew JS, Feng L, Bhalla KN, et al. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. <i>Cancer Res</i> (2005) 65(2):613&#x02013;21.</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=15695406" target="_blank">PubMed Abstract</a> | <a href="http://scholar.google.com/scholar_lookup?title=Inhibition+of+glycolysis+in+cancer+cells:+a+novel+strategy+to+overcome+drug+resistance+associated+with+mitochondrial+respiratory+defect+and+hypoxia&#x00026;author=R.+H.+Xu&#x00026;author=H.+Pelicano&#x00026;author=Y.+Zhou&#x00026;author=J.+S.+Carew&#x00026;author=L.+Feng&#x00026;author=K.+N.+Bhalla&#x00026;journal=Cancer+Res&#x00026;publication_year=2005&#x00026;volume=65&#x00026;pages=613&#x02013;21&#x00026;pmid=15695406" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B39"></a>39. Chandel NS, Budinger GR, Choe SH, Schumacker PT. Cellular respiration during hypoxia. Role of cytochrome oxidase as the oxygen sensor in hepatocytes. <i>J Biol Chem</i> (1997) 272(30):18808&#x02013;16. doi:10.1074/jbc.272.30.18808</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=9228055" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1074/jbc.272.30.18808" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Cellular+respiration+during+hypoxia.+Role+of+cytochrome+oxidase+as+the+oxygen+sensor+in+hepatocytes&#x00026;author=N.+S.+Chandel&#x00026;author=G.+R.+Budinger&#x00026;author=S.+H.+Choe&#x00026;author=P.+T.+Schumacker&#x00026;journal=J+Biol+Chem&#x00026;publication_year=1997&#x00026;volume=272&#x00026;pages=18808&#x02013;16&#x00026;doi=10.1074/jbc.272.30.18808&#x00026;pmid=9228055" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B40"></a>40. DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism. <i>Sci Adv</i> (2016) 2(5):e1600200. doi:10.1126/sciadv.1600200</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=27386546" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1126/sciadv.1600200" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Fundamentals+of+cancer+metabolism&#x00026;author=R.+J.+DeBerardinis&#x00026;author=N.+S.+Chandel&#x00026;journal=Sci+Adv&#x00026;publication_year=2016&#x00026;volume=2&#x00026;pages=e1600200&#x00026;doi=10.1126/sciadv.1600200&#x00026;pmid=27386546" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B41"></a>41. Lanning NJ, Looyenga BD, Kauffman AL, Niemi NM, Sudderth J, DeBerardinis RJ, et al. A mitochondrial RNAi screen defines cellular bioenergetic determinants and identifies an adenylate kinase as a key regulator of ATP levels. <i>Cell Rep</i> (2014) 7(3):907&#x02013;17. doi:10.1016/j.celrep.2014.03.065</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=24767988" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.celrep.2014.03.065" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=A+mitochondrial+RNAi+screen+defines+cellular+bioenergetic+determinants+and+identifies+an+adenylate+kinase+as+a+key+regulator+of+ATP+levels&#x00026;author=N.+J.+Lanning&#x00026;author=B.+D.+Looyenga&#x00026;author=A.+L.+Kauffman&#x00026;author=N.+M.+Niemi&#x00026;author=J.+Sudderth&#x00026;author=R.+J.+DeBerardinis&#x00026;journal=Cell+Rep&#x00026;publication_year=2014&#x00026;volume=7&#x00026;pages=907&#x02013;17&#x00026;doi=10.1016/j.celrep.2014.03.065&#x00026;pmid=24767988" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B42"></a>42. Hardie DG, Schaffer BE, Brunet A. AMPK: an energy-sensing pathway with multiple inputs and outputs. <i>Trends Cell Biol</i> (2016) 26(3):190&#x02013;201. doi:10.1016/j.tcb.2015.10.013</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=26616193" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.tcb.2015.10.013" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=AMPK:+an+energy-sensing+pathway+with+multiple+inputs+and+outputs&#x00026;author=D.+G.+Hardie&#x00026;author=B.+E.+Schaffer&#x00026;author=A.+Brunet&#x00026;journal=Trends+Cell+Biol&#x00026;publication_year=2016&#x00026;volume=26&#x00026;pages=190&#x02013;201&#x00026;doi=10.1016/j.tcb.2015.10.013&#x00026;pmid=26616193" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B43"></a>43. Denkert C, Budczies J, Weichert W, Wohlgemuth G, Scholz M, Kind T, et al. Metabolite profiling of human colon carcinoma &#x02013; deregulation of TCA cycle and amino acid turnover. <i>Mol Cancer</i> (2008) 7:72. doi:10.1186/1476-4598-7-72</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1186/1476-4598-7-72" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Metabolite+profiling+of+human+colon+carcinoma+&#x02013;+deregulation+of+TCA+cycle+and+amino+acid+turnover&#x00026;author=C.+Denkert&#x00026;author=J.+Budczies&#x00026;author=W.+Weichert&#x00026;author=G.+Wohlgemuth&#x00026;author=M.+Scholz&#x00026;author=T.+Kind&#x00026;journal=Mol+Cancer&#x00026;publication_year=2008&#x00026;volume=7&#x00026;pages=72&#x00026;doi=10.1186/1476-4598-7-72" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B44"></a>44. Nomura DK, Long JZ, Niessen S, Hoover HS, Ng SW, Cravatt BF. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. <i>Cell</i> (2010) 140(1):49&#x02013;61. doi:10.1016/j.cell.2009.11.027</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=20079333" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.cell.2009.11.027" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Monoacylglycerol+lipase+regulates+a+fatty+acid+network+that+promotes+cancer+pathogenesis&#x00026;author=D.+K.+Nomura&#x00026;author=J.+Z.+Long&#x00026;author=S.+Niessen&#x00026;author=H.+S.+Hoover&#x00026;author=S.+W.+Ng&#x00026;author=B.+F.+Cravatt&#x00026;journal=Cell&#x00026;publication_year=2010&#x00026;volume=140&#x00026;pages=49&#x02013;61&#x00026;doi=10.1016/j.cell.2009.11.027&#x00026;pmid=20079333" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B45"></a>45. Som P, Atkins HL, Bandoypadhyay D, Fowler JS, MacGregor RR, Matsui K, et al. A fluorinated glucose analog, 2-fluoro-2-deoxy-<span style="font-variant: small-caps">d</span>-glucose (F-18): nontoxic tracer for rapid tumor detection. <i>J Nucl Med</i> (1980) 21(7):670&#x02013;5.</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=7391842" target="_blank">PubMed Abstract</a> | <a href="http://scholar.google.com/scholar_lookup?title=A+fluorinated+glucose+analog,+2-fluoro-2-deoxy-d-glucose+(F-18):+nontoxic+tracer+for+rapid+tumor+detection&#x00026;author=P.+Som&#x00026;author=H.+L.+Atkins&#x00026;author=D.+Bandoypadhyay&#x00026;author=J.+S.+Fowler&#x00026;author=R.+R.+MacGregor&#x00026;author=K.+Matsui&#x00026;journal=J+Nucl+Med&#x00026;publication_year=1980&#x00026;volume=21&#x00026;pages=670&#x02013;5&#x00026;pmid=7391842" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B46"></a>46. Duhaylongsod FG, Lowe VJ, Patz EF Jr, Vaughn AL, Coleman RE, Wolfe WG. Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. <i>Ann Thorac Surg</i> (1995) 60(5):1348&#x02013;52. doi:10.1016/0003-4975(95)00754-9</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=8526625" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/0003-4975(95)00754-9" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Lung+tumor+growth+correlates+with+glucose+metabolism+measured+by+fluoride-18+fluorodeoxyglucose+positron+emission+tomography&#x00026;author=F.+G.+Duhaylongsod&#x00026;author=V.+J.+Lowe&#x00026;author=E.+F.+Patz&#x00026;author=A.+L.+Vaughn&#x00026;author=R.+E.+Coleman&#x00026;author=W.+G.+Wolfe&#x00026;journal=Ann+Thorac+Surg&#x00026;publication_year=1995&#x00026;volume=60&#x00026;pages=1348&#x02013;52&#x00026;doi=10.1016/0003-4975(95)00754-9&#x00026;pmid=8526625" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B47"></a>47. Wong N, De Melo J, Tang D. PKM2, a central point of regulation in cancer metabolism. <i>Int J Cell Biol</i> (2013) 2013:242513. doi:10.1155/2013/242513</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=23476652" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1155/2013/242513" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=PKM2,+a+central+point+of+regulation+in+cancer+metabolism&#x00026;author=N.+Wong&#x00026;author=J.+De+Melo&#x00026;author=D.+Tang&#x00026;journal=Int+J+Cell+Biol&#x00026;publication_year=2013&#x00026;volume=2013&#x00026;pages=242513&#x00026;doi=10.1155/2013/242513&#x00026;pmid=23476652" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B48"></a>48. Luo W, Semenza GL. Emerging roles of PKM2 in cell metabolism and cancer progression. <i>Trends Endocrinol Metab</i> (2012) 23(11):560&#x02013;6. doi:10.1016/j.tem.2012.06.010</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.tem.2012.06.010" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Emerging+roles+of+PKM2+in+cell+metabolism+and+cancer+progression&#x00026;author=W.+Luo&#x00026;author=G.+L.+Semenza&#x00026;journal=Trends+Endocrinol+Metab&#x00026;publication_year=2012&#x00026;volume=23&#x00026;pages=560&#x02013;6&#x00026;doi=10.1016/j.tem.2012.06.010" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B49"></a>49. Keller KE, Doctor ZM, Dwyer ZW, Lee YS. SAICAR induces protein kinase activity of PKM2 that is necessary for sustained proliferative signaling of cancer cells. <i>Mol Cell</i> (2014) 53(5):700&#x02013;9. doi:10.1016/j.molcel.2014.02.015</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=24606918" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.molcel.2014.02.015" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=SAICAR+induces+protein+kinase+activity+of+PKM2+that+is+necessary+for+sustained+proliferative+signaling+of+cancer+cells&#x00026;author=K.+E.+Keller&#x00026;author=Z.+M.+Doctor&#x00026;author=Z.+W.+Dwyer&#x00026;author=Y.+S.+Lee&#x00026;journal=Mol+Cell&#x00026;publication_year=2014&#x00026;volume=53&#x00026;pages=700&#x02013;9&#x00026;doi=10.1016/j.molcel.2014.02.015&#x00026;pmid=24606918" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B50"></a>50. Tang R, Yang C, Ma X, Wang Y, Luo D, Huang C, et al. miR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer. <i>Oncotarget</i> (2016) 7(5):5972&#x02013;84. doi:10.18632/oncotarget.6821</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=26745603" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.18632/oncotarget.6821" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=miR-let-7a+inhibits+cell+proliferation,+migration,+and+invasion+by+down-regulating+PKM2+in+gastric+cancer&#x00026;author=R.+Tang&#x00026;author=C.+Yang&#x00026;author=X.+Ma&#x00026;author=Y.+Wang&#x00026;author=D.+Luo&#x00026;author=C.+Huang&#x00026;journal=Oncotarget&#x00026;publication_year=2016&#x00026;volume=7&#x00026;pages=5972&#x02013;84&#x00026;doi=10.18632/oncotarget.6821&#x00026;pmid=26745603" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B51"></a>51. Hsu MC, Hung WC, Yamaguchi H, Lim SO, Liao HW, Tsai CH, et al. Extracellular PKM2 induces cancer proliferation by activating the EGFR signaling pathway. <i>Am J Cancer Res</i> (2016) 6(3):628&#x02013;38.</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=27152240" target="_blank">PubMed Abstract</a> | <a href="http://scholar.google.com/scholar_lookup?title=Extracellular+PKM2+induces+cancer+proliferation+by+activating+the+EGFR+signaling+pathway&#x00026;author=M.+C.+Hsu&#x00026;author=W.+C.+Hung&#x00026;author=H.+Yamaguchi&#x00026;author=S.+O.+Lim&#x00026;author=H.+W.+Liao&#x00026;author=C.+H.+Tsai&#x00026;journal=Am+J+Cancer+Res&#x00026;publication_year=2016&#x00026;volume=6&#x00026;pages=628&#x02013;38&#x00026;pmid=27152240" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B52"></a>52. Li N, Feng L, Liu H, Wang J, Kasembeli M, Tran MK, et al. PARP inhibition suppresses growth of EGFR-mutant cancers by targeting nuclear PKM2. <i>Cell Rep</i> (2016) 15(4):843&#x02013;56. doi:10.1016/j.celrep.2016.03.070</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=27149849" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.celrep.2016.03.070" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=PARP+inhibition+suppresses+growth+of+EGFR-mutant+cancers+by+targeting+nuclear+PKM2&#x00026;author=N.+Li&#x00026;author=L.+Feng&#x00026;author=H.+Liu&#x00026;author=J.+Wang&#x00026;author=M.+Kasembeli&#x00026;author=M.+K.+Tran&#x00026;journal=Cell+Rep&#x00026;publication_year=2016&#x00026;volume=15&#x00026;pages=843&#x02013;56&#x00026;doi=10.1016/j.celrep.2016.03.070&#x00026;pmid=27149849" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B53"></a>53. Hensley CT, Wasti AT, DeBerardinis RJ. Glutamine and cancer: cell biology, physiology, and clinical opportunities. <i>J Clin Invest</i> (2013) 123(9):3678&#x02013;84. doi:10.1172/JCI69600</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=23999442" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1172/JCI69600" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Glutamine+and+cancer:+cell+biology,+physiology,+and+clinical+opportunities&#x00026;author=C.+T.+Hensley&#x00026;author=A.+T.+Wasti&#x00026;author=R.+J.+DeBerardinis&#x00026;journal=J+Clin+Invest&#x00026;publication_year=2013&#x00026;volume=123&#x00026;pages=3678&#x02013;84&#x00026;doi=10.1172/JCI69600&#x00026;pmid=23999442" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B54"></a>54. Cheng T, Sudderth J, Yang C, Mullen AR, Jin ES, Mates JM, et al. Pyruvate carboxylase is required for glutamine-independent growth of tumor cells. <i>Proc Natl Acad Sci U S A</i> (2011) 108(21):8674&#x02013;9. doi:10.1073/pnas.1016627108</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=21555572" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1073/pnas.1016627108" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Pyruvate+carboxylase+is+required+for+glutamine-independent+growth+of+tumor+cells&#x00026;author=T.+Cheng&#x00026;author=J.+Sudderth&#x00026;author=C.+Yang&#x00026;author=A.+R.+Mullen&#x00026;author=E.+S.+Jin&#x00026;author=J.+M.+Mates&#x00026;journal=Proc+Natl+Acad+Sci+U+S+A&#x00026;publication_year=2011&#x00026;volume=108&#x00026;pages=8674&#x02013;9&#x00026;doi=10.1073/pnas.1016627108&#x00026;pmid=21555572" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B55"></a>55. Amelio I, Cutruzzola F, Antonov A, Agostini M, Melino G. Serine and glycine metabolism in cancer. <i>Trends Biochem Sci</i> (2014) 39(4):191&#x02013;8. doi:10.1016/j.tibs.2014.02.004</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.tibs.2014.02.004" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Serine+and+glycine+metabolism+in+cancer&#x00026;author=I.+Amelio&#x00026;author=F.+Cutruzzola&#x00026;author=A.+Antonov&#x00026;author=M.+Agostini&#x00026;author=G.+Melino&#x00026;journal=Trends+Biochem+Sci&#x00026;publication_year=2014&#x00026;volume=39&#x00026;pages=191&#x02013;8&#x00026;doi=10.1016/j.tibs.2014.02.004" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B56"></a>56. Jain M, Nilsson R, Sharma S, Madhusudhan N, Kitami T, Souza AL, et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. <i>Science</i> (2012) 336(6084):1040&#x02013;4. doi:10.1126/science.1218595</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1126/science.1218595" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Metabolite+profiling+identifies+a+key+role+for+glycine+in+rapid+cancer+cell+proliferation&#x00026;author=M.+Jain&#x00026;author=R.+Nilsson&#x00026;author=S.+Sharma&#x00026;author=N.+Madhusudhan&#x00026;author=T.+Kitami&#x00026;author=A.+L.+Souza&#x00026;journal=Science&#x00026;publication_year=2012&#x00026;volume=336&#x00026;pages=1040&#x02013;4&#x00026;doi=10.1126/science.1218595" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B57"></a>57. Ferreira GC, Gong J. 5-Aminolevulinate synthase and the first step of heme biosynthesis. <i>J Bioenerg Biomembr</i> (1995) 27(2):151&#x02013;9. doi:10.1007/BF02110030</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=7592562" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/BF02110030" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=5-Aminolevulinate+synthase+and+the+first+step+of+heme+biosynthesis&#x00026;author=G.+C.+Ferreira&#x00026;author=J.+Gong&#x00026;journal=J+Bioenerg+Biomembr&#x00026;publication_year=1995&#x00026;volume=27&#x00026;pages=151&#x02013;9&#x00026;doi=10.1007/BF02110030&#x00026;pmid=7592562" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B58"></a>58. Oexle H, Gnaiger E, Weiss G. Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation. <i>Biochim Biophys Acta</i> (1999) 1413(3):99&#x02013;107. doi:10.1016/S0005-2728(99)00088-2</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1016/S0005-2728(99)00088-2" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Iron-dependent+changes+in+cellular+energy+metabolism:+influence+on+citric+acid+cycle+and+oxidative+phosphorylation&#x00026;author=H.+Oexle&#x00026;author=E.+Gnaiger&#x00026;author=G.+Weiss&#x00026;journal=Biochim+Biophys+Acta&#x00026;publication_year=1999&#x00026;volume=1413&#x00026;pages=99&#x02013;107&#x00026;doi=10.1016/S0005-2728(99)00088-2" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B59"></a>59. Hooda J, Cadinu D, Alam MM, Shah A, Cao TM, Sullivan LA, et al. Enhanced heme function and mitochondrial respiration promote the progression of lung cancer cells. <i>PLoS One</i> (2013) 8(5):e63402. doi:10.1371/journal.pone.0063402</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=23704904" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1371/journal.pone.0063402" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Enhanced+heme+function+and+mitochondrial+respiration+promote+the+progression+of+lung+cancer+cells&#x00026;author=J.+Hooda&#x00026;author=D.+Cadinu&#x00026;author=M.+M.+Alam&#x00026;author=A.+Shah&#x00026;author=T.+M.+Cao&#x00026;author=L.+A.+Sullivan&#x00026;journal=PLoS+One&#x00026;publication_year=2013&#x00026;volume=8&#x00026;pages=e63402&#x00026;doi=10.1371/journal.pone.0063402&#x00026;pmid=23704904" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B60"></a>60. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, et al. An integrated genomic analysis of human glioblastoma multiforme. <i>Science</i> (2008) 321(5897):1807&#x02013;12. doi:10.1126/science.1164382</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=18772396" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1126/science.1164382" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=An+integrated+genomic+analysis+of+human+glioblastoma+multiforme&#x00026;author=D.+W.+Parsons&#x00026;author=S.+Jones&#x00026;author=X.+Zhang&#x00026;author=J.+C.+Lin&#x00026;author=R.+J.+Leary&#x00026;author=P.+Angenendt&#x00026;journal=Science&#x00026;publication_year=2008&#x00026;volume=321&#x00026;pages=1807&#x02013;12&#x00026;doi=10.1126/science.1164382&#x00026;pmid=18772396" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B61"></a>61. Dang L, Jin S, Su SM. IDH mutations in glioma and acute myeloid leukemia. <i>Trends Mol Med</i> (2010) 16(9):387&#x02013;97. doi:10.1016/j.molmed.2010.07.002</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.molmed.2010.07.002" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=IDH+mutations+in+glioma+and+acute+myeloid+leukemia&#x00026;author=L.+Dang&#x00026;author=S.+Jin&#x00026;author=S.+M.+Su&#x00026;journal=Trends+Mol+Med&#x00026;publication_year=2010&#x00026;volume=16&#x00026;pages=387&#x02013;97&#x00026;doi=10.1016/j.molmed.2010.07.002" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B62"></a>62. Prensner JR, Chinnaiyan AM. Metabolism unhinged: IDH mutations in cancer. <i>Nat Med</i> (2011) 17(3):291&#x02013;3. doi:10.1038/nm0311-291</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1038/nm0311-291" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Metabolism+unhinged:+IDH+mutations+in+cancer&#x00026;author=J.+R.+Prensner&#x00026;author=A.+M.+Chinnaiyan&#x00026;journal=Nat+Med&#x00026;publication_year=2011&#x00026;volume=17&#x00026;pages=291&#x02013;3&#x00026;doi=10.1038/nm0311-291" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B63"></a>63. Ghiam AF, Cairns RA, Thoms J, Dal Pra A, Ahmed O, Meng A, et al. IDH mutation status in prostate cancer. <i>Oncogene</i> (2012) 31(33):3826. doi:10.1038/onc.2011.546</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1038/onc.2011.546" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=IDH+mutation+status+in+prostate+cancer&#x00026;author=A.+F.+Ghiam&#x00026;author=R.+A.+Cairns&#x00026;author=J.+Thoms&#x00026;author=A.+Dal+Pra&#x00026;author=O.+Ahmed&#x00026;author=A.+Meng&#x00026;journal=Oncogene&#x00026;publication_year=2012&#x00026;volume=31&#x00026;pages=3826&#x00026;doi=10.1038/onc.2011.546" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B64"></a>64. Gross S, Cairns RA, Minden MD, Driggers EM, Bittinger MA, Jang HG, et al. Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. <i>J Exp Med</i> (2010) 207(2):339&#x02013;44. doi:10.1084/jem.20092506</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=20142433" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1084/jem.20092506" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Cancer-associated+metabolite+2-hydroxyglutarate+accumulates+in+acute+myelogenous+leukemia+with+isocitrate+dehydrogenase+1+and+2+mutations&#x00026;author=S.+Gross&#x00026;author=R.+A.+Cairns&#x00026;author=M.+D.+Minden&#x00026;author=E.+M.+Driggers&#x00026;author=M.+A.+Bittinger&#x00026;author=H.+G.+Jang&#x00026;journal=J+Exp+Med&#x00026;publication_year=2010&#x00026;volume=207&#x00026;pages=339&#x02013;44&#x00026;doi=10.1084/jem.20092506&#x00026;pmid=20142433" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B65"></a>65. Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. <i>Cancer Cell</i> (2010) 17(3):225&#x02013;34. doi:10.1016/j.ccr.2010.01.020</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.ccr.2010.01.020" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=The+common+feature+of+leukemia-associated+IDH1+and+IDH2+mutations+is+a+neomorphic+enzyme+activity+converting+alpha-ketoglutarate+to+2-hydroxyglutarate&#x00026;author=P.+S.+Ward&#x00026;author=J.+Patel&#x00026;author=D.+R.+Wise&#x00026;author=O.+Abdel-Wahab&#x00026;author=B.+D.+Bennett&#x00026;author=H.+A.+Coller&#x00026;journal=Cancer+Cell&#x00026;publication_year=2010&#x00026;volume=17&#x00026;pages=225&#x02013;34&#x00026;doi=10.1016/j.ccr.2010.01.020" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B66"></a>66. Zhao S, Lin Y, Xu W, Jiang W, Zha Z, Wang P, et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. <i>Science</i> (2009) 324(5924):261&#x02013;5. doi:10.1126/science.1170944</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=19359588" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1126/science.1170944" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Glioma-derived+mutations+in+IDH1+dominantly+inhibit+IDH1+catalytic+activity+and+induce+HIF-1alpha&#x00026;author=S.+Zhao&#x00026;author=Y.+Lin&#x00026;author=W.+Xu&#x00026;author=W.+Jiang&#x00026;author=Z.+Zha&#x00026;author=P.+Wang&#x00026;journal=Science&#x00026;publication_year=2009&#x00026;volume=324&#x00026;pages=261&#x02013;5&#x00026;doi=10.1126/science.1170944&#x00026;pmid=19359588" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B67"></a>67. Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. <i>Cancer Cell</i> (2010) 18(6):553&#x02013;67. doi:10.1016/j.ccr.2010.11.015</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.ccr.2010.11.015" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Leukemic+IDH1+and+IDH2+mutations+result+in+a+hypermethylation+phenotype,+disrupt+TET2+function,+and+impair+hematopoietic+differentiation&#x00026;author=M.+E.+Figueroa&#x00026;author=O.+Abdel-Wahab&#x00026;author=C.+Lu&#x00026;author=P.+S.+Ward&#x00026;author=J.+Patel&#x00026;author=A.+Shih&#x00026;journal=Cancer+Cell&#x00026;publication_year=2010&#x00026;volume=18&#x00026;pages=553&#x02013;67&#x00026;doi=10.1016/j.ccr.2010.11.015" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B68"></a>68. Rohle D, Popovici-Muller J, Palaskas N, Turcan S, Grommes C, Campos C, et al. An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. <i>Science</i> (2013) 340(6132):626&#x02013;30. doi:10.1126/science.1236062</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1126/science.1236062" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=An+inhibitor+of+mutant+IDH1+delays+growth+and+promotes+differentiation+of+glioma+cells&#x00026;author=D.+Rohle&#x00026;author=J.+Popovici-Muller&#x00026;author=N.+Palaskas&#x00026;author=S.+Turcan&#x00026;author=C.+Grommes&#x00026;author=C.+Campos&#x00026;journal=Science&#x00026;publication_year=2013&#x00026;volume=340&#x00026;pages=626&#x02013;30&#x00026;doi=10.1126/science.1236062" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B69"></a>69. Pizer ES, Wood FD, Heine HS, Romantsev FE, Pasternack GR, Kuhajda FP. Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer. <i>Cancer Res</i> (1996) 56(6):1189&#x02013;93.</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://scholar.google.com/scholar_lookup?title=Inhibition+of+fatty+acid+synthesis+delays+disease+progression+in+a+xenograft+model+of+ovarian+cancer&#x00026;author=E.+S.+Pizer&#x00026;author=F.+D.+Wood&#x00026;author=H.+S.+Heine&#x00026;author=F.+E.+Romantsev&#x00026;author=G.+R.+Pasternack&#x00026;author=F.+P.+Kuhajda&#x00026;journal=Cancer+Res&#x00026;publication_year=1996&#x00026;volume=56&#x00026;pages=1189&#x02013;93" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B70"></a>70. Baron A, Migita T, Tang D, Loda M. Fatty acid synthase: a metabolic oncogene in prostate cancer? <i>J Cell Biochem</i> (2004) 91(1):47&#x02013;53. doi:10.1002/jcb.10708</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=14689581" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1002/jcb.10708" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Fatty+acid+synthase:+a+metabolic+oncogene+in+prostate+cancer?&#x00026;author=A.+Baron&#x00026;author=T.+Migita&#x00026;author=D.+Tang&#x00026;author=M.+Loda&#x00026;journal=J+Cell+Biochem&#x00026;publication_year=2004&#x00026;volume=91&#x00026;pages=47&#x02013;53&#x00026;doi=10.1002/jcb.10708&#x00026;pmid=14689581" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B71"></a>71. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. <i>Nat Rev Cancer</i> (2007) 7(10):763&#x02013;77. doi:10.1038/nrc2222</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=17882277" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nrc2222" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Fatty+acid+synthase+and+the+lipogenic+phenotype+in+cancer+pathogenesis&#x00026;author=J.+A.+Menendez&#x00026;author=R.+Lupu&#x00026;journal=Nat+Rev+Cancer&#x00026;publication_year=2007&#x00026;volume=7&#x00026;pages=763&#x02013;77&#x00026;doi=10.1038/nrc2222&#x00026;pmid=17882277" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B72"></a>72. Mashima T, Seimiya H, Tsuruo T. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. <i>Br J Cancer</i> (2009) 100(9):1369&#x02013;72. doi:10.1038/sj.bjc.6605007</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1038/sj.bjc.6605007" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=De+novo+fatty-acid+synthesis+and+related+pathways+as+molecular+targets+for+cancer+therapy&#x00026;author=T.+Mashima&#x00026;author=H.+Seimiya&#x00026;author=T.+Tsuruo&#x00026;journal=Br+J+Cancer&#x00026;publication_year=2009&#x00026;volume=100&#x00026;pages=1369&#x02013;72&#x00026;doi=10.1038/sj.bjc.6605007" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B73"></a>73. Migita T, Ruiz S, Fornari A, Fiorentino M, Priolo C, Zadra G, et al. Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. <i>J Natl Cancer Inst</i> (2009) 101(7):519&#x02013;32. doi:10.1093/jnci/djp030</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=19318631" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/jnci/djp030" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Fatty+acid+synthase:+a+metabolic+enzyme+and+candidate+oncogene+in+prostate+cancer&#x00026;author=T.+Migita&#x00026;author=S.+Ruiz&#x00026;author=A.+Fornari&#x00026;author=M.+Fiorentino&#x00026;author=C.+Priolo&#x00026;author=G.+Zadra&#x00026;journal=J+Natl+Cancer+Inst&#x00026;publication_year=2009&#x00026;volume=101&#x00026;pages=519&#x02013;32&#x00026;doi=10.1093/jnci/djp030&#x00026;pmid=19318631" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B74"></a>74. Currie E, Schulze A, Zechner R, Walther TC, Farese RV Jr. Cellular fatty acid metabolism and cancer. <i>Cell Metab</i> (2013) 18(2):153&#x02013;61. doi:10.1016/j.cmet.2013.05.017</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.cmet.2013.05.017" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Cellular+fatty+acid+metabolism+and+cancer&#x00026;author=E.+Currie&#x00026;author=A.+Schulze&#x00026;author=R.+Zechner&#x00026;author=T.+C.+Walther&#x00026;author=R.+V.+Farese&#x00026;journal=Cell+Metab&#x00026;publication_year=2013&#x00026;volume=18&#x00026;pages=153&#x02013;61&#x00026;doi=10.1016/j.cmet.2013.05.017" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B75"></a>75. Liu Y. Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer. <i>Prostate Cancer Prostatic Dis</i> (2006) 9(3):230&#x02013;4. doi:10.1038/sj.pcan.4500879</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16683009" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/sj.pcan.4500879" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Fatty+acid+oxidation+is+a+dominant+bioenergetic+pathway+in+prostate+cancer&#x00026;author=Y.+Liu&#x00026;journal=Prostate+Cancer+Prostatic+Dis&#x00026;publication_year=2006&#x00026;volume=9&#x00026;pages=230&#x02013;4&#x00026;doi=10.1038/sj.pcan.4500879&#x00026;pmid=16683009" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B76"></a>76. Carracedo A, Cantley LC, Pandolfi PP. Cancer metabolism: fatty acid oxidation in the limelight. <i>Nat Rev Cancer</i> (2013) 13(4):227&#x02013;32. doi:10.1038/nrc3483</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=23446547" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nrc3483" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Cancer+metabolism:+fatty+acid+oxidation+in+the+limelight&#x00026;author=A.+Carracedo&#x00026;author=L.+C.+Cantley&#x00026;author=P.+P.+Pandolfi&#x00026;journal=Nat+Rev+Cancer&#x00026;publication_year=2013&#x00026;volume=13&#x00026;pages=227&#x02013;32&#x00026;doi=10.1038/nrc3483&#x00026;pmid=23446547" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B77"></a>77. Harris FT, Rahman SM, Hassanein M, Qian J, Hoeksema MD, Chen H, et al. Acyl-coenzyme A-binding protein regulates beta-oxidation required for growth and survival of non-small cell lung cancer. <i>Cancer Prev Res (Phila)</i> (2014) 7(7):748&#x02013;57. doi:10.1158/1940-6207.CAPR-14-0057</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=24819876" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1158/1940-6207.CAPR-14-0057" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Acyl-coenzyme+A-binding+protein+regulates+beta-oxidation+required+for+growth+and+survival+of+non-small+cell+lung+cancer&#x00026;author=F.+T.+Harris&#x00026;author=S.+M.+Rahman&#x00026;author=M.+Hassanein&#x00026;author=J.+Qian&#x00026;author=M.+D.+Hoeksema&#x00026;author=H.+Chen&#x00026;journal=Cancer+Prev+Res+(Phila)&#x00026;publication_year=2014&#x00026;volume=7&#x00026;pages=748&#x02013;57&#x00026;doi=10.1158/1940-6207.CAPR-14-0057&#x00026;pmid=24819876" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B78"></a>78. Chiarugi A, Dolle C, Felici R, Ziegler M. The NAD metabolome &#x02013; a key determinant of cancer cell biology. <i>Nat Rev Cancer</i> (2012) 12(11):741&#x02013;52. doi:10.1038/nrc3340</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1038/nrc3340" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=The+NAD+metabolome+&#x02013;+a+key+determinant+of+cancer+cell+biology&#x00026;author=A.+Chiarugi&#x00026;author=C.+Dolle&#x00026;author=R.+Felici&#x00026;author=M.+Ziegler&#x00026;journal=Nat+Rev+Cancer&#x00026;publication_year=2012&#x00026;volume=12&#x00026;pages=741&#x02013;52&#x00026;doi=10.1038/nrc3340" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B79"></a>79. Fan W, Evans R. PPARs and ERRs: molecular mediators of mitochondrial metabolism. <i>Curr Opin Cell Biol</i> (2015) 33:49&#x02013;54. doi:10.1016/j.ceb.2014.11.002</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=25486445" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.ceb.2014.11.002" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=PPARs+and+ERRs:+molecular+mediators+of+mitochondrial+metabolism&#x00026;author=W.+Fan&#x00026;author=R.+Evans&#x00026;journal=Curr+Opin+Cell+Biol&#x00026;publication_year=2015&#x00026;volume=33&#x00026;pages=49&#x02013;54&#x00026;doi=10.1016/j.ceb.2014.11.002&#x00026;pmid=25486445" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B80"></a>80. Gerhart-Hines Z, Rodgers JT, Bare O, Lerin C, Kim SH, Mostoslavsky R, et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. <i>EMBO J</i> (2007) 26(7):1913&#x02013;23. doi:10.1038/sj.emboj.7601633</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=17347648" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/sj.emboj.7601633" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Metabolic+control+of+muscle+mitochondrial+function+and+fatty+acid+oxidation+through+SIRT1/PGC-1alpha&#x00026;author=Z.+Gerhart-Hines&#x00026;author=J.+T.+Rodgers&#x00026;author=O.+Bare&#x00026;author=C.+Lerin&#x00026;author=S.+H.+Kim&#x00026;author=R.+Mostoslavsky&#x00026;journal=EMBO+J&#x00026;publication_year=2007&#x00026;volume=26&#x00026;pages=1913&#x02013;23&#x00026;doi=10.1038/sj.emboj.7601633&#x00026;pmid=17347648" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B81"></a>81. Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard DB, et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. <i>Nature</i> (2010) 464(7285):121&#x02013;5. doi:10.1038/nature08778</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=20203611" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nature08778" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=SIRT3+regulates+mitochondrial+fatty-acid+oxidation+by+reversible+enzyme+deacetylation&#x00026;author=M.+D.+Hirschey&#x00026;author=T.+Shimazu&#x00026;author=E.+Goetzman&#x00026;author=E.+Jing&#x00026;author=B.+Schwer&#x00026;author=D.+B.+Lombard&#x00026;journal=Nature&#x00026;publication_year=2010&#x00026;volume=464&#x00026;pages=121&#x02013;5&#x00026;doi=10.1038/nature08778&#x00026;pmid=20203611" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B82"></a>82. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. <i>Nature</i> (2002) 415(6869):339&#x02013;43. doi:10.1038/415339a</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=11797013" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/415339a" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Leptin+stimulates+fatty-acid+oxidation+by+activating+AMP-activated+protein+kinase&#x00026;author=Y.+Minokoshi&#x00026;author=Y.+B.+Kim&#x00026;author=O.+D.+Peroni&#x00026;author=L.+G.+Fryer&#x00026;author=C.+Muller&#x00026;author=D.+Carling&#x00026;journal=Nature&#x00026;publication_year=2002&#x00026;volume=415&#x00026;pages=339&#x02013;43&#x00026;doi=10.1038/415339a&#x00026;pmid=11797013" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B83"></a>83. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. <i>Nat Med</i> (2002) 8(11):1288&#x02013;95. doi:10.1038/nm788</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=12368907" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nm788" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Adiponectin+stimulates+glucose+utilization+and+fatty-acid+oxidation+by+activating+AMP-activated+protein+kinase&#x00026;author=T.+Yamauchi&#x00026;author=J.+Kamon&#x00026;author=Y.+Minokoshi&#x00026;author=Y.+Ito&#x00026;author=H.+Waki&#x00026;author=S.+Uchida&#x00026;journal=Nat+Med&#x00026;publication_year=2002&#x00026;volume=8&#x00026;pages=1288&#x02013;95&#x00026;doi=10.1038/nm788&#x00026;pmid=12368907" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B84"></a>84. Comerford SA, Huang Z, Du X, Wang Y, Cai L, Witkiewicz AK, et al. Acetate dependence of tumors. <i>Cell</i> (2014) 159(7):1591&#x02013;602. doi:10.1016/j.cell.2014.11.020</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=25525877" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.cell.2014.11.020" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Acetate+dependence+of+tumors&#x00026;author=S.+A.+Comerford&#x00026;author=Z.+Huang&#x00026;author=X.+Du&#x00026;author=Y.+Wang&#x00026;author=L.+Cai&#x00026;author=A.+K.+Witkiewicz&#x00026;journal=Cell&#x00026;publication_year=2014&#x00026;volume=159&#x00026;pages=1591&#x02013;602&#x00026;doi=10.1016/j.cell.2014.11.020&#x00026;pmid=25525877" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B85"></a>85. Lyssiotis CA, Cantley LC. Acetate fuels the cancer engine. <i>Cell</i> (2014) 159(7):1492&#x02013;4. doi:10.1016/j.cell.2014.12.009</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.cell.2014.12.009" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Acetate+fuels+the+cancer+engine&#x00026;author=C.+A.+Lyssiotis&#x00026;author=L.+C.+Cantley&#x00026;journal=Cell&#x00026;publication_year=2014&#x00026;volume=159&#x00026;pages=1492&#x02013;4&#x00026;doi=10.1016/j.cell.2014.12.009" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B86"></a>86. Mashimo T, Pichumani K, Vemireddy V, Hatanpaa KJ, Singh DK, Sirasanagandla S, et al. Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. <i>Cell</i> (2014) 159(7):1603&#x02013;14. doi:10.1016/j.cell.2014.11.025</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=25525878" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.cell.2014.11.025" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Acetate+is+a+bioenergetic+substrate+for+human+glioblastoma+and+brain+metastases&#x00026;author=T.+Mashimo&#x00026;author=K.+Pichumani&#x00026;author=V.+Vemireddy&#x00026;author=K.+J.+Hatanpaa&#x00026;author=D.+K.+Singh&#x00026;author=S.+Sirasanagandla&#x00026;journal=Cell&#x00026;publication_year=2014&#x00026;volume=159&#x00026;pages=1603&#x02013;14&#x00026;doi=10.1016/j.cell.2014.11.025&#x00026;pmid=25525878" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B87"></a>87. Kamphorst JJ, Chung MK, Fan J, Rabinowitz JD. Quantitative analysis of acetyl-CoA production in hypoxic cancer cells reveals substantial contribution from acetate. <i>Cancer Metab</i> (2014) 2:23. doi:10.1186/2049-3002-2-23140</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=25671109" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1186/2049-3002-2-23140" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Quantitative+analysis+of+acetyl-CoA+production+in+hypoxic+cancer+cells+reveals+substantial+contribution+from+acetate&#x00026;author=J.+J.+Kamphorst&#x00026;author=M.+K.+Chung&#x00026;author=J.+Fan&#x00026;author=J.+D.+Rabinowitz&#x00026;journal=Cancer+Metab&#x00026;publication_year=2014&#x00026;volume=2&#x00026;pages=23&#x00026;doi=10.1186/2049-3002-2-23140&#x00026;pmid=25671109" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B88"></a>88. Schug ZT, Peck B, Jones DT, Zhang Q, Grosskurth S, Alam IS, et al. Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. <i>Cancer Cell</i> (2015) 27(1):57&#x02013;71. doi:10.1016/j.ccell.2014.12.002</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=25584894" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.ccell.2014.12.002" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Acetyl-CoA+synthetase+2+promotes+acetate+utilization+and+maintains+cancer+cell+growth+under+metabolic+stress&#x00026;author=Z.+T.+Schug&#x00026;author=B.+Peck&#x00026;author=D.+T.+Jones&#x00026;author=Q.+Zhang&#x00026;author=S.+Grosskurth&#x00026;author=I.+S.+Alam&#x00026;journal=Cancer+Cell&#x00026;publication_year=2015&#x00026;volume=27&#x00026;pages=57&#x02013;71&#x00026;doi=10.1016/j.ccell.2014.12.002&#x00026;pmid=25584894" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B89"></a>89. Thurnher M, Gruenbacher G, Nussbaumer O. Regulation of mevalonate metabolism in cancer and immune cells. <i>Biochim Biophys Acta</i> (2013) 1831(6):1009&#x02013;15. doi:10.1016/j.bbalip.2013.03.003</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=23524243" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.bbalip.2013.03.003" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Regulation+of+mevalonate+metabolism+in+cancer+and+immune+cells&#x00026;author=M.+Thurnher&#x00026;author=G.+Gruenbacher&#x00026;author=O.+Nussbaumer&#x00026;journal=Biochim+Biophys+Acta&#x00026;publication_year=2013&#x00026;volume=1831&#x00026;pages=1009&#x02013;15&#x00026;doi=10.1016/j.bbalip.2013.03.003&#x00026;pmid=23524243" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B90"></a>90. Gruenbacher G, Thurnher M. Mevalonate metabolism in cancer. <i>Cancer Lett</i> (2015) 356(2 Pt A):192&#x02013;6. doi:10.1016/j.canlet.2014.01.013</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.canlet.2014.01.013" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Mevalonate+metabolism+in+cancer&#x00026;author=G.+Gruenbacher&#x00026;author=M.+Thurnher&#x00026;journal=Cancer+Lett&#x00026;publication_year=2015&#x00026;volume=356&#x00026;pages=192&#x02013;6&#x00026;doi=10.1016/j.canlet.2014.01.013" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B91"></a>91. Greife A, Tukova J, Steinhoff C, Scott SD, Schulz WA, Hatina J. Establishment and characterization of a bladder cancer cell line with enhanced doxorubicin resistance by mevalonate pathway activation. <i>Tumour Biol</i> (2015) 36(5):3293&#x02013;300. doi:10.1007/s13277-014-2959-9</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=25566959" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s13277-014-2959-9" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Establishment+and+characterization+of+a+bladder+cancer+cell+line+with+enhanced+doxorubicin+resistance+by+mevalonate+pathway+activation&#x00026;author=A.+Greife&#x00026;author=J.+Tukova&#x00026;author=C.+Steinhoff&#x00026;author=S.+D.+Scott&#x00026;author=W.+A.+Schulz&#x00026;author=J.+Hatina&#x00026;journal=Tumour+Biol&#x00026;publication_year=2015&#x00026;volume=36&#x00026;pages=3293&#x02013;300&#x00026;doi=10.1007/s13277-014-2959-9&#x00026;pmid=25566959" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B92"></a>92. Likus W, Siemianowicz K, Bienk K, Pakula M, Pathak H, Dutta C, et al. Could drugs inhibiting the mevalonate pathway also target cancer stem cells? <i>Drug Resist Updat</i> (2016) 25:13&#x02013;25. doi:10.1016/j.drup.2016.02.001</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=27155373" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.drup.2016.02.001" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Could+drugs+inhibiting+the+mevalonate+pathway+also+target+cancer+stem+cells?&#x00026;author=W.+Likus&#x00026;author=K.+Siemianowicz&#x00026;author=K.+Bienk&#x00026;author=M.+Pakula&#x00026;author=H.+Pathak&#x00026;author=C.+Dutta&#x00026;journal=Drug+Resist+Updat&#x00026;publication_year=2016&#x00026;volume=25&#x00026;pages=13&#x02013;25&#x00026;doi=10.1016/j.drup.2016.02.001&#x00026;pmid=27155373" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B93"></a>93. Freed-Pastor W, Prives C. Targeting mutant p53 through the mevalonate pathway. <i>Nat Cell Biol</i> (2016) 18(11):1122&#x02013;4. doi:10.1038/ncb3435</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1038/ncb3435" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Targeting+mutant+p53+through+the+mevalonate+pathway&#x00026;author=W.+Freed-Pastor&#x00026;author=C.+Prives&#x00026;journal=Nat+Cell+Biol&#x00026;publication_year=2016&#x00026;volume=18&#x00026;pages=1122&#x02013;4&#x00026;doi=10.1038/ncb3435" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B94"></a>94. Greenaway JB, Virtanen C, Osz K, Revay T, Hardy D, Shepherd T, et al. Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer. <i>Oncotarget</i> (2016) 7(30):47343&#x02013;65. doi:10.18632/oncotarget.10121</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=27329838" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.18632/oncotarget.10121" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Ovarian+tumour+growth+is+characterized+by+mevalonate+pathway+gene+signature+in+an+orthotopic,+syngeneic+model+of+epithelial+ovarian+cancer&#x00026;author=J.+B.+Greenaway&#x00026;author=C.+Virtanen&#x00026;author=K.+Osz&#x00026;author=T.+Revay&#x00026;author=D.+Hardy&#x00026;author=T.+Shepherd&#x00026;journal=Oncotarget&#x00026;publication_year=2016&#x00026;volume=7&#x00026;pages=47343&#x02013;65&#x00026;doi=10.18632/oncotarget.10121&#x00026;pmid=27329838" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B95"></a>95. Sharon C, Baranwal S, Patel NJ, Rodriguez-Agudo D, Pandak WM, Majumdar AP, et al. Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo. <i>Oncotarget</i> (2015) 6(17):15332&#x02013;47. doi:10.18632/oncotarget.3684</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=25895029" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.18632/oncotarget.3684" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Inhibition+of+insulin-like+growth+factor+receptor/AKT/mammalian+target+of+rapamycin+axis+targets+colorectal+cancer+stem+cells+by+attenuating+mevalonate-isoprenoid+pathway+in+vitro+and+in+vivo&#x00026;author=C.+Sharon&#x00026;author=S.+Baranwal&#x00026;author=N.+J.+Patel&#x00026;author=D.+Rodriguez-Agudo&#x00026;author=W.+M.+Pandak&#x00026;author=A.+P.+Majumdar&#x00026;journal=Oncotarget&#x00026;publication_year=2015&#x00026;volume=6&#x00026;pages=15332&#x02013;47&#x00026;doi=10.18632/oncotarget.3684&#x00026;pmid=25895029" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B96"></a>96. Goldman AR, Bitler BG, Schug Z, Conejo-Garcia JR, Zhang R, Speicher DW. The primary effect on the proteome of ARID1A-mutated ovarian clear cell carcinoma is downregulation of the mevalonate pathway at the post-transcriptional level. <i>Mol Cell Proteomics</i> (2016) 15(11):3348&#x02013;60. doi:10.1074/mcp.M116.062539</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=27654507" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1074/mcp.M116.062539" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=The+primary+effect+on+the+proteome+of+ARID1A-mutated+ovarian+clear+cell+carcinoma+is+downregulation+of+the+mevalonate+pathway+at+the+post-transcriptional+level&#x00026;author=A.+R.+Goldman&#x00026;author=B.+G.+Bitler&#x00026;author=Z.+Schug&#x00026;author=J.+R.+Conejo-Garcia&#x00026;author=R.+Zhang&#x00026;author=D.+W.+Speicher&#x00026;journal=Mol+Cell+Proteomics&#x00026;publication_year=2016&#x00026;volume=15&#x00026;pages=3348&#x02013;60&#x00026;doi=10.1074/mcp.M116.062539&#x00026;pmid=27654507" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B97"></a>97. Pampalakis G, Obasuyi O, Papadodima O, Chatziioannou A, Zoumpourlis V, Sotiropoulou G. The KLK5 protease suppresses breast cancer by repressing the mevalonate pathway. <i>Oncotarget</i> (2014) 5(9):2390&#x02013;403. doi:10.18632/oncotarget.1235</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=24158494" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.18632/oncotarget.1235" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=The+KLK5+protease+suppresses+breast+cancer+by+repressing+the+mevalonate+pathway&#x00026;author=G.+Pampalakis&#x00026;author=O.+Obasuyi&#x00026;author=O.+Papadodima&#x00026;author=A.+Chatziioannou&#x00026;author=V.+Zoumpourlis&#x00026;author=G.+Sotiropoulou&#x00026;journal=Oncotarget&#x00026;publication_year=2014&#x00026;volume=5&#x00026;pages=2390&#x02013;403&#x00026;doi=10.18632/oncotarget.1235&#x00026;pmid=24158494" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B98"></a>98. Jiang P, Mukthavaram R, Chao Y, Nomura N, Bharati IS, Fogal V, et al. In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells. <i>Br J Cancer</i> (2014) 111(8):1562&#x02013;71. doi:10.1038/bjc.2014.431</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1038/bjc.2014.431" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=In+vitro+and+in+vivo+anticancer+effects+of+mevalonate+pathway+modulation+on+human+cancer+cells&#x00026;author=P.+Jiang&#x00026;author=R.+Mukthavaram&#x00026;author=Y.+Chao&#x00026;author=N.+Nomura&#x00026;author=I.+S.+Bharati&#x00026;author=V.+Fogal&#x00026;journal=Br+J+Cancer&#x00026;publication_year=2014&#x00026;volume=111&#x00026;pages=1562&#x02013;71&#x00026;doi=10.1038/bjc.2014.431" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-1.7em;" class="ReferencesCopy1"><a id="B99"></a>99. Warita K, Warita T, Beckwitt CH, Schurdak ME, Vazquez A, Wells A, et al. Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion. <i>Sci Rep</i> (2014) 4:7593. doi:10.1038/srep07593</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=25534349" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/srep07593" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Statin-induced+mevalonate+pathway+inhibition+attenuates+the+growth+of+mesenchymal-like+cancer+cells+that+lack+functional+E-cadherin+mediated+cell+cohesion&#x00026;author=K.+Warita&#x00026;author=T.+Warita&#x00026;author=C.+H.+Beckwitt&#x00026;author=M.+E.+Schurdak&#x00026;author=A.+Vazquez&#x00026;author=A.+Wells&#x00026;journal=Sci+Rep&#x00026;publication_year=2014&#x00026;volume=4&#x00026;pages=7593&#x00026;doi=10.1038/srep07593&#x00026;pmid=25534349" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B100"></a>100. Yeganeh B, Wiechec E, Ande SR, Sharma P, Moghadam AR, Post M, et al. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease. <i>Pharmacol Ther</i> (2014) 143(1):87&#x02013;110. doi:10.1016/j.pharmthera.2014.02.007</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=24582968" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.pharmthera.2014.02.007" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Targeting+the+mevalonate+cascade+as+a+new+therapeutic+approach+in+heart+disease,+cancer+and+pulmonary+disease&#x00026;author=B.+Yeganeh&#x00026;author=E.+Wiechec&#x00026;author=S.+R.+Ande&#x00026;author=P.+Sharma&#x00026;author=A.+R.+Moghadam&#x00026;author=M.+Post&#x00026;journal=Pharmacol+Ther&#x00026;publication_year=2014&#x00026;volume=143&#x00026;pages=87&#x02013;110&#x00026;doi=10.1016/j.pharmthera.2014.02.007&#x00026;pmid=24582968" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B101"></a>101. Karlic H, Thaler R, Gerner C, Grunt T, Proestling K, Haider F, et al. Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells. <i>Cancer Genet</i> (2015) 208(5):241&#x02013;52. doi:10.1016/j.cancergen.2015.03.008</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.cancergen.2015.03.008" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Inhibition+of+the+mevalonate+pathway+affects+epigenetic+regulation+in+cancer+cells&#x00026;author=H.+Karlic&#x00026;author=R.+Thaler&#x00026;author=C.+Gerner&#x00026;author=T.+Grunt&#x00026;author=K.+Proestling&#x00026;author=F.+Haider&#x00026;journal=Cancer+Genet&#x00026;publication_year=2015&#x00026;volume=208&#x00026;pages=241&#x02013;52&#x00026;doi=10.1016/j.cancergen.2015.03.008" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B102"></a>102. Lin Z, Bishop KS, Sutherland H, Marlow G, Murray P, Denny WA, et al. A quinazoline-based HDAC inhibitor affects gene expression pathways involved in cholesterol biosynthesis and mevalonate in prostate cancer cells. <i>Mol Biosyst</i> (2016) 12(3):839&#x02013;49. doi:10.1039/c5mb00554j</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=26759180" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1039/c5mb00554j" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=A+quinazoline-based+HDAC+inhibitor+affects+gene+expression+pathways+involved+in+cholesterol+biosynthesis+and+mevalonate+in+prostate+cancer+cells&#x00026;author=Z.+Lin&#x00026;author=K.+S.+Bishop&#x00026;author=H.+Sutherland&#x00026;author=G.+Marlow&#x00026;author=P.+Murray&#x00026;author=W.+A.+Denny&#x00026;journal=Mol+Biosyst&#x00026;publication_year=2016&#x00026;volume=12&#x00026;pages=839&#x02013;49&#x00026;doi=10.1039/c5mb00554j&#x00026;pmid=26759180" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B103"></a>103. Wang T, Seah S, Loh X, Chan CW, Hartman M, Goh BC, et al. Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway. <i>Oncotarget</i> (2016) 7(3):2532&#x02013;44. doi:10.18632/oncotarget.6304</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=26565813" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.18632/oncotarget.6304" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Simvastatin-induced+breast+cancer+cell+death+and+deactivation+of+PI3K/Akt+and+MAPK/ERK+signalling+are+reversed+by+metabolic+products+of+the+mevalonate+pathway&#x00026;author=T.+Wang&#x00026;author=S.+Seah&#x00026;author=X.+Loh&#x00026;author=C.+W.+Chan&#x00026;author=M.+Hartman&#x00026;author=B.+C.+Goh&#x00026;journal=Oncotarget&#x00026;publication_year=2016&#x00026;volume=7&#x00026;pages=2532&#x02013;44&#x00026;doi=10.18632/oncotarget.6304&#x00026;pmid=26565813" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B104"></a>104. Youle RJ, Narendra DP. Mechanisms of mitophagy. <i>Nat Rev Mol Cell Biol</i> (2011) 12(1):9&#x02013;14. doi:10.1038/nrm3028</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1038/nrm3028" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Mechanisms+of+mitophagy&#x00026;author=R.+J.+Youle&#x00026;author=D.+P.+Narendra&#x00026;journal=Nat+Rev+Mol+Cell+Biol&#x00026;publication_year=2011&#x00026;volume=12&#x00026;pages=9&#x02013;14&#x00026;doi=10.1038/nrm3028" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B105"></a>105. Kim Y, Park J, Kim S, Song S, Kwon SK, Lee SH, et al. PINK1 controls mitochondrial localization of Parkin through direct phosphorylation. <i>Biochem Biophys Res Commun</i> (2008) 377(3):975&#x02013;80. doi:10.1016/j.bbrc.2008.10.104</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.bbrc.2008.10.104" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=PINK1+controls+mitochondrial+localization+of+Parkin+through+direct+phosphorylation&#x00026;author=Y.+Kim&#x00026;author=J.+Park&#x00026;author=S.+Kim&#x00026;author=S.+Song&#x00026;author=S.+K.+Kwon&#x00026;author=S.+H.+Lee&#x00026;journal=Biochem+Biophys+Res+Commun&#x00026;publication_year=2008&#x00026;volume=377&#x00026;pages=975&#x02013;80&#x00026;doi=10.1016/j.bbrc.2008.10.104" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B106"></a>106. Geisler S, Holmstrom KM, Skujat D, Fiesel FC, Rothfuss OC, Kahle PJ, et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. <i>Nat Cell Biol</i> (2010) 12(2):119&#x02013;31. doi:10.1038/ncb2012</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=20098416" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/ncb2012" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=PINK1/Parkin-mediated+mitophagy+is+dependent+on+VDAC1+and+p62/SQSTM1&#x00026;author=S.+Geisler&#x00026;author=K.+M.+Holmstrom&#x00026;author=D.+Skujat&#x00026;author=F.+C.+Fiesel&#x00026;author=O.+C.+Rothfuss&#x00026;author=P.+J.+Kahle&#x00026;journal=Nat+Cell+Biol&#x00026;publication_year=2010&#x00026;volume=12&#x00026;pages=119&#x02013;31&#x00026;doi=10.1038/ncb2012&#x00026;pmid=20098416" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B107"></a>107. Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J, et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. <i>PLoS Biol</i> (2010) 8(1):e1000298. doi:10.1371/journal.pbio.1000298</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1371/journal.pbio.1000298" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=PINK1+is+selectively+stabilized+on+impaired+mitochondria+to+activate+Parkin&#x00026;author=D.+P.+Narendra&#x00026;author=S.+M.+Jin&#x00026;author=A.+Tanaka&#x00026;author=D.+F.+Suen&#x00026;author=C.+A.+Gautier&#x00026;author=J.+Shen&#x00026;journal=PLoS+Biol&#x00026;publication_year=2010&#x00026;volume=8&#x00026;pages=e1000298&#x00026;doi=10.1371/journal.pbio.1000298" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B108"></a>108. Koyano F, Okatsu K, Kosako H, Tamura Y, Go E, Kimura M, et al. Ubiquitin is phosphorylated by PINK1 to activate parkin. <i>Nature</i> (2014) 510(7503):162&#x02013;6. doi:10.1038/nature13392</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=24784582" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nature13392" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Ubiquitin+is+phosphorylated+by+PINK1+to+activate+parkin&#x00026;author=F.+Koyano&#x00026;author=K.+Okatsu&#x00026;author=H.+Kosako&#x00026;author=Y.+Tamura&#x00026;author=E.+Go&#x00026;author=M.+Kimura&#x00026;journal=Nature&#x00026;publication_year=2014&#x00026;volume=510&#x00026;pages=162&#x02013;6&#x00026;doi=10.1038/nature13392&#x00026;pmid=24784582" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B109"></a>109. Bernardini JP, Lazarou M, Dewson G. Parkin and mitophagy in cancer. <i>Oncogene</i> (2016) 36:1315&#x02013;27. doi:10.1038/onc.2016.302</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1038/onc.2016.302" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Parkin+and+mitophagy+in+cancer&#x00026;author=J.+P.+Bernardini&#x00026;author=M.+Lazarou&#x00026;author=G.+Dewson&#x00026;journal=Oncogene&#x00026;publication_year=2016&#x00026;volume=36&#x00026;pages=1315&#x02013;27&#x00026;doi=10.1038/onc.2016.302" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B110"></a>110. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. <i>Am J Physiol Lung Cell Mol Physiol</i> (2000) 279(6):L1005&#x02013;28.</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://scholar.google.com/scholar_lookup?title=Reactive+oxygen+species+in+cell+signaling&#x00026;author=V.+J.+Thannickal&#x00026;author=B.+L.+Fanburg&#x00026;journal=Am+J+Physiol+Lung+Cell+Mol+Physiol&#x00026;publication_year=2000&#x00026;volume=279&#x00026;pages=L1005&#x02013;28" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B111"></a>111. Esposito LA, Kokoszka JE, Waymire KG, Cottrell B, MacGregor GR, Wallace DC. Mitochondrial oxidative stress in mice lacking the glutathione peroxidase-1 gene. <i>Free Radic Biol Med</i> (2000) 28(5):754&#x02013;66. doi:10.1016/S0891-5849(00)00161-1</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=10754271" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/S0891-5849(00)00161-1" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Mitochondrial+oxidative+stress+in+mice+lacking+the+glutathione+peroxidase-1+gene&#x00026;author=L.+A.+Esposito&#x00026;author=J.+E.+Kokoszka&#x00026;author=K.+G.+Waymire&#x00026;author=B.+Cottrell&#x00026;author=G.+R.+MacGregor&#x00026;author=D.+C.+Wallace&#x00026;journal=Free+Radic+Biol+Med&#x00026;publication_year=2000&#x00026;volume=28&#x00026;pages=754&#x02013;66&#x00026;doi=10.1016/S0891-5849(00)00161-1&#x00026;pmid=10754271" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B112"></a>112. Gladyshev VN, Liu A, Novoselov SV, Krysan K, Sun QA, Kryukov VM, et al. Identification and characterization of a new mammalian glutaredoxin (thioltransferase), Grx2. <i>J Biol Chem</i> (2001) 276(32):30374&#x02013;80. doi:10.1074/jbc.M100020200</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=11397793" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1074/jbc.M100020200" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Identification+and+characterization+of+a+new+mammalian+glutaredoxin+(thioltransferase),+Grx2&#x00026;author=V.+N.+Gladyshev&#x00026;author=A.+Liu&#x00026;author=S.+V.+Novoselov&#x00026;author=K.+Krysan&#x00026;author=Q.+A.+Sun&#x00026;author=V.+M.+Kryukov&#x00026;journal=J+Biol+Chem&#x00026;publication_year=2001&#x00026;volume=276&#x00026;pages=30374&#x02013;80&#x00026;doi=10.1074/jbc.M100020200&#x00026;pmid=11397793" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B113"></a>113. Patenaude A, Ven Murthy MR, Mirault ME. Mitochondrial thioredoxin system: effects of TrxR2 overexpression on redox balance, cell growth, and apoptosis. <i>J Biol Chem</i> (2004) 279(26):27302&#x02013;14. doi:10.1074/jbc.M402496200M402496200</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=15082714" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1074/jbc.M402496200M402496200" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Mitochondrial+thioredoxin+system:+effects+of+TrxR2+overexpression+on+redox+balance,+cell+growth,+and+apoptosis&#x00026;author=A.+Patenaude&#x00026;author=M.+R.+Ven+Murthy&#x00026;author=M.+E.+Mirault&#x00026;journal=J+Biol+Chem&#x00026;publication_year=2004&#x00026;volume=279&#x00026;pages=27302&#x02013;14&#x00026;doi=10.1074/jbc.M402496200M402496200&#x00026;pmid=15082714" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B114"></a>114. Li H, Kantoff PW, Giovannucci E, Leitzmann MF, Gaziano JM, Stampfer MJ, et al. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. <i>Cancer Res</i> (2005) 65(6):2498&#x02013;504. doi:10.1158/0008-5472.CAN-04-3535</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1158/0008-5472.CAN-04-3535" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Manganese+superoxide+dismutase+polymorphism,+prediagnostic+antioxidant+status,+and+risk+of+clinical+significant+prostate+cancer&#x00026;author=H.+Li&#x00026;author=P.+W.+Kantoff&#x00026;author=E.+Giovannucci&#x00026;author=M.+F.+Leitzmann&#x00026;author=J.+M.+Gaziano&#x00026;author=M.+J.+Stampfer&#x00026;journal=Cancer+Res&#x00026;publication_year=2005&#x00026;volume=65&#x00026;pages=2498&#x02013;504&#x00026;doi=10.1158/0008-5472.CAN-04-3535" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B115"></a>115. Fu X, Wan S, Lyu YL, Liu LF, Qi H. Etoposide induces ATM-dependent mitochondrial biogenesis through AMPK activation. <i>PLoS One</i> (2008) 3(4):e2009. doi:10.1371/journal.pone.0002009</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1371/journal.pone.0002009" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Etoposide+induces+ATM-dependent+mitochondrial+biogenesis+through+AMPK+activation&#x00026;author=X.+Fu&#x00026;author=S.+Wan&#x00026;author=Y.+L.+Lyu&#x00026;author=L.+F.+Liu&#x00026;author=H.+Qi&#x00026;journal=PLoS+One&#x00026;publication_year=2008&#x00026;volume=3&#x00026;pages=e2009&#x00026;doi=10.1371/journal.pone.0002009" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B116"></a>116. Martinez-Outschoorn UE, Lin Z, Whitaker-Menezes D, Howell A, Lisanti MP, Sotgia F. Ketone bodies and two-compartment tumor metabolism: stromal ketone production fuels mitochondrial biogenesis in epithelial cancer cells. <i>Cell Cycle</i> (2012) 11(21):3956&#x02013;63. doi:10.4161/cc.22136</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=23082721" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.4161/cc.22136" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Ketone+bodies+and+two-compartment+tumor+metabolism:+stromal+ketone+production+fuels+mitochondrial+biogenesis+in+epithelial+cancer+cells&#x00026;author=U.+E.+Martinez-Outschoorn&#x00026;author=Z.+Lin&#x00026;author=D.+Whitaker-Menezes&#x00026;author=A.+Howell&#x00026;author=M.+P.+Lisanti&#x00026;author=F.+Sotgia&#x00026;journal=Cell+Cycle&#x00026;publication_year=2012&#x00026;volume=11&#x00026;pages=3956&#x02013;63&#x00026;doi=10.4161/cc.22136&#x00026;pmid=23082721" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B117"></a>117. Sotgia F, Whitaker-Menezes D, Martinez-Outschoorn UE, Salem AF, Tsirigos A, Lamb R, et al. Mitochondria &#x0201C;fuel&#x0201D; breast cancer metabolism: fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cells. <i>Cell Cycle</i> (2012) 11(23):4390&#x02013;401. doi:10.4161/cc.22777</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.4161/cc.22777" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Mitochondria+&#x0201C;fuel&#x0201D;+breast+cancer+metabolism:+fifteen+markers+of+mitochondrial+biogenesis+label+epithelial+cancer+cells,+but+are+excluded+from+adjacent+stromal+cells&#x00026;author=F.+Sotgia&#x00026;author=D.+Whitaker-Menezes&#x00026;author=U.+E.+Martinez-Outschoorn&#x00026;author=A.+F.+Salem&#x00026;author=A.+Tsirigos&#x00026;author=R.+Lamb&#x00026;journal=Cell+Cycle&#x00026;publication_year=2012&#x00026;volume=11&#x00026;pages=4390&#x02013;401&#x00026;doi=10.4161/cc.22777" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B118"></a>118. Kong X, Wang R, Xue Y, Liu X, Zhang H, Chen Y, et al. Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. <i>PLoS One</i> (2010) 5(7):e11707. doi:10.1371/journal.pone.0011707</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=20661474" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1371/journal.pone.0011707" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Sirtuin+3,+a+new+target+of+PGC-1alpha,+plays+an+important+role+in+the+suppression+of+ROS+and+mitochondrial+biogenesis&#x00026;author=X.+Kong&#x00026;author=R.+Wang&#x00026;author=Y.+Xue&#x00026;author=X.+Liu&#x00026;author=H.+Zhang&#x00026;author=Y.+Chen&#x00026;journal=PLoS+One&#x00026;publication_year=2010&#x00026;volume=5&#x00026;pages=e11707&#x00026;doi=10.1371/journal.pone.0011707&#x00026;pmid=20661474" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B119"></a>119. Lee CH, Wu SB, Hong CH, Liao WT, Wu CY, Chen GS, et al. Aberrant cell proliferation by enhanced mitochondrial biogenesis via mtTFA in arsenical skin cancers. <i>Am J Pathol</i> (2011) 178(5):2066&#x02013;76. doi:10.1016/j.ajpath.2011.01.056</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.ajpath.2011.01.056" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Aberrant+cell+proliferation+by+enhanced+mitochondrial+biogenesis+via+mtTFA+in+arsenical+skin+cancers&#x00026;author=C.+H.+Lee&#x00026;author=S.+B.+Wu&#x00026;author=C.+H.+Hong&#x00026;author=W.+T.+Liao&#x00026;author=C.+Y.+Wu&#x00026;author=G.+S.+Chen&#x00026;journal=Am+J+Pathol&#x00026;publication_year=2011&#x00026;volume=178&#x00026;pages=2066&#x02013;76&#x00026;doi=10.1016/j.ajpath.2011.01.056" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B120"></a>120. Salem AF, Whitaker-Menezes D, Howell A, Sotgia F, Lisanti MP. Mitochondrial biogenesis in epithelial cancer cells promotes breast cancer tumor growth and confers autophagy resistance. <i>Cell Cycle</i> (2012) 11(22):4174&#x02013;80. doi:10.4161/cc.22376</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.4161/cc.22376" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Mitochondrial+biogenesis+in+epithelial+cancer+cells+promotes+breast+cancer+tumor+growth+and+confers+autophagy+resistance&#x00026;author=A.+F.+Salem&#x00026;author=D.+Whitaker-Menezes&#x00026;author=A.+Howell&#x00026;author=F.+Sotgia&#x00026;author=M.+P.+Lisanti&#x00026;journal=Cell+Cycle&#x00026;publication_year=2012&#x00026;volume=11&#x00026;pages=4174&#x02013;80&#x00026;doi=10.4161/cc.22376" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B121"></a>121. LeBleu VS, O&#x02019;Connell JT, Gonzalez Herrera KN, Wikman H, Pantel K, Haigis MC, et al. PGC-1alpha mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. <i>Nat Cell Biol</i> (2014) 16(10):992&#x02013;1003. doi:10.1038/ncb3039</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1038/ncb3039" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=PGC-1alpha+mediates+mitochondrial+biogenesis+and+oxidative+phosphorylation+in+cancer+cells+to+promote+metastasis&#x00026;author=V.+S.+LeBleu&#x00026;author=J.+T.+O&#x02019;Connell&#x00026;author=K.+N.+Gonzalez+Herrera&#x00026;author=H.+Wikman&#x00026;author=K.+Pantel&#x00026;author=M.+C.+Haigis&#x00026;journal=Nat+Cell+Biol&#x00026;publication_year=2014&#x00026;volume=16&#x00026;pages=992&#x02013;1003&#x00026;doi=10.1038/ncb3039" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B122"></a>122. Nisoli E, Clementi E, Paolucci C, Cozzi V, Tonello C, Sciorati C, et al. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. <i>Science</i> (2003) 299(5608):896&#x02013;9. doi:10.1126/science.1079368</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1126/science.1079368" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Mitochondrial+biogenesis+in+mammals:+the+role+of+endogenous+nitric+oxide&#x00026;author=E.+Nisoli&#x00026;author=E.+Clementi&#x00026;author=C.+Paolucci&#x00026;author=V.+Cozzi&#x00026;author=C.+Tonello&#x00026;author=C.+Sciorati&#x00026;journal=Science&#x00026;publication_year=2003&#x00026;volume=299&#x00026;pages=896&#x02013;9&#x00026;doi=10.1126/science.1079368" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B123"></a>123. Schreiber SN, Emter R, Hock MB, Knutti D, Cardenas J, Podvinec M, et al. The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis. <i>Proc Natl Acad Sci U S A</i> (2004) 101(17):6472&#x02013;7. doi:10.1073/pnas.0308686101</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1073/pnas.0308686101" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=The+estrogen-related+receptor+alpha+(ERRalpha)+functions+in+PPARgamma+coactivator+1alpha+(PGC-1alpha)-induced+mitochondrial+biogenesis&#x00026;author=S.+N.+Schreiber&#x00026;author=R.+Emter&#x00026;author=M.+B.+Hock&#x00026;author=D.+Knutti&#x00026;author=J.+Cardenas&#x00026;author=M.+Podvinec&#x00026;journal=Proc+Natl+Acad+Sci+U+S+A&#x00026;publication_year=2004&#x00026;volume=101&#x00026;pages=6472&#x02013;7&#x00026;doi=10.1073/pnas.0308686101" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B124"></a>124. Favre C, Zhdanov A, Leahy M, Papkovsky D, O&#x02019;Connor R. Mitochondrial pyrimidine nucleotide carrier (PNC1) regulates mitochondrial biogenesis and the invasive phenotype of cancer cells. <i>Oncogene</i> (2010) 29(27):3964&#x02013;76. doi:10.1038/onc.2010.146</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=20453889" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/onc.2010.146" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Mitochondrial+pyrimidine+nucleotide+carrier+(PNC1)+regulates+mitochondrial+biogenesis+and+the+invasive+phenotype+of+cancer+cells&#x00026;author=C.+Favre&#x00026;author=A.+Zhdanov&#x00026;author=M.+Leahy&#x00026;author=D.+Papkovsky&#x00026;author=R.+O&#x02019;Connor&#x00026;journal=Oncogene&#x00026;publication_year=2010&#x00026;volume=29&#x00026;pages=3964&#x02013;76&#x00026;doi=10.1038/onc.2010.146&#x00026;pmid=20453889" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B125"></a>125. Morita M, Gravel SP, Chenard V, Sikstrom K, Zheng L, Alain T, et al. mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation. <i>Cell Metab</i> (2013) 18(5):698&#x02013;711. doi:10.1016/j.cmet.2013.10.001</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=24206664" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.cmet.2013.10.001" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=mTORC1+controls+mitochondrial+activity+and+biogenesis+through+4E-BP-dependent+translational+regulation&#x00026;author=M.+Morita&#x00026;author=S.+P.+Gravel&#x00026;author=V.+Chenard&#x00026;author=K.+Sikstrom&#x00026;author=L.+Zheng&#x00026;author=T.+Alain&#x00026;journal=Cell+Metab&#x00026;publication_year=2013&#x00026;volume=18&#x00026;pages=698&#x02013;711&#x00026;doi=10.1016/j.cmet.2013.10.001&#x00026;pmid=24206664" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B126"></a>126. Albert V, Hall MN. mTOR signaling in cellular and organismal energetics. <i>Curr Opin Cell Biol</i> (2015) 33:55&#x02013;66. doi:10.1016/j.ceb.2014.12.001</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=25554914" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.ceb.2014.12.001" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=mTOR+signaling+in+cellular+and+organismal+energetics&#x00026;author=V.+Albert&#x00026;author=M.+N.+Hall&#x00026;journal=Curr+Opin+Cell+Biol&#x00026;publication_year=2015&#x00026;volume=33&#x00026;pages=55&#x02013;66&#x00026;doi=10.1016/j.ceb.2014.12.001&#x00026;pmid=25554914" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B127"></a>127. Morita M, Gravel SP, Hulea L, Larsson O, Pollak M, St-Pierre J, et al. mTOR coordinates protein synthesis, mitochondrial activity and proliferation. <i>Cell Cycle</i> (2015) 14(4):473&#x02013;80. doi:10.4161/15384101.2014.991572</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=25590164" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.4161/15384101.2014.991572" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=mTOR+coordinates+protein+synthesis,+mitochondrial+activity+and+proliferation&#x00026;author=M.+Morita&#x00026;author=S.+P.+Gravel&#x00026;author=L.+Hulea&#x00026;author=O.+Larsson&#x00026;author=M.+Pollak&#x00026;author=J.+St-Pierre&#x00026;journal=Cell+Cycle&#x00026;publication_year=2015&#x00026;volume=14&#x00026;pages=473&#x02013;80&#x00026;doi=10.4161/15384101.2014.991572&#x00026;pmid=25590164" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B128"></a>128. Ploumi C, Daskalaki I, Tavernarakis N. Mitochondrial biogenesis and clearance: a balancing act. <i>FEBS J</i> (2017) 284(2):183&#x02013;95. doi:10.1111/febs.13820</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1111/febs.13820" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Mitochondrial+biogenesis+and+clearance:+a+balancing+act&#x00026;author=C.+Ploumi&#x00026;author=I.+Daskalaki&#x00026;author=N.+Tavernarakis&#x00026;journal=FEBS+J&#x00026;publication_year=2017&#x00026;volume=284&#x00026;pages=183&#x02013;95&#x00026;doi=10.1111/febs.13820" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B129"></a>129. Khan MI, Mohammad A, Patil G, Naqvi SA, Chauhan LK, Ahmad I. Induction of ROS, mitochondrial damage and autophagy in lung epithelial cancer cells by iron oxide nanoparticles. <i>Biomaterials</i> (2012) 33(5):1477&#x02013;88. doi:10.1016/j.biomaterials.2011.10.080</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=22098780" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.biomaterials.2011.10.080" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Induction+of+ROS,+mitochondrial+damage+and+autophagy+in+lung+epithelial+cancer+cells+by+iron+oxide+nanoparticles&#x00026;author=M.+I.+Khan&#x00026;author=A.+Mohammad&#x00026;author=G.+Patil&#x00026;author=S.+A.+Naqvi&#x00026;author=L.+K.+Chauhan&#x00026;author=I.+Ahmad&#x00026;journal=Biomaterials&#x00026;publication_year=2012&#x00026;volume=33&#x00026;pages=1477&#x02013;88&#x00026;doi=10.1016/j.biomaterials.2011.10.080&#x00026;pmid=22098780" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B130"></a>130. Kim J, Lee JH, Iyer VR. Global identification of Myc target genes reveals its direct role in mitochondrial biogenesis and its E-box usage in vivo. <i>PLoS One</i> (2008) 3(3):e1798. doi:10.1371/journal.pone.0001798</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1371/journal.pone.0001798" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Global+identification+of+Myc+target+genes+reveals+its+direct+role+in+mitochondrial+biogenesis+and+its+E-box+usage+in+vivo&#x00026;author=J.+Kim&#x00026;author=J.+H.+Lee&#x00026;author=V.+R.+Iyer&#x00026;journal=PLoS+One&#x00026;publication_year=2008&#x00026;volume=3&#x00026;pages=e1798&#x00026;doi=10.1371/journal.pone.0001798" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B131"></a>131. Dang CV, Li F, Lee LA. Could MYC induction of mitochondrial biogenesis be linked to ROS production and genomic instability? <i>Cell Cycle</i> (2005) 4(11):1465&#x02013;6. doi:10.4161/cc.4.11.2121</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16205115" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.4161/cc.4.11.2121" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Could+MYC+induction+of+mitochondrial+biogenesis+be+linked+to+ROS+production+and+genomic+instability?&#x00026;author=C.+V.+Dang&#x00026;author=F.+Li&#x00026;author=L.+A.+Lee&#x00026;journal=Cell+Cycle&#x00026;publication_year=2005&#x00026;volume=4&#x00026;pages=1465&#x02013;6&#x00026;doi=10.4161/cc.4.11.2121&#x00026;pmid=16205115" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B132"></a>132. Kim JW, Dang CV. Cancer&#x02019;s molecular sweet tooth and the Warburg effect. <i>Cancer Res</i> (2006) 66(18):8927&#x02013;30. doi:10.1158/0008-5472.CAN-06-1501</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16982728" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1158/0008-5472.CAN-06-1501" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Cancer&#x02019;s+molecular+sweet+tooth+and+the+Warburg+effect&#x00026;author=J.+W.+Kim&#x00026;author=C.+V.+Dang&#x00026;journal=Cancer+Res&#x00026;publication_year=2006&#x00026;volume=66&#x00026;pages=8927&#x02013;30&#x00026;doi=10.1158/0008-5472.CAN-06-1501&#x00026;pmid=16982728" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B133"></a>133. Westermann B. Mitochondrial fusion and fission in cell life and death. <i>Nat Rev Mol Cell Biol</i> (2010) 11(12):872&#x02013;84. doi:10.1038/nrm3013</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1038/nrm3013" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Mitochondrial+fusion+and+fission+in+cell+life+and+death&#x00026;author=B.+Westermann&#x00026;journal=Nat+Rev+Mol+Cell+Biol&#x00026;publication_year=2010&#x00026;volume=11&#x00026;pages=872&#x02013;84&#x00026;doi=10.1038/nrm3013" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B134"></a>134. Mitra K. Mitochondrial fission-fusion as an emerging key regulator of cell proliferation and differentiation. <i>Bioessays</i> (2013) 35(11):955&#x02013;64. doi:10.1002/bies.201300011</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=23943303" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1002/bies.201300011" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Mitochondrial+fission-fusion+as+an+emerging+key+regulator+of+cell+proliferation+and+differentiation&#x00026;author=K.+Mitra&#x00026;journal=Bioessays&#x00026;publication_year=2013&#x00026;volume=35&#x00026;pages=955&#x02013;64&#x00026;doi=10.1002/bies.201300011&#x00026;pmid=23943303" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B135"></a>135. van der Bliek AM, Shen Q, Kawajiri S. Mechanisms of mitochondrial fission and fusion. <i>Cold Spring Harb Perspect Biol</i> (2013) 5(6):a011072. doi:10.1101/cshperspect.a011072</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=23732471" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1101/cshperspect.a011072" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Mechanisms+of+mitochondrial+fission+and+fusion&#x00026;author=A.+M.+van+der+Bliek&#x00026;author=Q.+Shen&#x00026;author=S.+Kawajiri&#x00026;journal=Cold+Spring+Harb+Perspect+Biol&#x00026;publication_year=2013&#x00026;volume=5&#x00026;pages=a011072&#x00026;doi=10.1101/cshperspect.a011072&#x00026;pmid=23732471" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B136"></a>136. Rehman J, Zhang HJ, Toth PT, Zhang Y, Marsboom G, Hong Z, et al. Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer. <i>FASEB J</i> (2012) 26(5):2175&#x02013;86. doi:10.1096/fj.11-196543</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1096/fj.11-196543" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Inhibition+of+mitochondrial+fission+prevents+cell+cycle+progression+in+lung+cancer&#x00026;author=J.+Rehman&#x00026;author=H.+J.+Zhang&#x00026;author=P.+T.+Toth&#x00026;author=Y.+Zhang&#x00026;author=G.+Marsboom&#x00026;author=Z.+Hong&#x00026;journal=FASEB+J&#x00026;publication_year=2012&#x00026;volume=26&#x00026;pages=2175&#x02013;86&#x00026;doi=10.1096/fj.11-196543" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B137"></a>137. Zhao J, Zhang J, Yu M, Xie Y, Huang Y, Wolff DW, et al. Mitochondrial dynamics regulates migration and invasion of breast cancer cells. <i>Oncogene</i> (2013) 32(40):4814&#x02013;24. doi:10.1038/onc.2012.494</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=23128392" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/onc.2012.494" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Mitochondrial+dynamics+regulates+migration+and+invasion+of+breast+cancer+cells&#x00026;author=J.+Zhao&#x00026;author=J.+Zhang&#x00026;author=M.+Yu&#x00026;author=Y.+Xie&#x00026;author=Y.+Huang&#x00026;author=D.+W.+Wolff&#x00026;journal=Oncogene&#x00026;publication_year=2013&#x00026;volume=32&#x00026;pages=4814&#x02013;24&#x00026;doi=10.1038/onc.2012.494&#x00026;pmid=23128392" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B138"></a>138. Tailor D, Hahm ER, Kale RK, Singh SV, Singh RP. Sodium butyrate induces DRP1-mediated mitochondrial fusion and apoptosis in human colorectal cancer cells. <i>Mitochondrion</i> (2014) 16:55&#x02013;64. doi:10.1016/j.mito.2013.10.004</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=24177748" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.mito.2013.10.004" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Sodium+butyrate+induces+DRP1-mediated+mitochondrial+fusion+and+apoptosis+in+human+colorectal+cancer+cells&#x00026;author=D.+Tailor&#x00026;author=E.+R.+Hahm&#x00026;author=R.+K.+Kale&#x00026;author=S.+V.+Singh&#x00026;author=R.+P.+Singh&#x00026;journal=Mitochondrion&#x00026;publication_year=2014&#x00026;volume=16&#x00026;pages=55&#x02013;64&#x00026;doi=10.1016/j.mito.2013.10.004&#x00026;pmid=24177748" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B139"></a>139. Ferreira-da-Silva A, Valacca C, Rios E, Populo H, Soares P, Sobrinho-Simoes M, et al. Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration. <i>PLoS One</i> (2015) 10(3):e0122308. doi:10.1371/journal.pone.0122308</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=25822260" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1371/journal.pone.0122308" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Mitochondrial+dynamics+protein+Drp1+is+overexpressed+in+oncocytic+thyroid+tumors+and+regulates+cancer+cell+migration&#x00026;author=A.+Ferreira-da-Silva&#x00026;author=C.+Valacca&#x00026;author=E.+Rios&#x00026;author=H.+Populo&#x00026;author=P.+Soares&#x00026;author=M.+Sobrinho-Simoes&#x00026;journal=PLoS+One&#x00026;publication_year=2015&#x00026;volume=10&#x00026;pages=e0122308&#x00026;doi=10.1371/journal.pone.0122308&#x00026;pmid=25822260" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B140"></a>140. Frohman MA. Role of mitochondrial lipids in guiding fission and fusion. <i>J Mol Med (Berl)</i> (2015) 93(3):263&#x02013;9. doi:10.1007/s00109-014-1237-z</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=25471483" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s00109-014-1237-z" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Role+of+mitochondrial+lipids+in+guiding+fission+and+fusion&#x00026;author=M.+A.+Frohman&#x00026;journal=J+Mol+Med+(Berl)&#x00026;publication_year=2015&#x00026;volume=93&#x00026;pages=263&#x02013;9&#x00026;doi=10.1007/s00109-014-1237-z&#x00026;pmid=25471483" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B141"></a>141. Kong B, Wang Q, Fung E, Xue K, Tsang BK. p53 is required for cisplatin-induced processing of the mitochondrial fusion protein <span style="font-variant: small-caps">l</span>-Opa1 that is mediated by the mitochondrial metallopeptidase Oma1 in gynecologic cancers. <i>J Biol Chem</i> (2014) 289(39):27134&#x02013;45. doi:10.1074/jbc.M114.594812</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=25112877" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1074/jbc.M114.594812" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=p53+is+required+for+cisplatin-induced+processing+of+the+mitochondrial+fusion+protein+l-Opa1+that+is+mediated+by+the+mitochondrial+metallopeptidase+Oma1+in+gynecologic+cancers&#x00026;author=B.+Kong&#x00026;author=Q.+Wang&#x00026;author=E.+Fung&#x00026;author=K.+Xue&#x00026;author=B.+K.+Tsang&#x00026;journal=J+Biol+Chem&#x00026;publication_year=2014&#x00026;volume=289&#x00026;pages=27134&#x02013;45&#x00026;doi=10.1074/jbc.M114.594812&#x00026;pmid=25112877" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B142"></a>142. Fan S, Liu B, Sun L, Lv XB, Lin Z, Chen W, et al. Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p-MFF axis. <i>Oncotarget</i> (2015) 6(17):14885&#x02013;904. doi:10.18632/oncotarget.3659</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.18632/oncotarget.3659" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Mitochondrial+fission+determines+cisplatin+sensitivity+in+tongue+squamous+cell+carcinoma+through+the+BRCA1-miR-593-5p-MFF+axis&#x00026;author=S.+Fan&#x00026;author=B.+Liu&#x00026;author=L.+Sun&#x00026;author=X.+B.+Lv&#x00026;author=Z.+Lin&#x00026;author=W.+Chen&#x00026;journal=Oncotarget&#x00026;publication_year=2015&#x00026;volume=6&#x00026;pages=14885&#x02013;904&#x00026;doi=10.18632/oncotarget.3659" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B143"></a>143. O&#x02019;Flanagan CH, Morais VA, Wurst W, De Strooper B, O&#x02019;Neill C. The Parkinson&#x02019;s gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes. <i>Oncogene</i> (2015) 34(11):1363&#x02013;74. doi:10.1038/onc.2014.81</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=24681957" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/onc.2014.81" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=The+Parkinson&#x02019;s+gene+PINK1+regulates+cell+cycle+progression+and+promotes+cancer-associated+phenotypes&#x00026;author=C.+H.+O&#x02019;Flanagan&#x00026;author=V.+A.+Morais&#x00026;author=W.+Wurst&#x00026;author=B.+De+Strooper&#x00026;author=C.+O&#x02019;Neill&#x00026;journal=Oncogene&#x00026;publication_year=2015&#x00026;volume=34&#x00026;pages=1363&#x02013;74&#x00026;doi=10.1038/onc.2014.81&#x00026;pmid=24681957" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B144"></a>144. Huang Q, Zhan L, Cao H, Li J, Lyu Y, Guo X, et al. Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways. <i>Autophagy</i> (2016) 12(6):999&#x02013;1014. doi:10.1080/15548627.2016.1166318</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=27124102" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1080/15548627.2016.1166318" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Increased+mitochondrial+fission+promotes+autophagy+and+hepatocellular+carcinoma+cell+survival+through+the+ROS-modulated+coordinated+regulation+of+the+NFKB+and+TP53+pathways&#x00026;author=Q.+Huang&#x00026;author=L.+Zhan&#x00026;author=H.+Cao&#x00026;author=J.+Li&#x00026;author=Y.+Lyu&#x00026;author=X.+Guo&#x00026;journal=Autophagy&#x00026;publication_year=2016&#x00026;volume=12&#x00026;pages=999&#x02013;1014&#x00026;doi=10.1080/15548627.2016.1166318&#x00026;pmid=27124102" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B145"></a>145. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. <i>Am J Physiol Cell Physiol</i> (2004) 287(4):C817&#x02013;33. doi:10.1152/ajpcell.00139.2004</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=15355853" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1152/ajpcell.00139.2004" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Calcium,+ATP,+and+ROS:+a+mitochondrial+love-hate+triangle&#x00026;author=P.+S.+Brookes&#x00026;author=Y.+Yoon&#x00026;author=J.+L.+Robotham&#x00026;author=M.+W.+Anders&#x00026;author=S.+S.+Sheu&#x00026;journal=Am+J+Physiol+Cell+Physiol&#x00026;publication_year=2004&#x00026;volume=287&#x00026;pages=C817&#x02013;33&#x00026;doi=10.1152/ajpcell.00139.2004&#x00026;pmid=15355853" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B146"></a>146. Monteith GR, McAndrew D, Faddy HM, Roberts-Thomson SJ. Calcium and cancer: targeting Ca2&#43; transport. <i>Nat Rev Cancer</i> (2007) 7(7):519&#x02013;30. doi:10.1038/nrc2171</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=17585332" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nrc2171" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Calcium+and+cancer:+targeting+Ca2&#43;+transport&#x00026;author=G.+R.+Monteith&#x00026;author=D.+McAndrew&#x00026;author=H.+M.+Faddy&#x00026;author=S.+J.+Roberts-Thomson&#x00026;journal=Nat+Rev+Cancer&#x00026;publication_year=2007&#x00026;volume=7&#x00026;pages=519&#x02013;30&#x00026;doi=10.1038/nrc2171&#x00026;pmid=17585332" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B147"></a>147. Amuthan G, Biswas G, Ananadatheerthavarada HK, Vijayasarathy C, Shephard HM, Avadhani NG. Mitochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells. <i>Oncogene</i> (2002) 21(51):7839&#x02013;49. doi:10.1038/sj.onc.1205983</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1038/sj.onc.1205983" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Mitochondrial+stress-induced+calcium+signaling,+phenotypic+changes+and+invasive+behavior+in+human+lung+carcinoma+A549+cells&#x00026;author=G.+Amuthan&#x00026;author=G.+Biswas&#x00026;author=H.+K.+Ananadatheerthavarada&#x00026;author=C.+Vijayasarathy&#x00026;author=H.+M.+Shephard&#x00026;author=N.+G.+Avadhani&#x00026;journal=Oncogene&#x00026;publication_year=2002&#x00026;volume=21&#x00026;pages=7839&#x02013;49&#x00026;doi=10.1038/sj.onc.1205983" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B148"></a>148. Raturi A, Simmen T. Where the endoplasmic reticulum and the mitochondrion tie the knot: the mitochondria-associated membrane (MAM). <i>Biochim Biophys Acta</i> (2013) 1833(1):213&#x02013;24. doi:10.1016/j.bbamcr.2012.04.013</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=22575682" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.bbamcr.2012.04.013" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Where+the+endoplasmic+reticulum+and+the+mitochondrion+tie+the+knot:+the+mitochondria-associated+membrane+(MAM)&#x00026;author=A.+Raturi&#x00026;author=T.+Simmen&#x00026;journal=Biochim+Biophys+Acta&#x00026;publication_year=2013&#x00026;volume=1833&#x00026;pages=213&#x02013;24&#x00026;doi=10.1016/j.bbamcr.2012.04.013&#x00026;pmid=22575682" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B149"></a>149. Marchi S, Giorgi C, Oparka M, Duszynski J, Wieckowski MR, Pinton P. Oncogenic and oncosuppressive signal transduction at mitochondria-associated endoplasmic reticulum membranes. <i>Mol Cell Oncol</i> (2014) 1(2):e956469. doi:10.4161/23723548.2014.956469956469</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=27308328" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.4161/23723548.2014.956469956469" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Oncogenic+and+oncosuppressive+signal+transduction+at+mitochondria-associated+endoplasmic+reticulum+membranes&#x00026;author=S.+Marchi&#x00026;author=C.+Giorgi&#x00026;author=M.+Oparka&#x00026;author=J.+Duszynski&#x00026;author=M.+R.+Wieckowski&#x00026;author=P.+Pinton&#x00026;journal=Mol+Cell+Oncol&#x00026;publication_year=2014&#x00026;volume=1&#x00026;pages=e956469&#x00026;doi=10.4161/23723548.2014.956469956469&#x00026;pmid=27308328" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B150"></a>150. Yoon MJ, Lee AR, Jeong SA, Kim YS, Kim JY, Kwon YJ, et al. Release of Ca2&#43; from the endoplasmic reticulum and its subsequent influx into mitochondria trigger celastrol-induced paraptosis in cancer cells. <i>Oncotarget</i> (2014) 5(16):6816&#x02013;31. doi:10.18632/oncotarget.2256</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=25149175" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.18632/oncotarget.2256" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Release+of+Ca2&#43;+from+the+endoplasmic+reticulum+and+its+subsequent+influx+into+mitochondria+trigger+celastrol-induced+paraptosis+in+cancer+cells&#x00026;author=M.+J.+Yoon&#x00026;author=A.+R.+Lee&#x00026;author=S.+A.+Jeong&#x00026;author=Y.+S.+Kim&#x00026;author=J.+Y.+Kim&#x00026;author=Y.+J.+Kwon&#x00026;journal=Oncotarget&#x00026;publication_year=2014&#x00026;volume=5&#x00026;pages=6816&#x02013;31&#x00026;doi=10.18632/oncotarget.2256&#x00026;pmid=25149175" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B151"></a>151. Mallilankaraman K, Doonan P, Cardenas C, Chandramoorthy HC, Muller M, Miller R, et al. MICU1 is an essential gatekeeper for MCU-mediated mitochondrial Ca(2&#43;) uptake that regulates cell survival. <i>Cell</i> (2012) 151(3):630&#x02013;44. doi:10.1016/j.cell.2012.10.011</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=23101630" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.cell.2012.10.011" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=MICU1+is+an+essential+gatekeeper+for+MCU-mediated+mitochondrial+Ca(2&#43;)+uptake+that+regulates+cell+survival&#x00026;author=K.+Mallilankaraman&#x00026;author=P.+Doonan&#x00026;author=C.+Cardenas&#x00026;author=H.+C.+Chandramoorthy&#x00026;author=M.+Muller&#x00026;author=R.+Miller&#x00026;journal=Cell&#x00026;publication_year=2012&#x00026;volume=151&#x00026;pages=630&#x02013;44&#x00026;doi=10.1016/j.cell.2012.10.011&#x00026;pmid=23101630" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B152"></a>152. Verfaillie T, Rubio N, Garg AD, Bultynck G, Rizzuto R, Decuypere JP, et al. PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress. <i>Cell Death Differ</i> (2012) 19(11):1880&#x02013;91. doi:10.1038/cdd.2012.74</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1038/cdd.2012.74" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=PERK+is+required+at+the+ER-mitochondrial+contact+sites+to+convey+apoptosis+after+ROS-based+ER+stress&#x00026;author=T.+Verfaillie&#x00026;author=N.+Rubio&#x00026;author=A.+D.+Garg&#x00026;author=G.+Bultynck&#x00026;author=R.+Rizzuto&#x00026;author=J.+P.+Decuypere&#x00026;journal=Cell+Death+Differ&#x00026;publication_year=2012&#x00026;volume=19&#x00026;pages=1880&#x02013;91&#x00026;doi=10.1038/cdd.2012.74" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B153"></a>153. Marchi S, Pinton P. Mitochondrial calcium uniporter, miRNA and cancer: live and let die. <i>Commun Integr Biol</i> (2013) 6(3):e23818. doi:10.4161/cib.238182013CIB0014</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=23713134" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.4161/cib.238182013CIB0014" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Mitochondrial+calcium+uniporter,+miRNA+and+cancer:+live+and+let+die&#x00026;author=S.+Marchi&#x00026;author=P.+Pinton&#x00026;journal=Commun+Integr+Biol&#x00026;publication_year=2013&#x00026;volume=6&#x00026;pages=e23818&#x00026;doi=10.4161/cib.238182013CIB0014&#x00026;pmid=23713134" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B154"></a>154. Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. <i>Oncogene</i> (2004) 23(16):2891&#x02013;906. doi:10.1038/sj.onc.1207521</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=15077152" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/sj.onc.1207521" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Autophagy+as+a+cell+death+and+tumor+suppressor+mechanism&#x00026;author=D.+Gozuacik&#x00026;author=A.+Kimchi&#x00026;journal=Oncogene&#x00026;publication_year=2004&#x00026;volume=23&#x00026;pages=2891&#x02013;906&#x00026;doi=10.1038/sj.onc.1207521&#x00026;pmid=15077152" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B155"></a>155. Zong WX, Thompson CB. Necrotic death as a cell fate. <i>Genes Dev</i> (2006) 20(1):1&#x02013;15. doi:10.1101/gad.1376506</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1101/gad.1376506" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Necrotic+death+as+a+cell+fate&#x00026;author=W.+X.+Zong&#x00026;author=C.+B.+Thompson&#x00026;journal=Genes+Dev&#x00026;publication_year=2006&#x00026;volume=20&#x00026;pages=1&#x02013;15&#x00026;doi=10.1101/gad.1376506" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B156"></a>156. Galluzzi L, Kroemer G. Necroptosis: a specialized pathway of programmed necrosis. <i>Cell</i> (2008) 135(7):1161&#x02013;3. doi:10.1016/j.cell.2008.12.004</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.cell.2008.12.004" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Necroptosis:+a+specialized+pathway+of+programmed+necrosis&#x00026;author=L.+Galluzzi&#x00026;author=G.+Kroemer&#x00026;journal=Cell&#x00026;publication_year=2008&#x00026;volume=135&#x00026;pages=1161&#x02013;3&#x00026;doi=10.1016/j.cell.2008.12.004" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B157"></a>157. Hunter AM, LaCasse EC, Korneluk RG. The inhibitors of apoptosis (IAPs) as cancer targets. <i>Apoptosis</i> (2007) 12(9):1543&#x02013;68. doi:10.1007/s10495-007-0087-3</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1007/s10495-007-0087-3" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=The+inhibitors+of+apoptosis+(IAPs)+as+cancer+targets&#x00026;author=A.+M.+Hunter&#x00026;author=E.+C.+LaCasse&#x00026;author=R.+G.+Korneluk&#x00026;journal=Apoptosis&#x00026;publication_year=2007&#x00026;volume=12&#x00026;pages=1543&#x02013;68&#x00026;doi=10.1007/s10495-007-0087-3" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B158"></a>158. Kang MH, Reynolds CP. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. <i>Clin Cancer Res</i> (2009) 15(4):1126&#x02013;32. doi:10.1158/1078-0432.CCR-08-0144</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1158/1078-0432.CCR-08-0144" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Bcl-2+inhibitors:+targeting+mitochondrial+apoptotic+pathways+in+cancer+therapy&#x00026;author=M.+H.+Kang&#x00026;author=C.+P.+Reynolds&#x00026;journal=Clin+Cancer+Res&#x00026;publication_year=2009&#x00026;volume=15&#x00026;pages=1126&#x02013;32&#x00026;doi=10.1158/1078-0432.CCR-08-0144" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B159"></a>159. Zhang H, Li Y, Huang Q, Ren X, Hu H, Sheng H, et al. miR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer. <i>Cell Death Differ</i> (2011) 18(11):1702&#x02013;10. doi:10.1038/cdd.2011.28</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=21455217" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/cdd.2011.28" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=miR-148a+promotes+apoptosis+by+targeting+Bcl-2+in+colorectal+cancer&#x00026;author=H.+Zhang&#x00026;author=Y.+Li&#x00026;author=Q.+Huang&#x00026;author=X.+Ren&#x00026;author=H.+Hu&#x00026;author=H.+Sheng&#x00026;journal=Cell+Death+Differ&#x00026;publication_year=2011&#x00026;volume=18&#x00026;pages=1702&#x02013;10&#x00026;doi=10.1038/cdd.2011.28&#x00026;pmid=21455217" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B160"></a>160. Ma Y, Ha CS, Hwang SW, Lee HJ, Kim GC, Lee KW, et al. Non-thermal atmospheric pressure plasma preferentially induces apoptosis in p53-mutated cancer cells by activating ROS stress-response pathways. <i>PLoS One</i> (2014) 9(4):e91947. doi:10.1371/journal.pone.0091947PONE-D-13-39326</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1371/journal.pone.0091947PONE-D-13-39326" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Non-thermal+atmospheric+pressure+plasma+preferentially+induces+apoptosis+in+p53-mutated+cancer+cells+by+activating+ROS+stress-response+pathways&#x00026;author=Y.+Ma&#x00026;author=C.+S.+Ha&#x00026;author=S.+W.+Hwang&#x00026;author=H.+J.+Lee&#x00026;author=G.+C.+Kim&#x00026;author=K.+W.+Lee&#x00026;journal=PLoS+One&#x00026;publication_year=2014&#x00026;volume=9&#x00026;pages=e91947&#x00026;doi=10.1371/journal.pone.0091947PONE-D-13-39326" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B161"></a>161. Shi Y, Nikulenkov F, Zawacka-Pankau J, Li H, Gabdoulline R, Xu J, et al. ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis. <i>Cell Death Differ</i> (2014) 21(4):612&#x02013;23. doi:10.1038/cdd.2013.186</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=24413150" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/cdd.2013.186" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=ROS-dependent+activation+of+JNK+converts+p53+into+an+efficient+inhibitor+of+oncogenes+leading+to+robust+apoptosis&#x00026;author=Y.+Shi&#x00026;author=F.+Nikulenkov&#x00026;author=J.+Zawacka-Pankau&#x00026;author=H.+Li&#x00026;author=R.+Gabdoulline&#x00026;author=J.+Xu&#x00026;journal=Cell+Death+Differ&#x00026;publication_year=2014&#x00026;volume=21&#x00026;pages=612&#x02013;23&#x00026;doi=10.1038/cdd.2013.186&#x00026;pmid=24413150" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B162"></a>162. Zhang J, Sun Q, Zhang Z, Ge S, Han ZG, Chen WT. Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop. <i>Oncogene</i> (2013) 32(1):61&#x02013;9. doi:10.1038/onc.2012.28</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=22330136" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/onc.2012.28" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Loss+of+microRNA-143/145+disturbs+cellular+growth+and+apoptosis+of+human+epithelial+cancers+by+impairing+the+MDM2-p53+feedback+loop&#x00026;author=J.+Zhang&#x00026;author=Q.+Sun&#x00026;author=Z.+Zhang&#x00026;author=S.+Ge&#x00026;author=Z.+G.+Han&#x00026;author=W.+T.+Chen&#x00026;journal=Oncogene&#x00026;publication_year=2013&#x00026;volume=32&#x00026;pages=61&#x02013;9&#x00026;doi=10.1038/onc.2012.28&#x00026;pmid=22330136" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B163"></a>163. Hoffmann G, Breitenbucher F, Schuler M, Ehrenhofer-Murray AE. A novel sirtuin 2 (SIRT2) inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancer. <i>J Biol Chem</i> (2014) 289(8):5208&#x02013;16. doi:10.1074/jbc.M113.487736</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=24379401" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1074/jbc.M113.487736" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=A+novel+sirtuin+2+(SIRT2)+inhibitor+with+p53-dependent+pro-apoptotic+activity+in+non-small+cell+lung+cancer&#x00026;author=G.+Hoffmann&#x00026;author=F.+Breitenbucher&#x00026;author=M.+Schuler&#x00026;author=A.+E.+Ehrenhofer-Murray&#x00026;journal=J+Biol+Chem&#x00026;publication_year=2014&#x00026;volume=289&#x00026;pages=5208&#x02013;16&#x00026;doi=10.1074/jbc.M113.487736&#x00026;pmid=24379401" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B164"></a>164. Sheridan C, Martin SJ. Mitochondrial fission/fusion dynamics and apoptosis. <i>Mitochondrion</i> (2010) 10(6):640&#x02013;8. doi:10.1016/j.mito.2010.08.005</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=20727425" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.mito.2010.08.005" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Mitochondrial+fission/fusion+dynamics+and+apoptosis&#x00026;author=C.+Sheridan&#x00026;author=S.+J.+Martin&#x00026;journal=Mitochondrion&#x00026;publication_year=2010&#x00026;volume=10&#x00026;pages=640&#x02013;8&#x00026;doi=10.1016/j.mito.2010.08.005&#x00026;pmid=20727425" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B165"></a>165. Jia Y, Zhou L, Tian C, Shi Y, Wang C, Tong Z. Dynamin-related protein 1 is involved in micheliolide-induced breast cancer cell death. <i>Onco Targets Ther</i> (2015) 8:3371&#x02013;81. doi:10.2147/OTT.S91805</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.2147/OTT.S91805" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Dynamin-related+protein+1+is+involved+in+micheliolide-induced+breast+cancer+cell+death&#x00026;author=Y.+Jia&#x00026;author=L.+Zhou&#x00026;author=C.+Tian&#x00026;author=Y.+Shi&#x00026;author=C.+Wang&#x00026;author=Z.+Tong&#x00026;journal=Onco+Targets+Ther&#x00026;publication_year=2015&#x00026;volume=8&#x00026;pages=3371&#x02013;81&#x00026;doi=10.2147/OTT.S91805" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B166"></a>166. Wang P, Liu B, Zhao J, Pang Q, Agrawal SG, Jia L, et al. Dynamin-related protein Drp1 is required for Bax translocation to mitochondria in response to irradiation-induced apoptosis. <i>Oncotarget</i> (2015) 6(26):22598&#x02013;612. doi:10.18632/oncotarget.4200</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=26093086" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.18632/oncotarget.4200" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Dynamin-related+protein+Drp1+is+required+for+Bax+translocation+to+mitochondria+in+response+to+irradiation-induced+apoptosis&#x00026;author=P.+Wang&#x00026;author=B.+Liu&#x00026;author=J.+Zhao&#x00026;author=Q.+Pang&#x00026;author=S.+G.+Agrawal&#x00026;author=L.+Jia&#x00026;journal=Oncotarget&#x00026;publication_year=2015&#x00026;volume=6&#x00026;pages=22598&#x02013;612&#x00026;doi=10.18632/oncotarget.4200&#x00026;pmid=26093086" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B167"></a>167. Pyakurel A, Savoia C, Hess D, Scorrano L. Extracellular regulated kinase phosphorylates mitofusin 1 to control mitochondrial morphology and apoptosis. <i>Mol Cell</i> (2015) 58(2):244&#x02013;54. doi:10.1016/j.molcel.2015.02.021</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=25801171" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.molcel.2015.02.021" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Extracellular+regulated+kinase+phosphorylates+mitofusin+1+to+control+mitochondrial+morphology+and+apoptosis&#x00026;author=A.+Pyakurel&#x00026;author=C.+Savoia&#x00026;author=D.+Hess&#x00026;author=L.+Scorrano&#x00026;journal=Mol+Cell&#x00026;publication_year=2015&#x00026;volume=58&#x00026;pages=244&#x02013;54&#x00026;doi=10.1016/j.molcel.2015.02.021&#x00026;pmid=25801171" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B168"></a>168. Ma LI, Chang Y, Yu L, He W, Liu Y. Pro-apoptotic and anti-proliferative effects of mitofusin-2 via PI3K/Akt signaling in breast cancer cells. <i>Oncol Lett</i> (2015) 10(6):3816&#x02013;22. doi:10.3892/ol.2015.3748OL-0-0-3748</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=26788214" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3892/ol.2015.3748OL-0-0-3748" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Pro-apoptotic+and+anti-proliferative+effects+of+mitofusin-2+via+PI3K/Akt+signaling+in+breast+cancer+cells&#x00026;author=L.+I.+Ma&#x00026;author=Y.+Chang&#x00026;author=L.+Yu&#x00026;author=W.+He&#x00026;author=Y.+Liu&#x00026;journal=Oncol+Lett&#x00026;publication_year=2015&#x00026;volume=10&#x00026;pages=3816&#x02013;22&#x00026;doi=10.3892/ol.2015.3748OL-0-0-3748&#x00026;pmid=26788214" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B169"></a>169. Wu Y, Zhou D, Xu X, Zhao X, Huang P, Zhou X, et al. Clinical significance of mitofusin-2 and its signaling pathways in hepatocellular carcinoma. <i>World J Surg Oncol</i> (2016) 14(1):179. doi:10.1186/s12957-016-0922-5</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=27389277" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1186/s12957-016-0922-5" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Clinical+significance+of+mitofusin-2+and+its+signaling+pathways+in+hepatocellular+carcinoma&#x00026;author=Y.+Wu&#x00026;author=D.+Zhou&#x00026;author=X.+Xu&#x00026;author=X.+Zhao&#x00026;author=P.+Huang&#x00026;author=X.+Zhou&#x00026;journal=World+J+Surg+Oncol&#x00026;publication_year=2016&#x00026;volume=14&#x00026;pages=179&#x00026;doi=10.1186/s12957-016-0922-5&#x00026;pmid=27389277" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B170"></a>170. Alonso A, Martin P, Albarran C, Aquilera B, Garcia O, Guzman A, et al. Detection of somatic mutations in the mitochondrial DNA control region of colorectal and gastric tumors by heteroduplex and single-strand conformation analysis. <i>Electrophoresis</i> (1997) 18(5):682&#x02013;5. doi:10.1002/elps.1150180504</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1002/elps.1150180504" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Detection+of+somatic+mutations+in+the+mitochondrial+DNA+control+region+of+colorectal+and+gastric+tumors+by+heteroduplex+and+single-strand+conformation+analysis&#x00026;author=A.+Alonso&#x00026;author=P.+Martin&#x00026;author=C.+Albarran&#x00026;author=B.+Aquilera&#x00026;author=O.+Garcia&#x00026;author=A.+Guzman&#x00026;journal=Electrophoresis&#x00026;publication_year=1997&#x00026;volume=18&#x00026;pages=682&#x02013;5&#x00026;doi=10.1002/elps.1150180504" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B171"></a>171. Liu VW, Shi HH, Cheung AN, Chiu PM, Leung TW, Nagley P, et al. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. <i>Cancer Res</i> (2001) 61(16):5998&#x02013;6001.</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=11507041" target="_blank">PubMed Abstract</a> | <a href="http://scholar.google.com/scholar_lookup?title=High+incidence+of+somatic+mitochondrial+DNA+mutations+in+human+ovarian+carcinomas&#x00026;author=V.+W.+Liu&#x00026;author=H.+H.+Shi&#x00026;author=A.+N.+Cheung&#x00026;author=P.+M.+Chiu&#x00026;author=T.+W.+Leung&#x00026;author=P.+Nagley&#x00026;journal=Cancer+Res&#x00026;publication_year=2001&#x00026;volume=61&#x00026;pages=5998&#x02013;6001&#x00026;pmid=11507041" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B172"></a>172. Parrella P, Xiao Y, Fliss M, Sanchez-Cespedes M, Mazzarelli P, Rinaldi M, et al. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. <i>Cancer Res</i> (2001) 61(20):7623&#x02013;6.</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=11606403" target="_blank">PubMed Abstract</a> | <a href="http://scholar.google.com/scholar_lookup?title=Detection+of+mitochondrial+DNA+mutations+in+primary+breast+cancer+and+fine-needle+aspirates&#x00026;author=P.+Parrella&#x00026;author=Y.+Xiao&#x00026;author=M.+Fliss&#x00026;author=M.+Sanchez-Cespedes&#x00026;author=P.+Mazzarelli&#x00026;author=M.+Rinaldi&#x00026;journal=Cancer+Res&#x00026;publication_year=2001&#x00026;volume=61&#x00026;pages=7623&#x02013;6&#x00026;pmid=11606403" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B173"></a>173. Tan DJ, Bai RK, Wong LJ. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. <i>Cancer Res</i> (2002) 62(4):972&#x02013;6.</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=11861366" target="_blank">PubMed Abstract</a> | <a href="http://scholar.google.com/scholar_lookup?title=Comprehensive+scanning+of+somatic+mitochondrial+DNA+mutations+in+breast+cancer&#x00026;author=D.+J.+Tan&#x00026;author=R.+K.+Bai&#x00026;author=L.+J.+Wong&#x00026;journal=Cancer+Res&#x00026;publication_year=2002&#x00026;volume=62&#x00026;pages=972&#x02013;6&#x00026;pmid=11861366" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B174"></a>174. Lee HC, Li SH, Lin JC, Wu CC, Yeh DC, Wei YH. Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. <i>Mutat Res</i> (2004) 547(1&#x02013;2):71&#x02013;8. doi:10.1016/j.mrfmmm.2003.12.011</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=15013701" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.mrfmmm.2003.12.011" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Somatic+mutations+in+the+D-loop+and+decrease+in+the+copy+number+of+mitochondrial+DNA+in+human+hepatocellular+carcinoma&#x00026;author=H.+C.+Lee&#x00026;author=S.+H.+Li&#x00026;author=J.+C.+Lin&#x00026;author=C.+C.+Wu&#x00026;author=D.+C.+Yeh&#x00026;author=Y.+H.+Wei&#x00026;journal=Mutat+Res&#x00026;publication_year=2004&#x00026;volume=547&#x00026;pages=71&#x02013;8&#x00026;doi=10.1016/j.mrfmmm.2003.12.011&#x00026;pmid=15013701" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B175"></a>175. He Y, Wu J, Dressman DC, Iacobuzio-Donahue C, Markowitz SD, Velculescu VE, et al. Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. <i>Nature</i> (2010) 464(7288):610&#x02013;4. doi:10.1038/nature08802</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=20200521" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nature08802" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Heteroplasmic+mitochondrial+DNA+mutations+in+normal+and+tumour+cells&#x00026;author=Y.+He&#x00026;author=J.+Wu&#x00026;author=D.+C.+Dressman&#x00026;author=C.+Iacobuzio-Donahue&#x00026;author=S.+D.+Markowitz&#x00026;author=V.+E.+Velculescu&#x00026;journal=Nature&#x00026;publication_year=2010&#x00026;volume=464&#x00026;pages=610&#x02013;4&#x00026;doi=10.1038/nature08802&#x00026;pmid=20200521" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B176"></a>176. Liu SA, Jiang RS, Wang WY, Lin JC. Somatic mutations in the D-loop of mitochondrial DNA in head and neck squamous cell carcinoma. <i>Head Neck</i> (2015) 37(6):878&#x02013;83. doi:10.1002/hed.23680</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=24976238" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1002/hed.23680" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Somatic+mutations+in+the+D-loop+of+mitochondrial+DNA+in+head+and+neck+squamous+cell+carcinoma&#x00026;author=S.+A.+Liu&#x00026;author=R.+S.+Jiang&#x00026;author=W.+Y.+Wang&#x00026;author=J.+C.+Lin&#x00026;journal=Head+Neck&#x00026;publication_year=2015&#x00026;volume=37&#x00026;pages=878&#x02013;83&#x00026;doi=10.1002/hed.23680&#x00026;pmid=24976238" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B177"></a>177. Chattopadhyay E, De Sarkar N, Singh R, Ray A, Roy R, Paul RR, et al. Genome-wide mitochondrial DNA sequence variations and lower expression of OXPHOS genes predict mitochondrial dysfunction in oral cancer tissue. <i>Tumour Biol</i> (2016) 37(9):11861&#x02013;71. doi:10.1007/s13277-016-5026-x</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=27055661" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s13277-016-5026-x" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Genome-wide+mitochondrial+DNA+sequence+variations+and+lower+expression+of+OXPHOS+genes+predict+mitochondrial+dysfunction+in+oral+cancer+tissue&#x00026;author=E.+Chattopadhyay&#x00026;author=N.+De+Sarkar&#x00026;author=R.+Singh&#x00026;author=A.+Ray&#x00026;author=R.+Roy&#x00026;author=R.+R.+Paul&#x00026;journal=Tumour+Biol&#x00026;publication_year=2016&#x00026;volume=37&#x00026;pages=11861&#x02013;71&#x00026;doi=10.1007/s13277-016-5026-x&#x00026;pmid=27055661" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B178"></a>178. Schon EA, DiMauro S, Hirano M. Human mitochondrial DNA: roles of inherited and somatic mutations. <i>Nat Rev Genet</i> (2012) 13(12):878&#x02013;90. doi:10.1038/nrg3275</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=23154810" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nrg3275" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Human+mitochondrial+DNA:+roles+of+inherited+and+somatic+mutations&#x00026;author=E.+A.+Schon&#x00026;author=S.+DiMauro&#x00026;author=M.+Hirano&#x00026;journal=Nat+Rev+Genet&#x00026;publication_year=2012&#x00026;volume=13&#x00026;pages=878&#x02013;90&#x00026;doi=10.1038/nrg3275&#x00026;pmid=23154810" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B179"></a>179. Itsara LS, Kennedy SR, Fox EJ, Yu S, Hewitt JJ, Sanchez-Contreras M, et al. Oxidative stress is not a major contributor to somatic mitochondrial DNA mutations. <i>PLoS Genet</i> (2014) 10(2):e1003974. doi:10.1371/journal.pgen.1003974</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1371/journal.pgen.1003974" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Oxidative+stress+is+not+a+major+contributor+to+somatic+mitochondrial+DNA+mutations&#x00026;author=L.+S.+Itsara&#x00026;author=S.+R.+Kennedy&#x00026;author=E.+J.+Fox&#x00026;author=S.+Yu&#x00026;author=J.+J.+Hewitt&#x00026;author=M.+Sanchez-Contreras&#x00026;journal=PLoS+Genet&#x00026;publication_year=2014&#x00026;volume=10&#x00026;pages=e1003974&#x00026;doi=10.1371/journal.pgen.1003974" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B180"></a>180. Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, et al. mtDNA mutations increase tumorigenicity in prostate cancer. <i>Proc Natl Acad Sci U S A</i> (2005) 102(3):719&#x02013;24. doi:10.1073/pnas.0408894102</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=15647368" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1073/pnas.0408894102" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=mtDNA+mutations+increase+tumorigenicity+in+prostate+cancer&#x00026;author=J.+A.+Petros&#x00026;author=A.+K.+Baumann&#x00026;author=E.+Ruiz-Pesini&#x00026;author=M.+B.+Amin&#x00026;author=C.+Q.+Sun&#x00026;author=J.+Hall&#x00026;journal=Proc+Natl+Acad+Sci+U+S+A&#x00026;publication_year=2005&#x00026;volume=102&#x00026;pages=719&#x02013;24&#x00026;doi=10.1073/pnas.0408894102&#x00026;pmid=15647368" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p style="margin-left:0.7em; text-indent:-2.3em;" class="ReferencesCopy1"><a id="B181"></a>181. Zhou S, Kachhap S, Sun W, Wu G, Chuang A, Poeta L, et al. Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. <i>Proc Natl Acad Sci U S A</i> (2007) 104(18):7540&#x02013;5. doi:10.1073/pnas.0610818104</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=17456604" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1073/pnas.0610818104" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?title=Frequency+and+phenotypic+implications+of+mitochondrial+DNA+mutations+in+human+squamous+cell+cancers+of+the+head+and+neck&#x00026;author=S.+Zhou&#x00026;author=S.+Kachhap&#x00026;author=W.+Sun&#x00026;author=G.+Wu&#x00026;author=A.+Chuang&#x00026;author=L.+Poeta&#x00026;journal=Proc+Natl+Acad+Sci+U+S+A&#x00026;publication_year=2007&#x00026;volume=104&#x00026;pages=7540&#x02013;5&#x00026;doi=10.1073/pnas.0610818104&#x00026;pmid=17456604" target="_blank">Google Scholar</a></p></div>
</div>
<div class="thinLineM20"></div>
<div class="AbstractSummary">
<p><span>Keywords:</span> mitochondria, cancer, metabolism, bioenergetics, hypoxia</p>
<p><span>Citation:</span> Chattopadhyay E and Roy B (2017) Altered Mitochondrial Signalling and Metabolism in Cancer. <i>Front. Oncol.</i> 7:43. doi: 10.3389/fonc.2017.00043</p>
<p id="timestamps"><span>Received:</span> 17 January 2017; <span>Accepted:</span> 03 March 2017;<br/> <span>Published:</span> 20 March 2017</p>
<div>
<p>Edited by:</p>
<a href="http://www.frontiersin.org/people/u/172855">Nad&#x000E8;ge Bellance</a> University of Bordeaux, France</div>
<div>
<p>Reviewed by:</p>
<a href="http://www.frontiersin.org/people/u/298374">Giovanni Sorrentino</a>, Laboratorio Nazionale CIB, Italy<br/> <a href="http://www.frontiersin.org/people/u/246282">Juan Antonio Rosado Dionisio</a>, University of Extremadura, Spain</div>
<p><span>Copyright:</span> &#x000A9; 2017 Chattopadhyay and Roy. This is an open-access article distributed under the terms of the <a rel="license" href="http://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons Attribution License (CC BY)</a>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
<p><span>*Correspondence:</span> Bidyut Roy, <a href="mailto:broy&#x00040;isical.ac.in">broy&#x00040;isical.ac.in</a></p>
<div class="clear"></div>
</div>                
                <div class="thin-line-dark"></div>
                    <div class="social-feed"></div>
              
            </div>
        </div>
    </div>
</div>

            <div class="clearfix visible-sm"></div>

            
    <div class="c col-xs-12 col-sm-12 col-lg-2 col-md-3 pull-right side-article related right-container-articles" style="clear: right !important">
        
        <div class="widget-listing commentary-article hidden">
            <h4>COMMENTARY</h4>
        </div>

        <div class="widget-listing original-article hidden">
            <h4>ORIGINAL ARTICLE</h4>
        </div>

        <div class="widget-listing people-also-looked-at side-article-related hidden">
            <h4>People also looked at</h4>
        </div>
            <div class="side-article-mrk clearfix hidden-md hidden-lg">
                <style type="text/css"><!--
.spotlight-title:hover,
.spotlight-title:focus {
 color: #555 !important; 
}
.spotlight-link {
 color: #f2b12f !important;
}
.spotlight-link:hover,
.spotlight-link:focus {
 color: #e5a812 !important;
}
--></style>
<div class="spotlight"><a href="https://blog.frontiersin.org/2016/11/25/second-annual-frontiers-spotlight-award-announced-for-2018/" target="_blank"><img src="http://e01f3a53c0bf5cbade8a-d4a9ca15fc46ba40e71f94dec0aad28c.r40.cf1.rackcdn.com/article-marketing-message-cbd91558-e517-4b02-9a0c-98fd19c36511.jpeg" alt="" /></a>
<h3 style="font-weight: 500;"><a class="spotlight-title" tabindex="0" href="https://blog.frontiersin.org/2016/11/25/second-annual-frontiers-spotlight-award-announced-for-2018/" target="_blank">Win $100,000 to host your own conference.</a></h3>
<a class="spotlight-link" href="https://blog.frontiersin.org/2016/11/25/second-annual-frontiers-spotlight-award-announced-for-2018/" target="_blank">Submit your Research Topic</a></div>
            </div>


    </div>


        </div>
    </div>
</div>
<div id="divTemplates">
    <div class="modal fade modal-container impact-modal-container" data-backdrop="static" id="impactModal" tabindex="-1" role="dialog" aria-labelledby="myModalLabel" aria-hidden="true">
</div>






<script type="text/template" id="template-impact-modal">

    <div class="container">
        <div class="row">
            <div style="padding-bottom: 100px">
                <div class="modal-dialog">
                    <div class="modal-content">
                        <div class="modal-header clearfix">
                            <button type="button" class="close btn-close" data-dismiss="modal" aria-hidden="true">&times;</button>
                            <h3 class="modal-title" id="myModalLabel">Impact</h3>
                            <h6>
                                <a href="javascript:void(0)" class="article-title" data-dismiss="modal" aria-hidden="true">
                                    Altered Mitochondrial Signalling and Metabolism in Cancer
                                </a>
                            </h6>
                        </div>
                        <div class="modal-body">
                            <img class="loader" src="/Images/Frontiers/Common/Icon/loading.gif" alt="Loading.." />

                            <div class="row article-impact-tabs hidden">
                                <!-- Nav tabs -->
                                <ul class="nav nav-tabs impact-tabs clearfix">
                                    <li class="active nav-tab-views"><a href="#views-tab" data-toggle="tab" data-tab-type="views" data-tracking='{ "category": "AP_Action", "action": "button", "label": "impact-tab-goto-views" }' ><span class="total-views" data-tab-type="views"></span>Views</a></li>
                                    <li class="nav-tab-citations"><a href="#citations-tab" data-toggle="tab" data-tab-type="citations" data-tracking='{ "category": "AP_Action", "action": "button", "label": "impact-tab-goto-citations" }'><span class="highest-Citation" data-tab-type="citations"></span>Citations</a></li>
                                    <li class="nav-tab-demographics"><a href="#demographics-tab" data-toggle="tab" data-tab-type="demographics" data-tracking='{ "category": "AP_Action", "action": "button", "label": "impact-tab-goto-demographics" }'>Demographics</a></li>
                                        <li class="nav-tab-social-buzz"><a href="#social-buzz-tab" data-toggle="tab" data-tab-type="socialbuzz" data-tracking='{ "category": "AP_Action", "action": "button", "label": "impact-tab-goto-social-buzz" }'>Social Buzz</a></li>
                                </ul>
                                <div class="tab-content impact-tabs">
                                    <!-- VIEWS TAB -->
                                    <div class="tab-pane active" id="views-tab">
                                        <h5 style="padding-left: 68px; display: none;" class="sincebeginning">Since beginning</h5>
                                        <h5 style="padding-left: 68px; display: none;" class="thisyear">Last 12 months</h5>
                                        <h5 style="padding-left: 68px; display: none;" class="thismonth">Last 30 days</h5>


                                        <p style="display: none;height:60px" class="views-empty-message lead">No records found</p>
                                        <div class="chart-container">
                                            <p class="info sincebeginning" style="display: none;"><strong class="begin-views-downloads download-font-styles"> </strong> views and downloads <strong class="begin-views year-font-styles"> </strong> views <strong class="begin-downloads year-font-styles"> </strong> downloads</p>
                                            <p class="info thisyear" style="display: none;"><strong class="year-views-downloads download-font-styles"> </strong> views and downloads <strong class="year-views year-font-styles"> </strong> views <strong class="year-downloads year-font-styles"> </strong> downloads</p>
                                            <p class="info thismonth" style="display: none;"><strong class="month-views-downloads download-font-styles"> </strong> views and downloads <strong class="month-views year-font-styles"> </strong> views <strong class="month-downloads year-font-styles"> </strong> downloads</p>
                                            <div id="views-timeline-chart" class="views-bar-charts"></div>
                                            <div id="views-bar-chart" class="views-timeline-charts"></div>
                                        </div>
                                        <div id="views-chart-controls" class="input-block-level" style="display: none;">
                                            <!-- Split button -->
                                            <div class="btn-group pull-right">
                                                <button type="button" class="btn btn-flat dropdown-toggle" data-toggle="dropdown" >
                                                    <span id="Period" data-bind="label">Select a time period</span>&nbsp;<span class="caret"></span>
                                                </button>
                                                <ul id="PeriodDrop" class="dropdown-menu" role="menu">
                                                    <li class="beginning" ><a>Since beginning</a></li>
                                                    <li class="year"><a>Last 12 months</a></li>
                                                    <li class="month"><a>Last 30 days</a></li>
                                                </ul>
                                            </div>
                                            <div style="padding-left: 72px;" class="btn-group pull-left" data-toggle="tooltip" title="Toggle between timeline and bar chart views">
                                                <button type="button" class="btn btn-flat btn-line active" id="views-timeline-button">
                                                    <span style="padding: 0 4px">&nbsp;&nbsp;</span>
                                                </button>
                                                <button type="button" class="btn btn-flat btn-line" id="views-bar-button">
                                                    <span style="padding: 0 4px">&nbsp;&nbsp;</span>
                                                </button>

                                            </div>
                                            <div class="clearfix"></div>
                                        </div><!-- /#views-chart-controls -->

                                    </div><!-- /#views-tab -->
                                    <!-- CITATIONS TAB -->
                                    <div class="tab-pane " id="citations-tab">
                                        <img class="citation-loader" src="/Images/Frontiers/Common/Icon/loading.gif" alt="Loading.." />
                                        <div style="width: 350px; margin: 0 auto;" class="citation-container hidden">
                                            <h5 style="text-align:center; margin-bottom: 0; padding-bottom: 0;">Article Citations</h5>
                                            <div class="scopus" style="width: 50%; float: left; text-align: center;">
                                                <a href= "http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;doi=10.3389/fonc.2017.00043&amp;origin=inward" data-tracking='{ "category": "AP_Action", "action": "link", "label": "goto-scopus" }'><h5><span class="repository">by Scopus</span></h5></a>
                                                <!-- Split button -->
                                                <div class="citation-count-container">
                                                    <div class="citation-panel">
                                                        <p class="citation-count"><span class="citaion-scopus"></span></p>
                                                    </div><!-- /.citation-panel -->
                                                </div><!-- /.well -->
                                            </div>

                                            <div class="crossref" style="width: 50%; float: right; text-align: center;">
                                                <a href="http://www.crossref.org/" data-tracking='{ "category": "AP_Action", "action": "link", "label": "goto-crossref" }'><h5><span class="repository">by CrossRef</span></h5></a>
                                                <!-- Split button -->
                                                <div class="clearfix"></div>
                                                <div class="citation-count-container">
                                                    <div class="citation-panel">
                                                        <p class="citation-count"><span class="citation-crossref"></span></p>
                                                    </div><!-- /.citation-panel -->

                                                </div><!-- /.well -->
                                            </div>
                                            <div class="clearfix"></div>
                                        </div>
                                    </div><!-- /#citations-tab -->
                                    <!-- DEMOGRAPHICS TAB -->
                                    <div class="tab-pane " id="demographics-tab">

                                        <div class="btn-group pull-right" id="demographics-dropdown" style="margin-right: 10px;">
                                            &nbsp;
                                        </div>

                                        <div id="map-container">

                                            <div id="map">

                                            </div>
                                            <img class="map-loading" src="/Images/Frontiers/Common/Icon/loading.gif" alt="Loading.." />
                                        </div>
                                        <div class="clearfix"></div>

                                        <div class="row">
                                            <div class="col-xs-6">
                                                <h5>Top countries</h5>
                                                <div id="demographics-top-countries"></div>
                                            </div>
                                            <div class="col-xs-6">
                                                <h5>Top referring sites</h5>
                                                <div id="demographics-top-sites"></div>
                                            </div>
                                        </div>
                                        <hr>
                                        <div class="row">
                                            <div class="col-xs-4">
                                                <h5 style="text-align: center;">Domain</h5>
                                                <div id="demographics-domain"></div>
                                            </div>
                                            <div class="col-xs-4">
                                                <h5 style="text-align: center;">Field</h5>
                                                <div id="demographics-field"></div>
                                            </div>
                                            <div class="col-xs-4">
                                                <h5 style="text-align: center;">Specialty</h5>
                                                <div id="demographics-specialty"></div>
                                            </div>
                                        </div>
                                        <hr>
                                        <div class="row">
                                            <div class="col-xs-4">
                                                <h5 style="text-align: center;">Industry</h5>
                                                <div id="demographics-industry"></div>
                                            </div>

                                            <div class="col-xs-4">
                                                <h5 style="text-align: center;">Education</h5>
                                                <div id="demographics-education"></div>
                                            </div>

                                            <div class="col-xs-4">
                                                <h5 style="text-align: center;">Position</h5>
                                                <div id="demographics-position"></div>
                                            </div>
                                          
                                        </div>
                                        <div class="clearfix"></div>

                                        <div class="demographics-age-gender">
                                            <hr>
                                            <h5 style="margin: 35px 0px;">Age and Gender</h5>
                                            <div id="demographics-age" style="min-width: 800px; height: 400px; margin: 0 auto"></div>
                                        </div>
                                    </div><!-- /#demographics-tab -->
                                        <!-- SOCIAL BUZZ TAB -->
                                        <div class="tab-pane " id="social-buzz-tab">
                                            <h5 class="altmetric-title">Altmetric</h5>
                                            <div id="altmetric-donut" data-badge-details="right" data-badge-type="medium-donut" data-doi="<%- doi %>" data-hide-no-mentions="false" class="altmetric-embed"></div>

                                            <div id='main' class="social-buzz-content-area hidden">
                                                <div id='content'>
                                                    <div id='details'>
                                                        <div class="row">
                                                            <div class="col-xs-6">
                                                                <h5>Sources</h5>
                                                            </div>
                                                            <div class="col-xs-6">
                                                                <ul class="nav nav-tabs pull-right">
                                                                    <li class='active'><a href="#altmetric-all-tab"  data-toggle="tab">All</a></li>
                                                                    <li id='tab_for_msm'><a href="#details_msm" data-toggle="tab">News</a></li>
                                                                    <li id='tab_for_blogs'><a href="#details_blogs" data-toggle="tab">Blogs</a></li>
                                                                </ul>
                                                            </div>
                                                        </div>

                                                        <div class="tabbable">
                                                            <div class="tab-content">

                                                                <div class='details tab-pane ' id='details_blogs'>

                                                                    <div class="blogs-posts"></div>
                                                                </div> <!--Blog-->

                                                                <div class='details tab-pane' id='details_msm'>

                                                                    <div class="news-posts"></div>
                                                                </div> <!--News-->

                                                                <div class='details tab-pane active' id='altmetric-all-tab'>
                                                                    <div class="all-posts"></div>
                                                                </div> <!--All-->

                                                            </div>
                                                        </div>

                                                    </div>

                                                    <div class='clearfix'></div>
                                                </div>
                                            </div>

                                        </div>
                                        <!-- /#social-buzz-tab -->
                                </div>
                            </div><!-- /.row -->

                        </div><!-- /.modal-body -->
                        <div class="modal-footer">
                            <span class="modal-footer-pmc">The displayed data aggregates results from <a href="http://www.frontiersin.org">Frontiers</a> and <a href="http://www.ncbi.nlm.nih.gov/pmc/">PubMed Central®</a>.</span>
                            <button type="button" class="btn btn-new-orange btn-flat btn-close" data-dismiss="modal">Close</button>
                        </div>
                    </div><!-- /.modal-content -->
                </div><!-- /.modal-dialog -->
            </div><!-- /.col-xs-9 -->
        </div><!-- /.row -->
    </div><!-- /.container -->

</script>



<script type="text/template" id="template-social-buzz-blogs-posts">
    <div class='posts_info'>So far Altmetric has seen <b><%- blogsCount %></b> posts.</div>
    <% _.each( socialBuzzPosts, function( socialBuzzPost ){ %>

    <div class='postbox'>
        <div class='title'><a target='_blank' href="<%- socialBuzzPost.Url%>" ><%- socialBuzzPost.Title %></a></div>
        <div class='source'><a target='_blank' href="<%- socialBuzzPost.Author.Url %>" ><%- socialBuzzPost.Author.Name %></a></div>
        <div class='snippet'>
            <p><%- socialBuzzPost.Summary %></p>
        </div>
        <div class="footer blog">
            <%-  FRArticleImpact.formattedPostedDate(socialBuzzPost.PostedOn) %>
        </div>
    </div>

    <% }); %>

</script>


<script type="text/template" id="template-social-buzz-news-posts">
    <div class='posts_info'>So far Altmetric has seen <b><%- newsCount %></b> stories.</div>
    <% _.each( socialBuzzPosts, function( socialBuzzPost ){ %>
    <div class='postbox'>
        <div class='author source' style='width: 80px;'>
            <div style='max-width: 80px; overflow: hidden;'>
                <img width='80' src="<%- socialBuzzPost.Author.Image %>" class="photo" />
            </div>
        </div>

        <div class="entry-content" style="margin-left: 0px;">
            <div class='title'>
                <a target='_blank' href="<%- socialBuzzPost.Url%>"><%- socialBuzzPost.Title %> </a>
            </div>
            <div class='source'><%- socialBuzzPost.Author.Name %></div>
            <div class='snippet'>
                <p><%- socialBuzzPost.Summary %></p>
            </div>
        </div>
        <div class="footer">
            <%-  FRArticleImpact.formattedPostedDate(socialBuzzPost.PostedOn) %>
        </div>
    </div>

    <% }); %>

</script>


<script type="text/template" id="template-social-buzz-all-posts">

    <div class="posts_info">So far Altmetric has seen <b><%- allCount %></b> stories.</div>

    <% _.each( socialBuzzPosts, function( socialBuzzPost ){ %>
    <% if (socialBuzzPost.Type == "Blogs") {%>

    <div class='postbox'>
        <div class='title'><a target='_blank' href="<%- socialBuzzPost.Url%>" ><%- socialBuzzPost.Title %></a></div>
        <div class='source'><a target='_blank' href="<%- socialBuzzPost.Author.Url %>" ><%- socialBuzzPost.Author.Name %></a></div>
        <div class='snippet'>
            <p><%- socialBuzzPost.Summary %></p>
        </div>
        <div class="footer blog">
            <%-  FRArticleImpact.formattedPostedDate(socialBuzzPost.PostedOn) %>
        </div>
    </div>

    <% } %>
    <%  if(socialBuzzPost.Type == "News"){ %>
    <div class='postbox'>
        <div class='author source' style='width: 80px;'>
            <div style='max-width: 80px; overflow: hidden;'>
                <img width='80' src="<%- socialBuzzPost.Author.Image %>" class="photo" />
            </div>
        </div>

        <div class="entry-content" style="margin-left: 0px;">
            <div class='title'>
                <a target='_blank' href="<%- socialBuzzPost.Url%>"><%- socialBuzzPost.Title %> </a>
            </div>
            <div class='source'><%- socialBuzzPost.Author.Name %></div>
            <div class='snippet'>
                <p><%- socialBuzzPost.Summary %></p>
            </div>
        </div>
        <div class="footer">
            <%-  FRArticleImpact.formattedPostedDate(socialBuzzPost.PostedOn)%>
        </div>
    </div>
    <% } %>
    <% }); %>

</script>






    <div class="modal fade modal-container supplementary-modal-container" data-backdrop="static" id="supplementaryFilesModal" tabindex="-1" role="dialog" aria-labelledby="mySupplementaryModalLabel" aria-hidden="true">
</div>




<script type="text/template" id="template-supplementary-files-modal">
    <div class="modal-f page-container supplementary-material-wrapper" id="supplementary-material-modal" tabindex="-1" role="dialog" aria-labelledby="mySupplementaryModalLabel">
        <div class="modal-dialog" role="document">
            <div class="modal-content">
                <div class="modal-body">
                    <a class="close" data-dismiss="modal" aria-label="Close"  data-tracking='{ "category": "AP_Action", "action": "button", "label": "supplementary-material-close-click" }'><span aria-hidden="true">×</span></a>
                    <h4>Supplementary Material</h4><br>
                    <p class="supplementary-empty-message">There is no supplementary material currently available for this article</p>
                    <div class="table-responsive">                       
                        <table class="table table-striped supplementary-content">
                            <thead>
                                <tr>
                                    <th>&nbsp;</th>
                                    <th>File Name</th>
                                    <th>&nbsp;</th>
                                </tr>
                            </thead>
                            <tbody class="file-content">
                                <% _.each(supplimentalFileDetails.FileDetails, function(fileViewModel){   %>
                                <tr>
                                    <th scope="row"><a data-test-id="<%= fileViewModel.TestId %>" data-tracking='{ "category": "AP_Action", "action": "button", "label": "supplementary-material-download-click" }' href="<%= fileViewModel.FileDownloadUrl %>"><img class="img-figure" src="<%= fileViewModel.ImageUrl %>"></a></th>
                                    <td>
                                        <a data-tracking='{ "category": "AP_Action", "action": "button", "label": "supplementary-material-download-click" }' href="<%= fileViewModel.FileDownloadUrl %>">
                                            <%= fileViewModel.FileName %>
                                        </a>
                                    </td>
                                    <td><a data-tracking='{ "category": "AP_Action", "action": "button", "label": "supplementary-material-download-click" }' href="<%= fileViewModel.FileDownloadUrl %>" class="btn-link"><i class="fa fa-download" aria-hidden="true"></i></a></td>
                                </tr>
                                <% }); %>
                            </tbody>
                        </table>
                    </div>
                </div>
                <div class="modal-footer bottom-links">
                    <a class="btn btn-default" data-dismiss="modal" data-tracking='{ "category": "AP_Action", "action": "button", "label": "supplementary-material-close-click" }'>Close</a>
                </div>
            </div>

        </div>
    </div>

</script>







    <div class="modal fade modal-container notifyme-modal-container" data-backdrop="static" id="notifyModal" tabindex="-1" role="dialog" aria-labelledby="Notify on publication" aria-hidden="true">
</div>






<script type="text/template" id="template-notify-me-modal">
    <div class="modal-f page-container simple-modal"   role="dialog" aria-labelledby="NotfifyMeModalLabel">
            <div class="modal-dialog" role="document">
                <div class="modal-content">
                    <form onsubmit="return false" id="modalnotifyme">
                                 <div class="modal-header">
                                <button type="button" class="close" data-dismiss="modal" aria-label="Close"><span aria-hidden="true">×</span></button>
                                <h3>Notify me on publication</h3>
                            </div>
                            <div class="modal-body">

                                <div class="form-group">
                                    <label>Please enter your email address:</label>
                                    <input type="email" required class="form-control" id="notifyMeEmail" placeholder="Email">

                                </div>
                                <p class="small" style="color: #555;">If you already have an account, please <a href="<%=login.FrontiersLoginUrl%>?returnUrl=<%=currentPage%>" class="text-blue">login</a>.</p>
                                <p class="small" style="color: #555;">You don't have a Frontiers account ? You can, please <a href="<%=login.FrontiersRegistrationUrl%>" class="text-blue">register here</a>.</p>


                            </div>
                            <div class="modal-footer">
                                <button type="button" id="article_notifynonregistereduser" class="btn btn-default btn-progress" style="width: 118px;">Notify me</button>
                            </div>
                        </form>
                </div>

            </div>

        </div>


    

</script>

<script type="text/template" id="template-notifyme-mailselection-modal">
    <div class="modal-f page-container simple-modal" tabindex="-1" role="dialog" aria-labelledby="NotfifyMeModalLabel">
        <div class="modal-dialog" role="document">
            <div class="modal-content">
                <div class="modal-header">
                    <button type="button" class="close" data-dismiss="modal" aria-label="Close"><span aria-hidden="true">×</span></button>
                    <h3>Select one of your emails</h3>
                </div>
                <div class="modal-body">
                    <form>
                        <div class="form-group">
                            <label>You have multiple emails registered with Frontiers:</label>
                          
                        </div>
                                           
                        <% _.each(userEmailList, function(user){   %>
                        <input type="radio" value="<%=user%>"  name="notify_Emailcollection" > <%=user%><br>
                        <% }); %>

                    </form>
                </div>
                <div class="modal-footer">
                    <button type="button" id="article_notifyloggedinuser" class="btn btn-default btn-progress" style="width: 118px;">Notify me</button>
                </div>
            </div>

        </div>

    </div>
</script>

<script type="text/template" id="template-notifyme-error-modal">
    <div class="modal-f page-container simple-modal" tabindex="-1" role="dialog" aria-labelledby="NotfifyMeModalLabel">
        <div class="modal-dialog" role="document">
            <div class="modal-content">
                <div class="modal-header">
                    <button type="button" class="close" data-dismiss="modal" aria-label="Close"><span aria-hidden="true">×</span></button>
                    <h3>Notify me on publication</h3>
                </div>
                <div class="modal-body">
                    <form>
                        <div class="form-group">
                            <p class="text-red"><strong>An error occured. Please try again later.</strong></p>

                        </div>

                    </form>
                </div>
                <div class="modal-footer">
                    <button type="button" data-dismiss="modal"   class="btn btn-default btn-progress" style="width: 118px;">Cancel</button>
                </div>
            </div>

        </div>

    </div>




</script>







</div>

        </div>

        
<div class="footer-new">
    <div class="container-fluid main-container-xxl">
        <div class="col-lg-2 col-lg-offset-2 col-md-3 col-sm-3">
            <ul class="list-unstyled">
                <li><a href="http://www.frontiersin.org/Journal/Frontiers.aspx">Home</a></li>
                <li><a href="http://www.frontiersin.org/about">About Frontiers</a></li>
                <li><a href="http://www.frontiersin.org/about/journalseries">Journals A-Z</a></li>
                <li><a href="http://www.frontiersin.org/about/Institutional_Membership">Institutional Membership</a></li>

            </ul>
        </div>
        <div class="col-lg-2 col-md-3 col-sm-3">
            <ul class="list-unstyled">
                <li><a href="http://www.frontiersin.org/about/contact">Contact</a></li>
                <li><a href="http://www.frontiersin.org/press">Media Relations</a></li>
                <li><a href="http://www.frontiersin.org/news/all_news">News</a></li>
                <li><a href="http://blog.frontiersin.org">Blog</a></li>
            </ul>
        </div>
        <div class="col-lg-2 col-md-3 col-sm-3">
            <ul class="list-unstyled">
                <li><a href="http://www.frontiersin.org/submissioninfo">Submit</a></li>
                <li><a target="_blank" href="https://frontiers.zendesk.com/hc/en-us">FAQs</a></li>
                <li><a href="http://www.frontiersin.org/TermsandConditions.aspx">Terms &amp; Conditions</a></li>
            </ul>
        </div>
        <div class="col-lg-2 col-md-3 col-sm-3">
            <ul class="list-unstyled">
                <li><a href="http://connect.frontiersin.org/subscriptions/subscribe">Newsletters</a></li>
                <li><a href="http://www.frontiersin.org/blog/Frontiers_Social_Media_and_RSS/496">RSS/Twitter</a></li>
                <li><a href="http://www.frontiersin.org/Team.aspx">Team</a></li>
                <li><a href="http://www.frontiersin.org/Careers">Careers</a></li>
            </ul>
        </div>
    </div>
</div>


<div class="footer-copyright-new">
    <div class="container-fluid main-container-xxl">
        <div class="col-md-12 text-center"> © 2007 - 2015 Frontiers Media S.A. All Rights Reserved </div>
    </div>
</div>


        <script src="//code.jquery.com/jquery-2.1.3.min.js"></script>

        
<script src="http://code.jquery.com/ui/1.10.2/jquery-ui.min.js"></script>
<script src="https://crossmark.crossref.org/javascripts/v1.5/crossmark.min.js"></script>
            <script type="text/javascript">

                var $ = jQuery.noConflict(); //==>>ToDo: Avoid this..!!
            </script>
        
        <script src="//maxcdn.bootstrapcdn.com/bootstrap/3.3.1/js/bootstrap.min.js"></script>

        <script src="/article/js/vendors?v=m3ItdAkHsKHA4JnU2Jk5BuO77bBpDeX0_4_qxHTdIcE1"></script>

        
        <script src="http://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
 

        <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script>
 

        <script src="/article/js/frontiers?v=QBOenRRnKrAm_Bji6Grk2qOq3MVi7GyktSLviyr4Mt81"></script>


        <script type="text/javascript">
            var FRArticle = (function() {
                return {
                    ArticleId: '254974',
                    DOI:'10.3389/fonc.2017.00043',
                    LoginUserId: '0',
                    DomainId: '2',
                    FieldId: '57',
                    SpecialityId: '1228',
                    IsPreview: FRSafe.boolean('False'),
                    IsViewImpactFromLoop: FRSafe.boolean('True'),
                    IsPublished : 'True'
                };
            })();

            var FRSocial = (function() {
                return {
                    itemId: 14,
                    itemTypeId: 1,
                    entityId: '254974',
                    ownerId: '400260',
                    sanPath: 'http://www.frontiersin.org/files/',
                    subItemId: '8',
                    loginUserId: '0',
                    ownerNWDBId: '21',
                    pageType: 1,
                    loopUrl:'http://loop.frontiersin.org'
                };
            })();
        </script>

        <script src="https://api-journal.frontiersin.org/areas/header/content/scripts/frontiers.header.v3.js"></script><script src="https://api-journal.frontiersin.org/header/taxonomy?v=1504596422652"></script><script src="https://api-journal.frontiersin.org/header/userprofile"></script>

        <script type="text/javascript">

            if (!FRArticle.IsPreview) {

                (function(i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function() {
                        (i[r].q = i[r].q || []).push(arguments);
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o),
                    m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m);
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');

                ga('create', 'UA-9164039-1', 'frontiersin.org');
                ga('send', 'pageview');
            }
        </script>

        
        <script src="/article/js/app?v=4Jk-DXDpgEZ_VPqWw1n7BYzfSl5nGRiJNQig7mnF0Io1"></script>

        
    </body>
</html>
